Publications 2000 - 2017

Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Blot W, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, and the PRACTIAL Consortium, Donovan J, Munafò MR.
Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.
International Journal of Cancer 2017; 140:322-328.

Brunner C, Davies NM, Martin RM, Eeles R, Easton DF,…, Brenner H,…, Teixeira MR, Pandha H, the PRACTICAL Consortium, Zuccolo L.
Alcohol consumption and prostate cancer incidence and progression: a Mendelian randomization study.
International Journal of Cancer 2017; 140:75-85.

Maierthaler M, Benner A, Hoffmeister M, Surowy H, Jansen L, Knebel P, Chang-Claude J, Brenner H, Burwinkel B.
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
International Journal of Cancer 2017; 140:176-187.

Weischenfeldt J, Dubash T, Drainas A, Mardin B, Chen Y, Stuetz A, Waszak S, Bosco G, Halvorsen AR, Raeder B, Efthymiopoulos T, Brenner H, Brustugun OT, Dieter S, Northcott P, Petersen I, Pfister S, Schneider M, Solberg S, Thunnissen E, Weichert W, Zichner T, Thomas R, Peifer M, Helland A, Ball C, Jechlinger M, Sotillo R, Glimm H, Siegl C, Korbel J.
Pan-cancer analysis of somatic copy number alterations implicates IRS4 and IGF2 in enhancer hijacking.
Nature Genetics 2017; 49:65-74.

Heiss JA, Breitling LP, Lehne B, Kooner JS, Chambers JC, Brenner H.
Training a model for estimating leukocyte composition using whole blood DNA methylation and cell counts as reference.
Epigenomics 2017; 9:13-20.

Jankovic N, Geelen A, Winkels RM, Mwungura B, Fedirko V, Jenab M, Illner AK, Brenner H, Ordonez-Mena JM, Kiefte-de Jong JC, Franco OH, Orfanos P, Trichopoulou A, Boffetta P, Agudo A, Peeters PH, Tjonneland A, Hallmans G, Bueno-de-Mesquita HB, Park Y, Feskens EJ, de Groot LC, Kampman E.
Adherence to the WCRF/AICR dietary recommendations for cancer prevention and risk of cancer in elderly from Europe and the United States: A Meta-Analysis within the CHANCES project.
Cancer Epidemiology, Biomarkers and Prevention 2017; 26:136-144.

Skender S, Böhm J, Schrotz-King P, Chang-Claude J, Siegel EM, Steindorf K, Owen RW, Ose J, Hoffmeister M, Brenner H, Ulrich CM.
Plasma 25-hydroxyvitamin D3 levels in colorectal cancer patients and associations with physical activity. 
Nutrition and Cancer 2017; 69:229-237.

Zhang Y, Hapala J, Brenner H, Wagner W.
Individual CpG sites that are associated with age and life expectancy become hypomethylated upon aging.
Clinical Epigenetics 2017; 9:9.

Logan CA, Bornemann R, König W, Reister F, Walter V, Fantuzzi G, Weyermann M, Brenner H, Genuneit J, Rothenbacher D.
Gestational weight gain and fetal-maternal adiponectin, leptin, and CRP: results of two birth cohorts studies.
Scientific Reports 2017; 7:41847.

Hoffmeister M, Holleczek B, Zwink N, Stock C, Stegmaier C, Brenner H.
Darmkrebsscreening – Steigerung der Teilnahmeraten durch persönliche Einladung.
Eine randomisierte Interventionsstudie.
Deutsches Ärzteblatt International 2017; 114:87-93.

Brenner H, Zwink N, Ludwig L, Hoffmeister M.
Should screening colonoscopy be offered from age 50 on? Participation rates and findings at colonoscopy in a statewide model project and results of a randomized intervention trial.
Deutsches Ärzteblatt International 2017; 114:94-100.

Pulte D, Castro FA, Brenner H, Jansen L.
Outcome disparities by insurance type for patients with acute myeloblastic leukemia.
Leukemia Research 2017; 56:75-81.

Katsoulis M, Benetou V, Karapetyan T, Feskanich D, Grodstein F, Kymmer U, Eriksson S, Wilsgaard T, Jorgensen L, Ahmed L, Schöttker B, Brenner H, Bellavia A, Wolk A, Kubinova R, Stegeman B, Bobak M, Boffetta P, Trichopoulou A.
Excess mortality after hip fractures in elderly from Europe and United States: the CHANCES project.
Journal of Internal Medicine 2017; 281:300-310.

Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schöttker B.
Association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies.
Journal of the American Medical Directors Association 2017; 18:211-220.

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H.
Quality of life in long-term and very long-term cancer survivors versus population controls in Germany.
Acta Oncologica 2017; 56:190-197.

Saum KU, Schöttker B, Meid A, Holleczek B, Haefeli W, Hauer K, Brenner H.
Is polypharmacy associated with frailty in older people? Results from the ESTHER Cohort Study.
Journal of the American Geriatrics Society 2017; 65:e27-e32.

Gao X, Zhang Y, Saum KU, Schöttker B, Breitling LP, Brenner H.
Tobacco smoking and smoking-related DNA methylation are associated with the development of frailty among older adults.
Epigenetics 2017; 12:149-156.

Wieland E, Rodriguez-Vita J, Liebler SS, Mogler C, Moll I, Herberich SE, Espinet E, Herpel E, Menuchin A, Chang-Claude J, Hoffmeister M, Gebhardt C, Brenner H, Trumpp A, Siebel CW, Hecker M, Utikal J, Sprinzak D, Fischer A.
Endothelial Notch1 activity facilitates metastasis.
Cancer Cell 2017; 31:355-367.

Heiss JA, Brenner H.
Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Clinical Epigenetics 2017; 9:24.

Brenner H, Niedermaier T, Chen H.
Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
International Journal of Cancer 2017; 140:2015-2022.

Pulte D, Jansen L, Brenner H.
Population level differences in rectal cancer survival in uninsured patients are partially explained by differences in treatment.
The Oncologist 2017; 22:351-358.

Fehringer G, Brenner DR, Zhang ZF, Lee YCA, Matsuo K,…, Brenner H,…, Consonni D, Olsson A, Straif K, Hung RJ.
Alcohol and lung cancer risk among never smokers: a pooled analysis from the International Lung Cancer Consortium and the SYNERGY study.
International Journal of Cancer 2017; 140:1976-1984.

Walter V, Jansen L, Knebel P, Chang-Claude J, Hoffmeister M, Brenner H.
Physical activity and survival of colorectal cancer patients: population-based study from Germany.
International Journal of Cancer 2017; 140:1985-1997.

Hajek A, Bock J-O, Brenner H, Saum K-U, Matschinger H, Haefeli WE, Quinzler R, Heider D, König H-H.
Welche Faktoren beeinflussen die privaten Zuzahlungen zu Gesundheitsleistungen im Alter? Ergebnisse einer Längsschnittstudie.
Das Gesundheitswesen 2017; 79:e18-e25.

Breitling LP, Mons U, Hahmann H, König W, Rothenbacher D, Brenner H.
The longer, the better? An empirical study of the extent and mechanisms of attenuating biomarker associations in cardiovascular patient cohorts.
Clinical Chemistry 2017; 63:673-682.

Brenner H, Weberpals J, Jansen L.
Epidemiologische Forschung mit Krebsregisterdaten, Überlebenszeitanalysen, Vergleich nationaler und internationaler Ergebnisse.
Der Onkologe 2017; 23:272-279.

Zwink N, Stock C, Birkner B, Hoffmeister M, Brenner H.
Screening colonoscopy volume and detection of colorectal neoplasms: A state-wide study from Bavaria, Germany.
European Journal of Cancer Prevention 2017; 26:181-188.

Berendsen A, Kang J, van de Rest O, Jankovic N, Kampman E, Kiefte-deJong J, Franco O, Ikram A, Pikhart H, Nilsson L, Brenner H, Boffetta P, Rafnsson S, Gustafson D, Kyrozis A, Trichopoulou A, Feskens E, Grodstein F, de Groot L.
Association of adherence to a healthy diet with cognitive decline in European and American older adults: a meta-analysis within the CHANCES consortium.
Dementia and Geriatric Cognitive Disorders 2017; 43:215-227.

Zhang Y, Wilson R, Heiss J, Breitling LP, Saum KU, Schöttker B, Holleczek B, Waldenberger M, Peters A, Brenner H.
DNA methylation signatures in peripheral blood strongly predict all-cause mortality.
Nature Communications 2017; 8:14617.

Zuber V, Bettella F, Witoelar A, PRACTICAL Consortium*, CRUK GWAS, BCAC Consortium, TRICL Consortium, Andreassen OA, Mills IG, Urbanucci A.
Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
BMC Genomics 2017; 18:270.
*Collaborator from DKFZ: Brenner H

Steele CJ, Schöttker B, Marshall AH, Kouvonen A, O’Doherty MG, Mons U, Saum KU, Boffetta P, Trichopoulou A, Brenner H*, Kee F*.
Education achievement and type 2 diabetes – What mediates the relationship in older adults? Data from the ESTHER study: a population-based cohort study.
BMJ Open 2017; 0:e013569.
*shared last authorship

Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R, EUROCARE-5 Working Group*.
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.
European Journal of Cancer 2017; 77:140-152.
*Collaborator from DKFZ: Brenner H

Pulte D, Jansen L, Brenner H.
Social disparities in survival after diagnosis with colorectal cancer: contribution of race and insurance status.
Cancer Epidemiology 2017; 48:41-47.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P,…, Brenner H,…, Pharoah PDP, Chenevix-Trench G, Blomqvist C, Nevanlinna H.
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.
Oncotarget 2017; 8:18381-18398.

Mayer T, Meid AD, Saum KU, Brenner H, Schöttker B, Seidling HM, Haefeli WE.
Comparison of nine instruments to calculate anticholinergic load in a large cohort of older outpatients: association with cognitive and functional decline, falls, and use of laxatives.
American Journal of Geriatric Psychiatry 2017; 25:531-540.

NCD Risk Factor Collaboration (NCD-RisC)*.
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1,479 population-based measurement studies with 19.1 million participants.
The Lancet 2017; 389:37-55.
*Collaborators on behalf of the ESTHER study: Brenner H, Saum KU.

Ordóñez-Mena JM, Maalmi H, Schöttker B, Saum KU, Holleczek B, Wang TJ, Burwinkel B, Brenner H.
Genetic variants in the vitamin D pathway, 25(OH)D levels, and mortality in a large population-based cohort study.
Journal of Clinical Endocrinology & Metabolism 2017; 102:470-477.

Global Burden of Disease Cancer Collaboration*.
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer Groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study.
JAMA Oncology 2017; 3:524-548.
*Collaborator from DKFZ: Brenner H

Winter A, Sirri E, Jansen L, Wawroschek F, Kieschke J, Castro FA, Krilaviciute A, Holleczek B, Emrich K, Waldmann A, Brenner H, for the Association for Population-based Cancer Registries in Germany (GEKID) Cancer Survival Working Group.
Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
BJU International 2017; 119:550-559.

Sluik D, Jankovic N, Hughes M, O’Doherty MG, Schöttker B,…, Brenner H,…, Iacoviello L, Boffetta P, Kee F, Feskens EJM.
Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project.
European Journal of Clinical Nutrition 2017; 71:659-668.

Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A,…, Brenner H,…, Pandha H, Lu YJ, the PRACTICAL consortium, Park JY.
SNP interaction pattern identifier (SIPI): An intensive search for SNP-SNP interaction patterns.
Bioinformatics 2017; 33:822-833.

Zwink N, Holleczek B, Stegmaier C, Hoffmeister M, Brenner H.
Complication rates in colonoscopy screening for cancer – a prospective cohort study of complications arising during the procedure and in the ensuing four weeks.
Deutsches Ärzteblatt International 2017; 114:321-327.

Freisling H, Arnold M, Soerjomataram I, O’Doherty M, Ordóñez-Mena J, Bamia C, Kampman E, Leitzmann M, Romieu I, Kee F, Tsilidis K, Tjonneland A, Trichopoulou A, Boffetta P, Benetou V, Bueno-de-Mesquita HB, Huerta JM, Brenner H, Wilsgaard T, Jenab M.
Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe.
British Journal of Cancer 2017; 116:1486-1497.

Ben Khedher S, Neri M, Papadopoulos A, Christiani DC, Diao N, Harris CC, Olivo-Marston S, Schwartz AG, Cote M, Koushik A, Siemiatycki J, Landi MT, Hung RJ, McLaughlin J, Duell EJ, Andrew AS, Orlow I, Park BJ, Brenner H, Saum KU, Pesatori AC, Stücker I.
Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium (ILCCO).
International Journal of Cancer 2017; 141:309-323.

Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H,…, Brenner H,..., Murabito JM, Stefansson K, Ong KK, Perry JRB.
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.
Nature Genetics 2017; 49:834-841.

Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Pineros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C, CONCORD Working Group*.
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
Lancet Haematology 2017; 4:e202-e217.
*Collaborator from DKFZ: Brenner H

GBD 2015 Tobacco Collaborators.*
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
The Lancet 2017; 389:1885-1906.
*Collaborators from DKFZ: Brenner H, Schöttker B

Jansen L*, Weberpals J*, Kuiper JG, Vissers PAJ, Wolkewitz M, Hoffmeister M, Brenner H.
Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
International Journal of Cancer 2017; 141:62-71.
*Contributed equally

Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S,…, Brenner H, Arndt V,…, Dennis J, Easton DF, Schmidt MK, Nevanlinna H.
Genetic modifiers of CHEK2*1100delC associated breast cancer risk.
Genetics in Medicine 2017; 19:599-603.

Weberpals J, Jansen L, Haefeli WE, Hoffmeister M, Wolkewitz M, van Herk-Sukel M, Vissers PAJ, Brenner H.
Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
Scientific Reports 2017; 7:2911.

Heiss JA, Brenner H.
Impact of confounding by leukocyte composition on associations of leukocyte DNA methylation with common risk factors.
Epigenomics 2017; 9:659-668.

Carr P, Holleczek B, Stegmaier C, Brenner H, Hoffmeister M.
Meat intake and risk of colorectal polyps: results from a large population based screening study in Germany.
American Journal of Clinical Nutrition 2017; 105:1453-1461.

Weberpals J*, Pulte D*, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H, for the GEKID Cancer Survival Working Group.
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States in the early 21^st century.
Haematologica 2017; 102:e229-e232.
*Contributed equally to the paper

Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L,…, Arndt V,…, Brenner H,…, Goldgar DE, Carreira A, Vreeswijk MPG, Couch FJ.
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer.
Cancer Research 2017; 77:2789-2799.

Arnold A, Kloor M, Jansen L, Chang-Claude J, Brenner H, von Winterfeld M, Hoffmeister M, Bläker H.
The association between microsatellite instability and lymph node count in colorectal cancer.
Virchows Archiv 2017; 471:57-64.

Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF,…, Mons U, Brenner H,…, Fliser D, März W, Scharnagl H, Speer T.
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Lancet Diabetes & Endocrinology 2017; 5:534-543.

Mons U, Brenner H.
Demographic ageing and the evolution of smoking-attributable mortality: the example of Germany.
Tobacco Control 2017; 26:455-457.

Pfetsch V, Sanin V, Jaensch A, Dallmeier D, Mons U, Brenner H, König W, Rothenbacher D.
Increased plasma concentrations of soluble ST2 independently predict mortality but not cardiovascular events in stable coronary heart disease patients: 13-year follow-up of the KAROLA study.
Cardiovascular Drugs and Therapy 2017; 31:167-177.

Brenner H, Chen H.
Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population.
Clinical Epidemiology 2017; 9:377-384.

Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowsky S, Botta L, and the EUROCARE-5 Working Group*.
Geographical variability in survival of European children with central nervous system tumours.
European Journal of Cancer 2017; 82:137-148.
*Collaborator from DKFZ: Brenner H

Reuter B, Sauer T, Gumbinger G, Bruder I, Preussler S, Hacke W, Hennerici MG, Ringleb PA, Kern R, Stock C.
Diurnal variation of intravenous thrombolysis rates for acute ischemic stroke and associated quality performance parameters.
Frontiers in Neurology 2017; 8:341.

Carr PR, Jansen L, Bienert S, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M.
Associations of red and processed meat intake with major molecular pathological features of colorectal cancer.
European Journal of Epidemiology 2017; 32:409-418.

Schöttker B, Saum KU, Muhlack DC, Hoppe LK, Holleczek B, Brenner H.
Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
European Journal of Clinical Pharmacology 2017; 73:1041-1048.

Brenner H, Jansen L, Saum KU, Holleczek B, Schöttker B.
Vitamin D supplementation trials aimed at reducing mortality have much higher power when focusing on people with low serum 25-hydroxyvitamin D concentrations.
Journal of Nutrition 2017; 147:1325-1333.

GBD 2015 Healthcare Access and Quality Collaborators.*
Healthcare access and quality index based on mortality from causes amenable to personal healthcare in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.
Lancet 2017; 390:231-266.
*Collaborators from DKFZ: Brenner H, Schöttker B

Butt J, Werner S, Willhauck-Fleckenstein M, Michel A, Waterboer T, Zörnig I, Boleij A, Dramsi S, Brenner H, Pawlita M.
Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
International Journal of Cancer 2017; 141:897-904.

Gao X, Gào X, Zhang Y, Breitling LP, Schöttker B, Brenner H.
Associations of self-reported smoking, cotinine levels and epigenetic smoking indicators with oxidative stress among older adults: a population-based study.
European Journal of Epidemiology 2017; 32:443-456.

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Ärnlöv J,…, Brenner H,…, Schöttker B,…, Vos T, Global Burden of Disease 2013 GFR Collaborators, CKD Prognosis Consortium, Global Burden of Disease Genitourinary Expert Group.
Global cardiovascular and renal outcomes of reduced GFR.
Journal of the American Society of Nephrology 2017; 28:2167-2179.

Chen C, Läcke E, Stock C, Hoffmeister M, Brenner H.
Colonoscopy and sigmoidoscopy use among older adults in different countries: a systematic review.
Preventive Medicine 2017; 103:33-42.

GBD 2016 Mortality Collaborators.*
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
The Lancet 2017; 390:1084-1150.
*Collaborator from DKFZ: Brenner H

GBD 2016 Risk Factors Collaborators.*
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
The Lancet 2017; 390:1345-1422.
*Collaborator from DKFZ: Brenner H

Breitling LP, Mons U, Hahmann H, König W, Rothenbacher D, Brenner H.
Composite End Points: Implications of changing compositions with longer follow-up.
Circulation: Cardiovascular Quality and Outcomes 2017; 10:e003458.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M, The EUROCARE-5 Working Group.*
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.
European Journal of Cancer 2017; 84:335-353.
*Collaborator from DKFZ: Brenner H

Ordóñez-Mena JM, Schöttker B, Saum KU, Holleczek B, Burwinkel B, Wang TJ, Brenner H.
No association of vitamin D pathway genetic variants with cancer risks in a population-based cohort of German older adults.
Cancer Epidemiology, Biomarkers & Prevention 2017; 26:1459-1461.

Christiansen H, Brandt S, Walter V, Wabitsch M, Rothenbacher D, Brenner H, Schimmelmann BG, Hirsch O.
Prediction of BMI at age 11 in a longitudinal sample of the Ulm Birth Cohort Study.
PLoS ONE 2017; 12:e0182338.

Gao X, Thomsen H, Zhang Y, Breitling LP, Brenner H.
The impact of methylation quantitative trait loci (mQTLs) on active smoking-related DNA methylation changes.
Clinical Epigenetics 2017; 9:87.

Kirchberg FF, Brandt S, Moß A, Peissner W, König W, Rothenbacher D, Brenner H, Koletzko B, Hellmuth C*, Wabitsch M*.
Metabolomics reveals an entanglement of fasting leptin concentrations with fatty acid oxidation and gluconeogenesis in healthy children.
PLoS ONE 2017; 12:e0183185.
*Contributed equally

Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group.
Survival for patients with rare hematologic malignancies: changes in the early 21^st century.
European Journal of Cancer 2017; 84:81-87.

Bamia C, Orfanos P, Juerges H, Schöttker B, Brenner H, Lorbeer R, Aadahl M, Matthews CE, Klinaki E, Katsoulis M, Lagiou P, Bueno-de-Mesquita HBA, Eriksson S, Mons U, Saum KU, Kubinova R, Pajak A, Tamosiunas A, Malyutina S, Gardiner J, Peasey A, de Groot LC, Wilsgaard T, Boffetta P, Trichopoulou A, Trichopoulos D.
Self-rated health and all-cause and cause-specific mortality of older adults. Individual data meta-analysis of prospective cohort studies participating in the CHANCES Consortium.
Maturitas 2017; 103:37-44.

Brenner H, Werner S.
Selecting a cut-off for colorectal cancer screening with a fecal immunochemical test.
Clinical and Translational Gastroenterology 2017; 8:e111.

Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Al Olama AA, Benlloch Garcia S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM, Southey MC, Pharoah P, Pashayan N, Gronberg H, Wiklund F, Aly M, Stanford JL, Brenner H, Dieffenbach AK, Arndt V, Park JY, Lin HY, Sellers T, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA, APCB BioResource, The PRACTICAL consortium, Easton D, Eeles RA, Muir K.
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.
British Journal of Cancer 2017; 117:734-743.

Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F, Chronic Kidney Disease Prognosis Consortium.
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.
Lancet Diabetes & Endocrinology 2017; 5:718-728.
Collaborators from the ESTHER study: Brenner H, Schöttker B, Rothenbacher D, Saum KU

Krilaviciute A, Stock C, Brenner H.
International variation in the prevalence of preclinical colorectal cancer: implications for predictive values of noninvasive screening tests and potential target populations for screening.
International Journal of Cancer 2017; 141:1566-1575.

Amitay EL, Werner S, Vital M, Pieper DH, Höfler D, Gierse IJ, Butt J, Balavarca Y, Cuk K, Brenner H.
Fusobacterium and colorectal cancer: Causal factor or passenger? Results from a large colorectal cancer screening study.
Carcinogenesis 2017; 38:781-788.

Niedermaier T, Weigl K, Hoffmeister M, Brenner H.
Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis & modeling.
European Journal of Epidemiology 2017; 32:481-493.

Meistere I, Werner S, Zayakin P, Siliņa K, Rulle U, Pismennaja A, Šantare D, Kikuste I, Isajevs S, Leja M, Kupčinskas L, Kupčinskas J, Jonaitis L, Wu CY, Brenner H, Linē A, Kalniņa Z.
The prevalence of cancer-associated autoantibodies in patients with gastric cancer and progressive grades of premalignant lesions.
Cancer Epidemiology, Biomarkers & Prevention 2017; 26:1564-1574.

Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, the ELLIPSE consortium, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P, Chang-Claude J, Conti DV, Doherty J, Gruber SB, Harrison TA, Hayes RB, Hoffmeister M, Houlston RS, Hung RJ, Jenkins MA, Kraft P, Lawrenson K, McKay J, Markt S, Mucci L, Phelan CM, Qu C, Risch A, Rossing MA, Wichmann HE, Shi J, Schernhammer E, Yu K, Landi MT, Caporaso NE.
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
International Journal of Cancer 2017; 141:1794-1802.

Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A,…, Brenner H, Arndt V,…, Garcia-Closas M, Easton DF, Milne RL, Chang-Claude J.
Gene-environment interactions involving functional variants: results from the Breast Cancer Association Consortium.
International Journal of Cancer 2017; 141:1830-1840.

Logan CA, Brandt S, Wabitsch M, Brenner H, Wiens F, Stahl S, Marosvölgyi T, Decsi T, Rothenbacher D, Genuneit J.
New approach shows no association between maternal milk fatty acid composition and childhood wheeze or asthma.
Allergy 2017; 72:1374-1383.

Gao X, Zhang Y, Brenner H.
Associations of Helicobacter pylori infection and chronic atrophic gastritis with accelerated epigenetic ageing in older adults.
British Journal of Cancer 2017; 117:1211-1214.

Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K, GEKID Cancer Survival Working Group.
Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.
International Journal of Cancer 2017; 141:2270-2280.

Boehlen FH, Herzog W, Schellberg D, Maatouk I, Saum KU, Brenner H, Wild B.
Self-perceived coping resources of middle-aged and older adults – results of a large population-based study.
Aging and Mental Health 2017; 21:1303-1309.

Chen H, Werner S, Brenner H.
Fresh vs frozen samples and ambient temperature have little effect on detection of colorectal cancer or adenomas by a fecal immunochemical test in a colorectal cancer screening cohort in Germany.
Clinical Gastroenterology and Hepatology 2017; 15:1547-1556.

Maddock J, Zhou A, Cavadino A, Kuzma E, Bao Y,…, Brenner H, Kumari M, Power C, Llewellyn DJ, Hyppönen E.
Vitamin D and cognitive function: A mendelian randomisation study.
Scientific Reports 2017; 7:13230.

Mons U, Müezzinler A, Schöttker B, Dieffenbach AK, Butterbach K, Schick M, Peasey A, De Vivo I, Trichopoulou A, Boffetta P, Brenner H.
Leukocyte telomere length and all-cause, cardiovascular disease, and cancer mortality: Results from individual participant-data meta-analysis of two large prospective cohort studies.
American Journal of Epidemiology 2017; 185:1317-1326.

Barrow TM, Klett H, Toth R, Böhm J, Gigic B, Habermann N, Scherer D, Schrotz-King P, Skender S, Abbenhardt-Martin C, Zielske L, Schneider M, Ulrich A, Schirmacher P, Herpel E, Brenner H, Busch H, Boerries M, Ulrich CM, Michels KB.
Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.
Journal of Pathology 2017; 243:366-375.

Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K,…, Brenner H,…, Hoffmeister M,…, the PRACTICAL Consortium, Kraft P, Pierce BL, Schildkraut JM, on behalf of GECCO, PRACTICAL and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI-OCAC and TRICL-ILCCO.
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomization study.
The BMJ 2017; 359:j4761.

Michailidou K, Lindström S, Dennis J, Beesley J, Hui S,…, Arndt V,…, Brenner H,…, Chenevix-Trench G, Simard J, Kraft P, Easton DF.
Association analysis identifies 65 new breast cancer risk loci.
Nature 2017; 551:92-94.

Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK,…, Arndt V,…, Brenner H,…, Garcia-Closas M, Chang-Claude J, Lambrechts D, Neven P.
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Breast Cancer Research 2017; 19:119.

Maalmi H, Walter V, Jansen L, Chang-Claude J, Owen RW, Ulrich A, Schöttker B, Hoffmeister M, Brenner H.
Relationship of very low serum 25-hydroxyvitamin D3 levels with long-term survival in a large cohort of colorectal cancer patients from Germany.
European Journal of Epidemiology 2017; 32:961-971.

Weberpals J, Jansen L, van Herk-Sukel MPP, Kuiper JG, Aarts MJ, Vissers PAJ, Brenner H.
Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
European Journal of Epidemiology 2017; 32:1019-1031.

Bhardwaj M, Erben V, Schrotz-King P, Brenner H.
Cell line secretome and tumor tissue proteome markers for early detection of colorectal cancer: a systematic review.
Cancers 2017; 9:156.

Bien SA, Auer PL, Harrison TA, Qu C, Conolly CM, Greenside PG, Chen S, Berndt SI, Bézieau S, Kang HM, Huyghe J, Brenner H, Casey G, Chan AT, Hopper JL, Banbury BL, Chang-Claude J, Chanock SJ, Haile RW, Hoffmeister M, Fuchsberger C, Jenkins MA, Leal SM, Lemire M, Newcomb PA, Gallinger S, Potter JD, Schoen RE, Slattery ML, Smith JD, Le Marchand L, White E, Zanke BW, Abecasis GR, Carlson CS, Peters U, Nickerson DA, Kundaje A, Hsu L, on behalf of GECCO and CCFR.
Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.
PLoS ONE 2017; 12:e0186518.

Chen H, Qian J, Werner S, Cuk K, Knebel P, Brenner H.
Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer.
Clinical Epidemiology 2017; 9:517-526.

Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S,…, Arndt V,…, Brenner H,…, Chenevix-Trench G, Garcia-Closas M, Schmidt MK, Antoniou AC, Simard J.
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Nature Genetics 2017; 49: 1767-1778.

Bozorgmehr K, Razum O, Szecsenyi J, Maier W, Stock C.
Regional deprivation is associated with the distribution of vulnerable asylum-seekers: a nation-wide small-area analysis in Germany.
Journal of Epidemiology & Community Health 2017; 71:857-862.

Bock JO, Hajek A, Brenner H, Saum KU, Matschinger H, Haefeli WE, Schöttker B, Quinzler R, Heider D, König HH.
A longitudinal investigation of willingness to pay for health insurance in Germany.
Health Services Research 2017; 52:1099-1117.

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Fear of progression >=5 years after diagnosis of cancer. Results of the cancer registry and population-based CAESAR study.
Onkologe 2017; 23:295-299.

Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE, Soerjomataram I, Künn-Nelen A, Pettersson-Kymmer U, Eriksson S, Brenner H, Schöttker B, Saum KU, Holleczek B, Grodstein FD, Feskanich D, Orsini N, Wolk A, Bellavia A, Wilsgaard T, Jorgensen L, Boffetta P, Trichopoulos D, Trichopoulou A.
Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium.
Lancet Public Health 2017; 2:e239-246.

Guo Q, Burgess S, Turman C, Bolla MK, Wang Q,…, Arndt V,…, Brenner H,…, Hopper JL, Zheng W, Schmidt MK, Pharoah PDP.
Body mass index and breast cancer survival: A Mendelian randomisation analysis.
International Journal of Epidemiology 2017; 46:1814-1822.

Sud A, Thomsen H, Law PJ, Försti A, Inacio da Silva Filho M, Holroyd A, Broderick P, Orlando G, Lenive O, Wright L, Cooke R, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N, The PRACTICAL consortium*, Hoffmann P, Nöthen MM, Jöckel KH, Pogge von Strandmann E, Lightfoot T, Kane E, Roman E, Lake A, Montgomery D, Jarrett RF, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS.
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.
Nature Communications 2017; 8:1892.
*Collaborator from DKFZ: Brenner H

Matz M, Coleman MP, Sant M, Dolores Chirlaque M, Visser O, Gore M, Allemani C, the CONCORD Working Group*.
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).
Gynecologic Oncology 2017; 144:405-413.
*Collaborator from DKFZ: Brenner H

NCD Risk Factor Collaboration (NCD-RisC).*
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults.
The Lancet 2017; 390:2627-2642.
*Collaborators on behalf of the ESTHER study: Brenner H, Saum KU

Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S,…, Arndt V,…, Brenner H,…, Easton DF, Czene K, Hall P, Lindblom.
PHIP – a novel candidate breast cancer susceptibility locus on 6q14.1.
Oncotarget 2017; 8:102769-102782.

Gao X, Schöttker B.
Reduction-oxidation pathways involved in cancer development: a systematic review ofliterature reviews. 
Oncotarget 2017; 8:51888-51906.

Bhardwaj M, Gies A, Werner S, Schrotz-King P, Brenner H.
Blood-based protein signatures for early detection of colorectal cancer: A systematic review.
Clinical and Translational Gastroenterology 2017; 8:e128.

Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L., for the GEKID Cancer Survival Workgroup.
Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time.
European Journal of Cancer 2016; 52:102-108.

Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, ..., Brenner H, ..., Tomlinson I, Dowsett M, Easton DF, Spurdle AB.
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer.
Endocrine-Related Cancer 2016; 23:77-91.

Florath I, Butterbach K, Heiss JA, Bewerunge-Hudler M, Zhang Y, Schöttker B, Brenner H.
Type 2 diabetes and leucocyte DNA methylation: An epigenome-wide association study in over 1500 older adults.
Diabetologia 2016; 59:130-138.

Zhang Y, Schöttker B, Florath I, Stock C, Butterbach K, Holleczek B, Mons U, Brenner H.
Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortality.
Environmental Health Perspectives 2016; 124:67-74.

Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, ..., Brenner, Arndt V, ..., Ambrosone CB, Swerdlow A, Jones M, Chang-Claude J.
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
Human Genetics 2016; 135:137-154.

Carr PR, Jansen L, Walter V, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M.
Association of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment.
American Journal of Clinical Nutrition 2016; 103:192-200.

Mons U, Muscat JE, Modesto J, Richie JP, Brenner H.
Effect of smoking reduction and cessation on the plasma levels of the oxidative stress biomarker glutathione - post-hoc analysis of data from a smoking cessation trial.
Free Radical Biology & Medicine 2016; 91:172-177.

Müezzinler A*, Mons U*, Dieffenbach AK, Butterbach K, Saum KU, Schick M, Stammer H, Boukamp P, Holleczek B, Stegmaier C, Brenner H.
Body mass index and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort.
Experimental Gerontology 2016; 74:1-8.
*=equal contribution.

Phipps A, Passarelli MN, Chan AT, Harrison TA, Jeon J, Hutter CM, Berndt SI, Brenner H, Caan BJ, Campbell PT, Chang-Claude J, Chanock SJ, Cheadle JP, Curtis KR, Duggan D, Fisher D, Fuchs CS, Gala M, Giovannucci EL, Hayes RB, Hoffmeister M, Hsu L, Jacobs EJ, Jansen L, Kaplan R, Kap L, Maughan TS, Potter JD, Schoen RE, Seminara D, Slattery ML, West H, White E, Peters U, Newcomb PA.
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.
Carciogenesis 2016; 37:87-95.

Carr P, Walter V, Brenner H, Hoffmeister M.
Meat subtypes and their association with colorectal cancer: systematic reveiw and meta-analysis.
International Journal of Cancer 2016; 138:293-302.

Schöttker B, Saum KU, Jansen EHJM, Holleczek B, Brenner H.
Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults.
Age and Ageing 2016; 45:127-135.

Pattaro C, Teumer A, Gorski M, Chu AY, Li M, ..., Brenner H, ..., Butterbach K, ..., Köttgen A, Kao L, Fox CS.
Genetic association at 53 loci highlight cell types and biologic pathways for kidney function.
Nature Communications 2016; 7:10023.

Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, ..., Brenner H, ..., Hoffmeister M, Butterbach K, ..., Hsu L, Chan A, Peters U, Chang-Claude J.
CYP24A1 variant modifies the association between use of estrogen plus progestogen therapy and colorectal cancer.
British Journal of Cancer 2016; 114:221-229.

Brenner H, Jansen L.
Timely disclosure of progress in long-term cancer survival: The boomerang method substantially improved estimates in a comparative study.
Journal of Clinical Epidemiology 2016;70:224-232.

Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, ..., Brenner H, Butterbach K, ..., Couch FJ, Spurdle AB, Goldgar DE.
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate and ovarian cancers.
Journal of the National Cancer Institute 2016; 108:djv315.

Zhang Y, Florath I, Saum KU, Brenner H.
Self-reported smoking, serum cotinine, and blood DNA methylation.
Environmental Research 2016; 146:395-403.

Horvat P, Gardiner J, Kubinova R, Pajak A, Tamosiunas, Schöttker B, Pikhart H, Peasey A, Jansen E, Bobak M.
Serum folate, vitamin B-12 and cognitive function in middle and older age: The HAPIEE study.
Experimental Gerontology 2016; 76:33-38.

Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M.
Declining bowel cancer incidence and mortality in Germany - an analysis of time trends in the first ten years after the introduction of screening colonoscopy.
Deutsches Ärzteblatt International 2016; 113:101-106.

Jia M, Gao X, Zhang Y, Hoffmeister M, Brenner H.
Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review.
Clinical Epigenetics 2016; 8:25.

Boehlen F, Herzog W, Maatouk I, Saum K-U, Brenner H, Wild B.
Behandlungswünsche von älteren Menschen mit psychischen Erkrankungen.
Zeitschrift für Gerontologie und Geriatrie 2016; 49:120-125.

Bock JO, Heider D, Matschinger H, Brenner H, Saum KU, Haefeli WE, König HH.
Willingness to pay for health insurance among the elderly population in Germany.
European Journal of Health Economics 2016; 17:149-158.

Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, ..., Dieffenbach AK, ..., Brenner H, ..., Butterbach K, ..., Böger CA, Fox CS, Pattaro C, Köttgen A.
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes.
Diabetes 2016; 65:803-817.

Petridis C, Brook MN, Shah V, Kohut K, Gorman P, ..., Brenner H, Arndt V, ..., Tomlinson I, Roylance R, Garcia-Closas M, Sawyer EJ.
Genetic predisposition to ductal carcinoma in situ of the breast.
Breast Cancer Research 2016; 18:22.

Logan CA, Thiel L, Striebel S, Reister F, Brenner H, Rothenbacher D, Genuneit J.
Delivery mode, duration of labor, and cord blood adiponectin, leptin, and C-reactive protein: Results of the population-based Ulm Birth Cohort Studies.
PLoS ONE 2016;11:e0149918.

Schöttker B, Rathmann W, Herder C, Thorand B, Wilsgaard T, Njølstad I, Siganos G, Mathiesen EB, Saum KU, Peasey A, Feskens E, Boffetta P, Trichopoulou A, Kuulasmaa KK, Kee F, Brenner H.
HbA1c levels in non-diabetic older adults - No J-shaped associations with primary cardovascular events, cardiovascular and all-cause mortality after adjustment for confounders. A meta-analysis of individual participant data from six cohort studies.
BMC Medicine 2016; 14:26.

Chen T, Fallah M, Brenner H, Jansen L, Mai E, Castro F, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, for the GEKID Cancer Survival Working Group.
Risk of second primary cancers in multiple myeloma survivors in German and Swedish cancer registries.
Scientific Reports 2016; 6:22084.

Breitling LP, Saum KU, Perna L, Schöttker B, Holleczek B, Brenner H.
Frailty is associated with the epigenetic clock but not with telomere length in a German cohort.
Clinical Epigenetics 2016; 8:21.

Gdynia G, Sauer SW, Kopitz J, Fuchs D, Duglova K, Ruppert T, Miller M, Pahl J, Cerwenka A, Enders M, Mairlbäurl H, Kaminski MM, Penzel R, Zhang C, Fuller JC, Wade R Benner A, Chang-Claude J, Brenner H, Hoffmeister M, Zentgraf H, Schirmacher P, Roth W.
The HMGB1 protein induces a metabolic type of tumor cell death by blocking aerobic respiration.
Nature Communication 2016; 7:10764.

Pulte D, Castro F, Jansen L, Luttmann S, Holleczek B Nennecke A, Ressing M, Katalinic A, Brenner H.
Trends in survival of chronic lymphocytic leukemia patients in Germany and the United States in the first decade of th 21st century.
Journal of Hematology & Oncology 2016; 9:28.

Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, …, Arndt V, Brenner H, …, Chenevix-Trench G, Antoniou AC, Easton DF, Edwards SL.
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Nature Genetics 2016; 48:374-86.

Ordóñez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, O’Doherty MG, Scott A, Kee F, Stricker BH, Hofmann A, de Keyser CE, Ruiter R, Söderberg S, Jousilahti P, Kuulasmaa K, Freedman ND, Wilsgaard T, de Groot L, Kampman E, Håkansson N, Orsini N, Wolk A, Nilsson LM, Tjønneland A, Pająk A, Malyutina S, Kubínová R, Tamosiunas A, Bobak M, Katsoulis M, Oranos P, Boffetta P, Trichopoulou A, Brenner H.
Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of indivivual participant data from cohorts of the CHANCES consortium.
BMC Medicine 2016; 14:62.

Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Smith GD. The PRACTICAL consortium.
Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.
BMC Medicine 2016; 14:66.

Gusev A, Shi H, Kichaev G, Pomerantz M, Li F,…, Brenner H,…, Volker Arndt,…, Price AL, Freedman ML, Haiman CA, Pasaniuc B.
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.
Nature Communications 2016; 7:10979.

Werner S, Krause F, Rolny V, Strobl M, Morgenstern D, Datz C, Chen H, Brenner H.
Evaluation of a 5-marker blood test for colorectal cancer early detection in a colorectal cancer screening setting.
Clinical Cancer Research 2016; 22:1725-1733.

Ordóñez-Mena JM, Schöttker B, Fedirko V, Jenab M, Olsen A, Halkjær J, Kampman E, de Groot L, Jansen E, Bas Bueno-de-Mesquita H, Peeters PH, Siganos G, Wilsgaard T, Perna L, Holleczek B, Pettersson-Kymmer U, Orfanos P, Trichopoulou A, Boffetta P, Brenner H.
Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium.
European Journal of Epidemiology 2016; 31:311-323.

Holleczek B, Brenner H.
Implications from under-reporting, death certificate notifications and trace-back on the recorded incidence of a newly established population-based cancer registry.
Methods of Information in Medicine 2016; 55:182-192.

Bock JO, Konig HH, Brenner H, Haefeli WE, Quinzler R, Matschinger H, Saum KU, Schöttker B, Heider D.
Associations of frailty with health care costs? Results of the ESTHER cohort study.
BMC Health Services Research 2016; 16:128.

Lüthgens K, Albert S, Brenner H.
Unterschiedliche Nachweisgrenzen immunologischer Tests auf Blut im Stuhl unterstreichen die Notwendigkeit der Standardisierung und Qualitätssicherung.
Zeitschrift für Gastroenterologie 2016; 54:299-303.

Kap EJ, Seibold P, Scherer D, Habermann N, Balavarca Y, Jansen L, Zucknick M, Becker N, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J.
SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients.
International Journal of Cancer 2016; 138:2993-3001.

Florath I, Schöttker B, Butterbach K, Bewerunge-Hudler M, Brenner H.
Epigenome-wide search for association of serum 25-hydroxyvitamin D concentration with leukocyte DNA methylation in a large cohort of older men.
Epigenomics 2016; 8:487-499.

Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q,…, Arndt V,…, Brenner H,…, Pharoah P, Hunter D, Easton DF, Zheng W.
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.
Cancer Causes Control 2016; 27:679-693.

Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H for the GEKID Cancer Survival Working Group.
Survival of elderly patients with multiple myeloma – Effect of upfront autologous stem cell transplantation.
European Journal of Cancer 2016; 62:1-8.

Weberpals J, Jansen L, Carr P, Hoffmeister M, Brenner H.
Beta blockers and cancer prognosis – the role of immortal time bias: A systematic review and meta-analysis.
Cancer Treatment Reviews 2016; 47:1-11.

Tsilidis KK, Papadimitriou N, Capothanassi D, Bamia C, Benetou V, Jenab M, Freisling H, Kee F, Nelen A, O’Doherty MG, Scott A, Soerjomataram I, Tjonneland A, May AM, Quirós JR, Pettersson-Kymmer U, Brenner H, Schöttker B, Ordónez-Mena J, Dieffenbach AK, Eriksson S, Bogeberg Mathiesen E, Njolstad I, Siganos G, Wilsgaard T, Boffetta P, Trichopoulos D, Trichopoulou A.
Burden of cancer in a large consortium of prospective cohorts in Europe.
Journal of the National Cancer Institute 2016; 108:djw127.

Pelttari LM, Khan S, Vuorela M, Kiiski JI, Vilske S,…, Brenner H, Arndt V,…, Mattson J, Blomqvist C, Aittomäki K, Nevanlinna H.
RAD51B in Familial Breast Cancer.
PLOS ONE 2016; 11:e0153788.

Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, Zornig I, Eichmüller SB, Jäger D, Pawlita M, Waterboer T, Brenner H.
Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.
Scientific Reports 2016; 6:25467.

Couch F, Kuchenbaecker K, Michailidou K, Mendoza-Fandino G, Nord S,..., Brenner H,..., Monteiro A, Garcia-Closas M, Easton D, Antoniou A.
Identification of four novel susceptibility loci for estrogen receptor negative breast cancer.
Nature Communications 2016; 7:11375.

NCD Risk Factor Collaboration (NCD-RisC).*
The weight of the world - trends in adult body mass index in 200 countries since 1975: pooled analysis of 1,698 population-based measurement studies with 19.2 million participants.
The Lancet 2016; 387:1377-1396.
*Collaborators on behalf of the ESTHER study: Brenner H, Saum KU.

Perna L, Mons U, Schöttker B, Brenner H.
Association of cognitive function and serum uric acid: Are cardiovascular diseases a mediator among women?
Experimental Gerontology 2016; 81:37-41.

Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, for the GEKID Cancer Survival Working Group.
Survival from non-melanoma skin cancer in Germany.
British Journal of Dermatology 2016; 174:713-714.

Chen H, Werner S, Butt J, Zörnig I, Knebel P, Michel A, Eichmüller SB, Jäger D, Waterboer T, Pawlita M, Brenner H.
Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Oncotarget 2016; 7:16420-16432.

Chen X*, Schöttker B*, Castro F, Chen H, Zhang Y, Holleczek B, Brenner H.
Association of Helicobacter pylori infection and chronic athrophic gastritis with risk of colonic, pancreatic and gastric cancer: a ten-year follow-up of the ESTHER cohort study.
Oncotarget 2016; 7:17182-17193.
*shared first authorship

NCD Risk Factor Collaboration (NCD-RisC).*
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.
The Lancet 2016; 387:1513-1530.
*Collaborators on behalf of the ESTHER study: Brenner H, Saum KU.

Lechner S, Herzog W, Boehlen F, Maatouk I, Saum KU, Brenner H, Wild B.
Control preferences in treatment decisions among older adults – results of a large population-based study.
Journal of Psychosomatic Research 2016; 86:28-33.

Niedermaier T, Weigl K, Hoffmeister M, Brenner H.
Fecal immunochemical tests combined with other stool tests for colorectal cancer and advanced adenoma detection. A systematic review.
Clinical and Translational Gastroenterology 2016; 7:e175.

Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V,…, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H.
Minimally invasive colorectal cancer surgery in Europe: Implementation and outcomes.
Medicine 2016; 95:e3812.

Khodadost M, Yavari P, Khodadost B, Babaei M, Sarvi F, Khatibi SR, Barzegari S.
Estimating the esophagus cancer incidence rate in Ardabil, Iran: A capture-recapture method.
Iran Journal of Cancer Prevention 2016; 9:e3972.

Logan C, Zittel T, Striebel S, Reister F, Brenner H, Rothenbacher D, Genuneit J.
Changing societal and lifestyle factors and breastfeeding patterns over time.
Pediatrics 2016; 137:e20154473.

Walter V, Jansen L, Ulrich A, Roth W, Bläker H, Chang-Claude J, Hoffmeister M, Brenner H.
Alcohol consumption and survival of colorectal cancer patients: population-based study from Germany.
American Journal of Clinical Nutrition 2016; 103:1497-1506.

Cheng THT, Thompson DJ, O’Mara TA, Painter JN, Glubb DM,…, Burwinkel B, Brenner H,…, Chang-Claude J,…, Edwards SL, Easton DF, Tomlinson I, Spurdle AB.
Five endometrial cancer risk loci identified through genomewide association analysis.
Nature Genetics 2016; 48:667-674.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, ..., Arndt V, ..., Brenner H, ..., Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trenche G.
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Journal of Medical Genetics 2016; 53:298-309.

Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johannsson U, Tvedskof TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgois P, Moreau M, Mátrai Z, Sávolt A, Nagy P, Kásler M, Schrotz-King P, Ulrich C, Brenner H.
Time trends in axilla management among early breast cancer patients: persisting major variation in clinical practice across European centers.
Acta Oncologica 2016; 55:712-719.

Ovarian Cancer Association Consortium, Breast Cancer Association Consortium and Consortium of Modifiers of BRCA1 and BRCA2, Hollestelle A, van der Baan F, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, …, Arndt V, …, Brenner H, …, Pharoah PDP, Rookus MA, Hooning MJ, Goode EL.
No clinical utility of KRAS Variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology 2016; 141:386-401.

Meid AD, Quinzler R, Groll A, Wild B, Saum K-U, Schöttker B, Heider D, König H-H, Brenner H, Haefeli WE.
Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life.
European Journal of Pharmacology 2016; 72:877-885.

Chen H, Knebel P, Brenner H.
Empirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false positive findings.
Journal of Clinical Epidemiology 2016; 75:108-114.

Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H.
Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a german case cohort.
Clinical Epigenetics 2016; 8:64.

Pulte D, Jansen L, Castro F, Brenner H.
Changes in survival of older patients with hematologic malignancies in the early 21st century.
Cancer 2016; 122:2031-2040.

Zeng C, Matsuda K, Jia WH, Chang J, Kweon SS,…, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Brenner H,…, Shu XO, Lin D, Zeng YX, Zheng W.
Identification of susceptibility loci and genes for colorectal cancer risk.
Gastroenterology 2016; 150:1633-1645.

Sirri E, Castro F, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H for the GEKID Cancer Survival Group. 
Recent trends in survival of patients with pancreas cancer in Germany and the United States.
Pancreas 2016; 45:908-914.

Du M, Jiao S, Bien SA, Gala M, Abecasis G,…, Brenner H,…, Hoffmeister M,…, Chan AT, White E, Berndt SI, Peters U.
Fine-Mapping of common genetic variants associated with colorectal tumor risk identified potential functional variants.
PLoS One 2016; 11(7):e0157521.

Dallmeier D, Brenner H, Mons U, Rottbauer W, Koenig W, Rothenbacher D.
Growth Differentiation Factor 15, its 12-month relative change, and risk of cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA Study.
Clinical Chemistry 2016; 62:982-992.

Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, for the GEKID Cancer Survival Working Group.
Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.
International Journal of Cancer 2016; 139:1289-1296.

Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, …, Arndt V, …, Brenner H, …, Antoniou AC, Easton DE, Cai Q, Long J.
Fine-scale mapping of 8q24 locus identifies multiple risk variants for breast cancer.
International Journal of Cancer 2016; 139:1303-1317.

Bull CJ, Bonilla C, Holly JMP, Perks CM, Davies N, Haycock P, Yu OHYY, Richards B, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, MacInnis RJ, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Michael A, Pandha H, and the PRACTICAL Consortium, Smith GD, Lewis SJ, Martin RM.
Blood lipids and prostate cancer: a Mendelian randomization analysis.
Cancer Medicine 2016; 5:1125-1136.

Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Smith GD,…, Brenner H,…, the PRACTIAL consortium, Lathrop M, Martin RM, Holly JMP.
Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: genetic variants as instruments for circulating levels.
International Journal of Cancer 2016; 139:1520-1533.

Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ.
Chronic kidney disease prevalence varies across European general population.
Journal of the American Society of Nephrology 2016; 27:2135-2147.

O'Doherty MG, Cairns K, O'Neill V, Lamrock F, Jørgensen T, Brenner H, Schöttker B, Wilsgaard T, Siganos G, Kuulasmaa K, Boffetta P, Trichopoulou A, Kee F, on behalf of the CHANCES consortium.
Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES).
European Journal of Epidemiology 2016; 31:455-468.

Maatouk I, Herzog W, Böhlen F, Quinzler R, Löwe B, Saum KU, Brenner H, Wild B.
Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults.
Journal of Hypertension 2016; 34:1711-1720.

Abubakar M, Orr N, Howat WJ, Daley F, Coulson P, Blows F, Ali HR, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, Martens JWM, Van Deurzen CHM, kConFab Investigators, Bolla MK, Wang Q, Jones M, Schoemaker M, Broeks A, Van Leeuwen FE, Van ´t Veer L, Easton D, Swerdlow AJ, Dowsett M, Pharoah PD, Schmidt MK, Garcia-Closas M.
High-throughput automated scoring of Ki67 in breast cancer tissue microarrays in the Breast Cancer Association Consortium (BCAC).
Journal of Pathology: Clinical Research 2016; 2:138-153.

Schmidt M, Hogervorst F, van Hien R, Cornelissen S, Broeks A,..., Arndt V,..., Brenner H,..., Nevanlinna H, Dörk T, Bojesen S, Easton D.
Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers.
Journal of Clinical Oncology 2016; 34:2750-2760.

Brenner H, Jansen L, Ulrich A, Chang-Claude J, Hoffmeister M.
Survival of patients with symptom- and screening-detected colorectal cancer.
Oncotarget 2016; 7:44695-44704.

Yang B, Thrift AP, Figueiredo JC, Jenkins MA, Schumacher FR, Lin Y, Win AK, Limburg PJ, Berndt SI, Brenner H, Chan AT, Chang-Claude J, Hoffmeister M, Hudson TJ, Le Marchand L, Newcomb PA, Slattery ML, White E, Peters U, Casey G, Campbell PT.
Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer.
Cancer Epidemiology 2016; 44:1-4.

Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A,…, Arndt V,…, Brenner H,..., Couch FJ, Antoniou AC, Easton DF, Zheng W.
Identification of independent association signals and putative functional variants for breast cancer risk though fine-scale mapping of the 12p11 locus.
Breast Cancer Research 2016; 18:64.

NCD Risk Factor Collaboration (NCD-RisC).
A century of trends in adult human height.
eLife 2016; 5:e13410.

Brenner H, Kretschmann J, Stock C, Hoffmeister M.
Expected long-term impact of screening endoscopy on colorectal cancer incidence: A modelling study.
Oncotarget 2016; 7:48168-48179.

Guo Y, Andersen SW, Shu XO, Michailidou K, Bolla MK,…, Arndt V,…, Brenner H,…, Pharoah P, Hunter D, Easton DF, Zheng W.
Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of european descent.
PLOS Medicine 2016; 13:e1002105.

Horne HN, Chung CE, Zhang H, Yu K, Prokunina-Olsson L,…, Brenner H, Arndt V,…, Easton DF, Chanock SJ, Dunning AM, Figueroa J.
Fine-mapping of the 1p11.2 breast cancer susceptibility locus.
PLOS ONE 2016; 11:e0160316.

Leja M, Axon A, Brenner H.
Epidemiology of Helicobacter pylori infection.
Helicobacter 2016; 21 (Suppl 1):3-7.

Dumstrei K, Chen H, Brenner H.
A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Oncotarget 2016; 7:11151-11164.

Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K,…, Arndt V,…, Brenner H,…, Edwards SL, Chenevix-Trench G, Antoniou AC, Gayther SA.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Nature Communications 2016; 7:12675.

Darabi H, Beesley J, Droit A, Kar S, Nord S,…, Arndt V,…, Brenner H,…, Simard J, French JD, Chenevix-Trench G, Dunning AM.
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Scientific Reports 2016; 6:32512.

Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F,…, Brenner H, Arndt V, Stegmaier C,…, Giles GG, Tavtigian SV, Easton DF, Milne RL.
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Journal of Medical Genetics 2016; 53:800-811.

Fehringer G, Kraft P, Pharoah PD, on behalf of Ovarian Cancer Association Consortium (OCAC); Eeles RA, on behalf of The PRACTICAL Consortium; Chatterjee N,…, Brenner H,…, Kaaks R,…, Hunter DJ, Haiman CA, on behalf of African American Breast Cancer Consortium (AABC) and African Ancestry Prostate Cancer Consortium (AAPC); Henderson BE, Hung RJ.
Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
Cancer Research 2016; 76:5103-5114.

Kar SP, Beesley J, Al Olama AA, Michailidou K, Tyrer J,..., Brenner H,…, Arndt V,…, Chenevix-Trench G, Eeles R, Pharoah PDP, Lambrechts D.
Genome-wide meta-analyses of breast, ovarian and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types.
Cancer Discovery 2016; 6:1052-1067.

Weigl K, Jansen L, Chang-Claude J, Knebel P, Hoffmeister M, Brenner H.
Family history and the risk of colorectal cancer: the importance of patients’ history of colonoscopy.
International Journal of Cancer 2016; 139:2213-2220.

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund f, Gronberg H, Haiman CA, Schleutker J, Nordestgaard B, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Canon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Panda H, Govindasami K, Muir K, COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative, The UK Genetic Prostate Cancer Study Collaborators, The PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z.
Gene and pathway level analyses of germline DNA repair gene variants and prostate cancer susceptibility using the iCOGS genotyping array.
British Journal of Cancer 2016; 114:945-952.

Breitling LP, Saum KU, Schöttker B, Holleczek B, Herth FJ, Brenner H.
Pneumonien in der nicht-institutionalisierten älteren Allgemeinbevölkerung: prospektive Beobachtungsstudie über 11 Jahre.
Deutsches Ärzteblatt 2016; 113:607-614.

Walter V, Jansen L, Hoffmeister M, Ulrich A, Roth W, Bläker H, Chang-Claude J,  Brenner H.
Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer.
The American Journal of Clinical Nutrition 2016; 104:1110-1120.

Chen LS, Baker T, Hung RJ, Horton A, Culverhouse R,…, Saum KU,…, Brenner H,…, Zhang ZF, Spitz MR, Amos CI, Bierut LJ.
Genetic risk can be decreased: Quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes – A meta-analysis.
EBiomedicine 2016; 11:219-226.

Jansen H, König W, Jaensch A, Mons U, Breitling L, Scharnagl H, Stojakovic T, Schunkert H, Brenner H, Rothenbacher D.
Prognostic utility of Galectin-3 for recurrent cardiovascular events during long-term follow-up in patients with stable coronary heart disease. Results of the KAROLA study.
Clinical Chemistry 2016; 62:1372-1379.

Zhang Y, Breitling LP, Balavarca Y, Holleczek B, Schöttker B, Brenner H.
Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer related genes in prediction of lung cancer mortality.
International Journal of Cancer 2016; 139:2482-2492.

Gao X, Zhang Y, Breitling L, Brenner H.
Tobacco smoking and methylation of genes related to lung cancer development.
Oncotarget 2016; 7:59017-59028.

Gao X, Zhang Y, Breitling LP, Brenner H.
Relationship of tobacco smoking and smoking-related DNA methylation with epigenetic age acceleration.
Oncotarget 2016; 7:46878-46889.

GBD 2015 Risk Factors Collaborators.*
Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 195 countries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
The Lancet 2016; 388:1659-1724.
*Collaborators from DKFZ: Brenner H, Schöttker B

GBD 2015 Mortality and Causes of Death Collaborators.*
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
The Lancet 2016; 388:1459-1544.
*Collaborators from DKFZ: Brenner H, Schöttker B

Gong J, Hutter CM, Newcomb PA, Ulrich CM, Bien SA, Campbell PT, Baron JA, Berndt SI, Bezieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Du M, Duggan D, Figueiredo JC, Gallinger S, Giovannucci EL, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jeon J, Jenkins MA, Kocarnik J, Küry S, Le Marchand L, Lin Y, Lindor NM, Nishihara R, Ogino S, Potter JD, Rudoph A, Schoen RE, Schrotz-King P, Seminara D, Slattery ML, Thibodeau SN, Thornquist M, Toth R, Wallace R, White E, Jiao S, Lemire M, Hsu L, Peters U, CCFR and GECCO.
Genome-wide interaction analyses between genetic variants and alcohol consumption and smoking for risk of colorectal cancer.
PLOS Genetics 2016; 12:e1006296.

Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J,…, Brenner H, Arndt V,…, Chenevix-Trench G, Easton DF, Dunning AM, Edwards SL.
Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation.
The American Journal of Human Genetics 2016; 99:903-911.

Karami S, Han Y, Pande M, Cheng I, Rudd J,…, Brenner H,…, Zheng W, Chatterjee N, Amos CI, Doherty JA, on behalf of GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL.
Telomere structure and maintenance gene variants and risk of five cancer types.
International Journal of Cancer 2016; 139:2655-2670.

Jia M, Jansen L, Walter V, Tagscherer K, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M.
No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.
British Journal of Cancer 2016; 115:1359-1366

Abubakar M, Orr N, Daley F, Coulson P, Raza Ali H, Blows F, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RAEM, Seynaeve C, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, Martens JWM, van Deurzen CHM, kConFab Investigators, Bolla MK, Wang Q, Jones M, Schoemaker M, Wesseling J, van Leeuwen FE, Van ‘t Veer L, Easton D, Swerdlow AJ, Dowsett M, Pharoah PD, Schmidt MK, Garcia-Closas M.
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
Breast Cancer Research 2016; 18:104.

Liu J, Loncar I, Collée JM, Bolla MK, Dennis J,…, Brenner H,…, Cuk K,…, Hooning MJ, van den Ouweland AMW, Martens JWM, Hollestelle A.
rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk.
Scientific Reports 2016; 6:36874.

Painter JN, O’Mara TA, Marquart L, Webb PM on behalf of the AOCS Group, Attia J,…, Brenner H,…, Dunning AM, Easton DF, Thompson DJ, Spurdle AB on behalf of The Australian National Endometrial Cancer Study Group (ANECS).
Genetic risk score Mendelian randomization shows obesity measured as body mass index, but not waist: hip ratio, is causal for endometrial cancer.
Cancer Epidemiology, Biomarkers & Prevention 2016; 25:1503-1510.

Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA,..., Brenner H,..., Teixeira MR, Pandha H, Zheng W, PRACTICAL Consortium
Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium.
British Journal of Cancer 2016; 115:624-631.

Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DMJ, Nally J, Rothenbacher D, Stengel B, Iseki K, Matsushita K, Levey AS, the CKD Prognosis Consortium*.
Past decline versus current eGFR and subsequent ESRD risk.
Journal of the American Society of Nephrology 2016; 27:2447-2455.
*Investigators and collaborators on behalf of the ESTHER study: Rothenbacher D, Brenner H, Müller H, Schöttker B.

Naimark DMJ, Grams ME, Matsushita K, Black C, Drion I, Fox CS, Inker LA, Ishani A, Jee SH, Kitajura A, Lea JP, Nally J, Peralta CA, Rothenbacher D, Ryu S, Tonelli M, Yatsuya H, Coresh J, Gansevoort RT, Warnock DG, Woodward M, de Jong PE, the CKD Prognosis Consorstium*.
Past decline versus current eGFR and subsequent mortality risk.
Journal of the American Society of Nephrology 2016; 27:2456-2466.
*Investigators and collaborators on behalf of the ESTHER study: Rothenbacher D, Brenner H, Müller H, Schöttker B.

Zhang Y, Elgizouli M, Schöttker B, Holleczek B, Nieters A, Brenner H.
Smoking-associated DNA methylation markers predict lung cancer incidence.
Clinical Epigenetics 2016; 8:127.

Meid AD, Heider D, Adler JB, Quinzler R, Brenner H, Günster C, König HH, Haefeli WE.
Comparative evaluation of methods approximating drug prescription durations in claims data: Modeling, simulation, and application to real data.
Pharmacoepidemiology and Drug Safety 2016; 25:1434-1442.

Koch-Gallenkamp L, Betram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Fear of recurrence in long-term cancer survivors - do cancer-type, sex, time since diagnosis, and social support matter?
Health Psychology 2016; 35:1329-1333.

Shi J, Park JH, Duan J, Berndt S, Moy W,..., Brenner H,…, Landi MT, Levinson DF, Chanock SJ, Chatterjee N.
Winner’s curse correction and variable thresholding improve performance of polygenic risk modeling based on genome-wide association study summary-level data.
PLOS Genetics 2016; 12:e1006493.

Gao X, Mons U, Zhang Y, Breitling LP, Brenner H.
DNA methylation changes in response to active smoking exposure are associated with leukocyte telomere length among older adults.
European Journal of Epidemiology 2016; 31:1231-1241.

Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S,…, Arndt V,…, Brenner H,…, Hall P, Easton DF, Pastinen T, Nord S.
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Oncotarget 2016; 7:80140-80163.

Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C,…, Brenner H,…, Amos C, Ambrosone C, Easton DF, Cole MD.
An intergenetic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
Human Molecular Genetics 2016; 25:3863-3876.

Zhang M, Wang Z, Obazee O, Jia J, Childs E,…, Brenner H,..., Kaaks R,...,Kraft P, Klein AP, Canzian F, Amundadottir LT.
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.
Oncotarget 2016; 7:66328-66343.

Lin W-Y, Camp NJ, Ghoussaini M, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Dunning A, Easton DF, Cox A.
Identification and characterisation of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Human Molecular Genetics 2015; 24:285-298.

Campa D, Martino A, Varkonyi J, Lesueur F, Jamrozial K, Landi S, Jurczyszyn  A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, Garcia-Sanz R, Buda G, Gemignani F, Rios R, Vangsted AJ, Dumontet C, Martinez-Lopez J, Moreno MJ, Stepien A, Watek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SEH, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudzinski M, Weinhold N, Reis RM, Canzian F.
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.
International Journal of Cancer 2015:136:E351-E358.

Conway DI, Brenner DR, McMahon AD, Macpherson LMD, Agudo A, Ahrens W, Bosetti C, Brenner H, ..., Müller H, ..., Lee YCA, Hashibe M, Brennan P.
Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries.
International Journal of Cancer 2015; 136:1125-1139.

Elgizouli M, Logan C, Nieters A, Brenner H, Rothenbacher D.
Cord blood PRF1 methylation patterns and risk of lower respiratory tract infections in infants: findings from the Ulm Birth Cohort.
Medicine 2015; 94:e332.

Glubb DM, Maranian MJ, Michailidou K, Pooley KA, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, .., Dunning AM, French JD.
Fine scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
American Journal of Human Genetics 2015; 96:5-20.

Carvajal-Carmona L, O'Mara TA, Painter JN, ..., Brenner H, Dieffenbach AK, ..., Easton DF, Spurdle AB, Thompson DJ.
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
Human Genetics 2015; 134:231-245.

Rudolph A, Milne RL, Truong T, ..., Dieffenbach AK, Arndt V, Stegmaier C, ..., Brenner H, ..., Pharoah PDP, Garcia-Closas M, Chang-Claude J.
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.
International Journal of Cancer 2015; 136:E685-E696.

GBD 2013 Mortality and Causes of Death Collaborators*.
Global, regional and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Lancet 2015; 385:117-171.
*Collaborators from DKFZ: Brenner H, Schöttker B.

Brenner H, Hoffmeister M, Birkner B, Stock C.
Which adenomas are detected by fecal occult blood testing? A state-wide analysis from Bavaria, Germany.
International Journal of Cancer 2015; 136:1672-1679.

Ashwin N, Ananthakrishnan AN, Du M, Berndt SI, Brenner H, Caan BJ, Casey G, Chang-Claude J, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hou L, Hsu L, Jenkins MA, Kraft P, Ma J, Nan H, Newcomb PA, Ogino S, Potter JD, Seminara D, Slattery ML, Thornquist M, White E, Wu K, Peters U, Chan AT.
Red meat intake, NAT2, and risk of colorectal cancer: A pooled analysis of 11 studies.
Cancer Epidemiology, Biomarkers and Prevention 2015; 24:198-205.

Dallmeier D, Pencina MJ, Rajman I, Koenig W, Rothenbacher D, Brenner H.
Serial measurements of N-Terminal Pro-Brain Natriuretic Peptide in patients with coronary heart disease.
PLoS One 2015; 10:e0117143.

Braig S, Brandt S, Wabitsch M, Florath I, Brenner H, Rothenbacher D, Genuneit J.
Age-specific influence of wheezing phenotypes on preadolescent and adolescent health-related quality of life.
Pediatric Allergy and Immunology 2015; 25:781-787.

Breitling LP.
Smoking as an effect modifier of the association of calcium intake with bone mineral density.
Journal of Clinical Endocrinology and Metabolism 2015; 100:326-635.

Stock C, Uhlmann L, Hoffmeister M, Laux G, Kieser M, Brenner H.
Identification of physicians with unusual performance in screening colonoscopy databases: a Bayesian approach.
Gastrointestinal Endoscopy 2015; 81:646-654.

Kabisch M, Lorenzo Bermejo J, Dünnebier T, Ying S, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Hamann U.
Inherited variants in the inner contromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER negative breast cancer.
Carcinogenesis 2015; 36:256-271.

Painter JN, O'Mara TA, Batra J, ..., Brenner H, Dieffenbach AK, ..., Edwards SL, Thompson DJ, Spurdle AB.
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Human Molecular Genetics 2015; 24:1478-1492.

Yang R, Pfütze K, Zucknick M, Sutter C, Wappenschmidt B, Marma F, Qu B, Cuk K, Engel C, Schott S, Schneeweiss A, Brenner H, Claus R, Plass C, Bugert P, Hoth M, Sohn C, Schmutzler R, Bartram CR, Burwinkel B.
DNA methylation array analyses identified breast cancer associated HYAL2 methylation in peripheral blood.
International Journal of Cancer 2015; 136:1845-1855.

Bläker H, Hildebrandt B, Riess H, von Winterfeld M, Ingold-Heppner B, Roth W, Kloor M, Schirmacher P, Dietel M, Tao S, Jansen L, Chang-Claude J, Ulrich A, Brenner H, Hoffmeister M.
Lymph node count and prognosis in colorectal cancer: the influence of examination quality.
International Journal of Cancer 2015; 136:1957-1966.

Bickeböller M, Tagscherer K, Kloor M, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Toth C, Schirmacher P, Roth W, Bläker H.
Functional characterization of the tumor suppressor MARCKS in colorectal cancer and its association with survival.
Oncogene 2015; 34:1150-1159.

Bozorgmehr K, San Sebastian M, Brenner H, Razum O, Maier W, Saum KU, Holleczek B, Miksch A, Szecsenyi J.
Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008 - 2010.
International Journal for Equity in Health 2015; 14:28.

Jansen L, Castro F, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H for the GEKID Cancer Survival Workgroup.
Recent cancer survival in Germany: an analysis of common and less common cancers.
International Journal of Cancer 2015; 136:2649-2658.

Allemani C, Weir HK, ..., Tucker TC, Coleman MP, Concord Working Group*.
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,877 patients from 279 population-based registries in 67 countries (CONCORD-2).
The Lancet 2015; 385:977-1010.
*Member of the CONCORD Working Group from DKFZ: Brenner H.

Heiss JA, Brenner H.
Between-array normalization for 450K data.
Frontiers in Genetics 2015; 6:92.

Brandt S, Moß A, Koenig W, Rothenbacher D, Brenner H, Wabitsch M.
Intrafamilial  associations of cardiometabolic risk factors - results of the Ulm Birth Cohort Study.
Atherosclerosis 2015; 240:174-183.

Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, haarrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman J, Peters U Hsu L, Chan AT; for the CCFR and GECCO.
Association of Aspirin and NSAID use with risk of colorectal cancer according genetic variants.
JAMA 2015; 313:1133-1142.

Michailidou K, Beesley J, Lindstrom S, Canisius S, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Hall P, Easton DF.
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Nature Genetics 2015; 47:373-381.

Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Standford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeria MR, Consortium P, Bioresource AP, Spurdle AB, Clements JA, Park JY, Batra J.
A large scale analysis of genetic variants within putative miRNA binding sites in prostate cancer.
Cancer Discovery 2015; 5:368-379.

Brenner H, Altenhofen L, Stock C, Hoffmeister M.
Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany.
Clinical Gastroenterology and Hepatology 2015; 13:717-723.

Emrich IE, Pickering J, Schöttker B, Lennartz CS, Rogacev KS, Brenner H, Rothenbacher D, Holleczek B, Saum KU, Fliser D, Heine GH.
Comparison of the performance of two GFR Estimating Equations using creatinine and cystatin C to predict adverse outcomes in elderly individuals.
Americal Journal of Kidney Diseases 2015; 65:632-638.

Schöttker B, Saum KU, Jansen EHJM, Boffetta P, Trichopoulou A, Holleczek B, Dieffenbach AK, Brenner H.
Oxidative stress markers and all-cause mortality at older age. A population-based cohort study.
Journal of Gerontology: Medical Sciences 2015; 70:518-524.

Nagelhout GE, Willemsen MC, de Vries H, Mons U, Hitchman SC, Kunst AE, Guignard R, Siahpush M, Yong HH, van den Putte B, Fong GT, Thrasher JF.
Educational differences in the impact of pictorial cigarette warning labels on smokers: findings from the International Tobacco Control (ITC) Europe surveys.
Tobacco Control (published Online First, 14 April 2015).

Brenner H.
Colorectal cancer screening for older adults.
BMJ 2015; 350:h2029.

Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, de Groot L, Freedman ND, Jansen E, Kee F, Kromhout D, Kuulasmaa K, Laatikainen T, O'Doherty MG, Bueno-de-Mesquita B, Orfanos P, Peters A, van der Schouw YT, Wilsgaard T, Wolk A, Trichopoulou A, Bofetta P, Brenner H, on behalf of the CHANCES consortium.
Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults - Meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium.
British Medical Journal 2015; 350:h1551.

Orr N, Dudbridge F, Dryden N, ..., Brenner H, Dieffenbach AK, Arndt V, ..., dos Santos Silva I, Fletcher O, Peto J.
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Human Molecular Genetics 2015; 24:2966-2984.

Song M, Gong J, Giovannucci EL, ..., Brenner H, Chang-Claude J, ..., Hoffmeister M, ..., Jensen M, Peters U, Chan AT.
Genetic variants of adiponectin and risk of colorectal cancer.
International Journal of Cancer 2015; 137:154-164.

Laitinen VH, Rantapero T, Fischer D, Vuorinen EM, Tammela TLJ, PRACTICAL Consortium*, Wahlfors T, Schleutker J.
Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
International Journal of Cancer 2015; 136:2316-2327.
*Author on behalf of the ESTHER study: Brenner H.

Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, ..., Brenner H, Butterbach K, Arndt V, ..., Fasching PA, Pharoah PDP, Schmidt MK.
Common germline polymorphisms associated with breast cancer specific survival.
Breast Cancer Research 2015; 17:58.

Perna L, Wahl HW, Mons U, Saum KU, Holleczek B, Brenner H.
Cognitive impairment, all-cause and cause-specific mortality among non-demented older adults.
Age and Ageing 2015; 44:445-451.

Panagiotou OA, Travis RC, Campa D, Berndt SI, Lindstrom S, Kraft P, Schumacher FR, Siddiq A, Papatheodourou SI, Stanford JL, Albanes D, Virtamo J, Weinstein SJ, Diver WR, Gapstur SM Stevens VL, Boeing H, Bas Bueno-de- Mesquita H, Barricarte Guerrea A, Kaaks R, Khaw KT, Krogh V, Overvad K, Riboli E, Trichopoulos D, Giovannucci E, Stampfer M, Haiman c, Henderson B, Le Marchand L, Gaziano JM, Hunter DJ, Koutros S, Yeager M, Hoover RN, The PRACICAL Consortium*, Chanock SJ, Wacholder S, Key TJ, Tsilidis KK.
A genome-wide pleiotropy scan for prostate cancer risk.
European Urology 2015; 67:649-657.
*Author on behalf of the ESTHER study: Brenner H.

Schöttker B, Brenner H.
Vitamin D as a resilience factor, helpful for survival of potentially fatal conditions. A hypothesis emerging from recent findings of the ESTHER cohort study and the CHANCES consortium.
Nutrients 2015; 7:3264-3278.

Pulte D, Jansen L, Brenner H.
Survival disparities by insurance type for patients age 15-64 with Non-Hodgekin Lymphoma.
The Oncologist 2015; 20:554-561.

Chen H, Chen XZ, Waterboer T, Castro FA, Brenner H.
Viral infections and colorectal cancer: a systematic review of epidemiological studies.
International Journal of Cancer 2015; 137:12-24.

Werner S, Chen H, Tao S, Brenner H.
Systematic Review: Serum autoantibodies in the early detection of gastric cancer.
International Journal of Cancer 2015; 136:2243-2252.

Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V.
Utilisation of psychosocial and informational services in immigrant and non-immigrant German cancer survivors.
Psycho-Oncology 2015; DOI:10.1002/pon.3742.

Zeissig SR, Singer S, Koch L, Blettner M, Arndt V für die CAESAR Studiengruppe.
Inanspruchnahme psychoonkologischer Versorgung im Krankenhaus und in der Krebsberatungsstelle durch Brust-, Darm- und Prostatakrebsüberlebende.
Psychotherapie-Psychosomatik-Medizinische Psychologie 2015; 65:177-182.

Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, Nishihara R, Ogino S, Prentice RL, Schumacher FR, Seminara D, Slattery ML, Thomas DC, Thornquist M, Newcomb PA, Potter JD, Zheng Y, White E, Peters U on behalf of the Colorecal Transdisciplinary (CORECT) Study and Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO).
A model to determine colorectal cancer risk using common genetic susceptibility loci.
Gastroenterology 2015; 148:1330-1339.

Brenner H, Altenhofen L, Stock C, Hoffmeister M.
Expected long-term impact of the German screening colonoscopy program on colorectal cancer prevention: analyses based on 4,407,971 screening colonoscopies.
European Journal of Cancer 2015; 51:1346-1353.

Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H.
Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.
Journal of the National Cancer Institute 2015; 107:djv045.

Benetou V, Orfanos P, Feskanich D, Michaelsson K, Pettersson-Kymmer U, Ahmed L, Peasey A, Wolk A, Brenner H, Bobak M, Wilsgaard T, Schöttker B, Saum KU, Bellavia A, Grodstein F, Klinaki E, Valanou E, Papatesta HM, Boffetta P, Trichopoulou A.
Education, martial status and risk of hip fractures in older men and women: the CHANCES project.
Osteoporosis International 2015; 26:1733-1746.

Brown AK, Nagelhout GE, van den Putta B, Willemsen MC, Mons U, Guignard R, Thompson ME.
Trends and socioeconomic differences in roll-your-own tobacco use: findings from the ITC Europe Surveys.
Tobacco Control 2015; 24:iii11-iii16.

König HH, Lehnert T, Brenner H, Schöttker B, Quinzler R, Haefeli WE, Matschinger H. Heider D.
Health service use and costs associated with excess weight in older adults in Germany.
Age and Ageing 2015; 44:616-623.

Sobral-Leite M, Wesseling J, Smit V, Nevanlinna H, van Miltenburg MH, ..., Brenner H, Butterbach K, Arndt V, Holleczek B, ..., García-Closas M, de Graauw M, Schmidt MK.
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
BMC Medicine 2015; 13:156.

Schumacher F, Schmit S, Jiao S, Edlund C, Wang H, ..., Butterbach K, ..., Brenner H, ... Hoffmeister M, ..., Casey G, Gruber S, Peters U.
Genome-wide association study of colorectal cancer identifies six new susceptibility loci.
Nature Communication 2015; 6:7138.

The Emerging Risk Factors Collaboration.*
Association of cardiometabolic multimorbidity with mortality.
JAMA 2015; 314:52-60.
* Author on behalf of the ESTHER study: Brenner H.

Al Olama AA, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal D, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman C, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler -Johnson C, Habuchi T, Thibodeau SN, Cooney K, Chappius PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF.
Risk analysis of prostate cancer in PRACTICAL, a multinational consortium, using 25 unknown prostate cancer susceptibility loci.
Cancer Epidemiology, Biomarkers and Prevention 2015; 24:1121-1129

Darabi H, McCue K, Beesley J, Michailidou K, ..., Brenner H, ..., Arndt V, ..., Dunning AM, Easton DF, Hall P, Cevenix-Trench G.
Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 expression.
American Journal of Human Genetics 2015; 97:22-34.

Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, Pers TH, Gallinger S, Hayes RB, Baron JA, Caan BJ, Ogino S, Berndt SI, Chanock SJ, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lindor NM, Seminara D, Song M, Wu K, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT.
Mendelian randomization study of body mass index and colorectal cancer risk.
Cancer Epidemiology, Biomarkers and Prevention 2015; 24:1024-1031.

Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H.
Smoking and survival of colorectal cancer patients: population-based study from Germany.
International Journal of Cancer 2015; 137:1433-1445.

Chen H, Zucknick M, Werner S, Brenner H.
Head-to head comparison and evaluation of 92 plasma protein biomarkers for early detection of colorectal cancer in a true screening setting.
Clinical Cancer Research 2015; 21:3318-3326.

Breitling LP.
Calcium intake and bone mineral density as an example of non-linearity and threshold analysis.
Osteoporosis International 2015; 26:1271-1281.

Schöttker B, Zhang Y, Heiss JA, Butterbach K, Jansen EHJM, Bewerunge-Hudler M, Saum KU, Holleczek B, Brenner H.
Discovery of a novel epigenetic cancer marker related to the oxidative status of human blood.
Genes Chromosomes and Cancer 2015; 54:583-594.

Gondos A, Krilaviciute A, Smailyte G, Ulys A, Brenner H.
Cancer surveillance using registry data: results and recommendations for the Lithuanian national prostate cancer early detection programme.
European Journal of Cancer 2015; 51:1630-1637.

Zhang Y, Schöttker B, Ordonez-Mena J, Holleczek B, Yang R, Burwinkel B, Butterbach K, Brenner H.
F2RL3 methylation, lung cancer incidence and mortality.
International Journal of Cancer 2015; 137:1739-1748.

Brenner H, Altenhofen L, Kretschmann J, Rösch T, Pox C, Stock C, Hoffmeister M.
Trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program.
Gastroenterology 2015; 149:356-366.

Müezzinler A, Mons U, Dieffenbach AK, Butterbach K, Saum KU, Schick M, Stammer H, Boukamp P, Holleczek B, Stegmaier B, Brenner H.
Smoking habits and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort.
Experimental Gerontology 2015; 70:18-25.

Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, ..., Brenner H, Butterbach K, Stegmaier C, ..., the PRACTICAL consortium, Gronberg H, Wiklund F.
Prediction of individual genetic risk to prostate cancer using a polygenic score.
The Prostate 2015; 75:1467-1474.

Freigofas J, Seidling HM, Quinzler R, Schöttker B, Saum KU, Brenner H, Haefeli WE.
Characteristics of medication schedules used by elderly ambulatory patients.
European Journal of Clinical Pharmacology 2015; 71:1109-1120.

Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins MG, Li D, Neale R, Olson SH, Scelo G, Bamlet WR, Bijlsma M, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F. Capurso G, Cavestro GM, Chaffee KG, Cleary SP, Cotterchio M, Foretova L, Funel N, Gazouli M, Hassan M, Holcatova I, Holly EA, Janout V, Key TJ, Kupcinskas J, Kurtz RC Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A,  Scarpa A, Strobel O, Tavano F, Vashist YK, Vodicka P, Yu H, Petersen GM, Risch H, Klein AP.
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
Nature Genetics 2015; 47:911-916.

Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M.
Overexpression of SIX1 is an independent prognostic marker in stage I - III colorectal cancer.
International Journal of Cancer 2015; 137:2104-2113.

Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary S, Capurso G, Bas Bueno-de-Mesquita H, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Hassan M, Greenhalf W, Pasquali C, Hackert T, Fuchs C, Mohelníková-Duchoñová B, Sperti C, Funel N, Dieffenbach AK, Wareham NJ, Buring J, Holcátová I, Costello-Goldring E, Zambone C-F, Kupcinskas J, Risch HA, Kraft P, Bracci PM, Pezzilli R, Olson SH, Sesso H, Hartge P, Strobel O, Malecka-Panas E, Visvanathan K, Arslan AA, Pedrazzoli S, Sucek P, Gioffreda D, Key TJ, Talar-Wojnarowska R, Scarpa A, Mambrini A, Jacobs EJ, Jamroziak K, Klein A, Tavano F, Bambi F, Landi S, Austin MA, Vodickova L, Brenner H, Chanock SJ, Delle Fave G, Piepoli A, Cantore M, Zheng W, Wolpin B, Amundadottir L, Canzian F.
The TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
International Journal of Cancer 2015; 137:2175-2183.

Boehlen F, Herzog W, Quinzler R, Haefeli WE, Maatouk I, Niehoff D, Saum KU, Brenner H, Wild B.
Loneliness in the elderly is associated with the use of psychotropic drugs.
International Journal of Geriatric Psychiatry 2015; 30:957-964.

Rothenbacher D, Jaensch A, Mons U, Hahmann H, Becker T, Koenig W, Brenner H.
Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: role of physical activity and unmet medical need.
European Journal of Preventive Cardiology 2015; 22:1129-1138.

Candido do Reis FJ, Lynn S, Ali HR, Eccles D, Hanby A, Provenzano E, Caldas C, Howqat WJ, McDuffus LA, Liu B, Daley F, Coulson P, Vyas RJ, Harris LM, Owens JM, Carton AFM, McQuillan JP, Paterson AM, Hirji Z, Christie SK, Holmes AR, Schmidt MK, Garcia-Closas M, Easton DF, Bolla MK, Wang Q, Benitez J, Milne RL, Mannermaa A, couch F, Defilee P, cox A, Cross SS, Blows FM, Sanders J, de Groot R, Figueroa J, Sherman M, Hooning M, Brenner H, Holleczek B, Stegmaier C, Lintott C, Pharoah PDP for the Citizen Science Alliance.
Croudsourcing the general public for large scale molecular pathology studies in cancer.
EBioMedicine 2015; 2:681-689.

Meid AD, Quinzler R, Feigofas J, Saum K-U, Schöttker B, Holleczek B, Heider D, König H-H, Brenner H, Haefeli WE.
Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study.
PLoS One 2015;10:e0136339.

Surinova S, Choi M, Tao S, Schüffler PJ, Chang CY, Clough T, Vyslouzil K, Khoylou M, Srovnal J, Liu Y, Matondo M, Hüttenhain R, Weisser H, Buhmann JM, Hajdúch M, Brenner H, Vitek O, Aebersold R.
Prediction of colorectal cancer diagnosis based on circulating plasma proteins.
EMBO Molecular Medicine 2015; 7:1166-1178.

Surinova S, Radová L, Choi M, Srovnal J, Brenner H, Vitek O, Hajdúch M,  Aebersold R.
Non-invasive prognostic protein biomarker signatures associated with colorectal cancer.
EMBO Molecular Medicine 2015; 7:1153-1165.

Khalili H, Gong J, Brenner H, Austin TR, Hutter CM, Baba Y, Baron JA, Berndt SI, Bézieau S, Caan B, Campbell PT, Chang-Claude J, Chanock SJ, Chen C, Hus L, Jiao S, Conti DV, Duggan D, Fuchs CS, Gala M, Gallinger S, Haile RW, Harrison TA, Hayes R, Hazra A, Henderson B, Haiman C, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Küry S, LaCroix A, le Marchand L, Lemire M, Lindor NM, Ma J, Manson JE, Morikawa T, nan H, Ng K, Newcomb PA, Nishihara R, Potter JD, Qu C, Schoen RE, Schumacher FR, Seminara D, Taverna D, Thibodeau S, Wactawski-Wende J, White E, Wu K, Zanke BW, Casey G, Hudson TJ, Kraft P, Peters U, Slattery ML, Ogino S, Chan AT on behalf of GECCO and CCFR.
Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.
Carciogenesis 2015; 36:999-1007.

Saum KU, Dieffenbach AK, Jansen EHJM, Schöttker B, Holleczek B, Hauer K, Brenner H.
Association between oxidative stress and frailty in an elderly German population: results from the ESTHER cohort study.
Gerontology 2015; 61:407-415.

Guo Q, Schmidt MK, Kraft P, Canisius S, ..., Brenner H, Dieffenbach AK, Arndt V, ..., Pharoah PDP.
Identification of novel genetic markers of breast cancer survival.
Journal of the National Cancer Institute 2015; 107:djv081.

Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kin C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach AK, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Heinrich H, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P,  Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ.
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis - a meta-analysis.
Journal of the National Cancer Institute 2015; 107:djv100.

Dworschak GC, Draaken M, Hilger AC, Schramm C, Bartels E, Schmiedeke E, Grasshoff-Derr S, Märzheuser S, Holland-Cunz S, Lacher M, Jenetzky E, Zwink N, Schmidt D, Nöthen MM, Ludwig M, Reutter H.
Genome-wide mapping of copy number variations in patients with both anorectal malformations and central nervous system abnormalities.
Birth Defects Research Part A: Clinical and Molecular Teratology 2015; 103:235-242.

Draaken M, Knapp M, Pennimpede T, Schmidt JM, Ebert AK, Rösch W, Stein R, Utsch B, Hirsch K, Boemers TM, Mangold E, Heilmann S, Ludwig KU, Jenetzky E, Zwink N, Moebus S, Herrmann BG, Mattheisen M, Nöthen MM, Ludwig M, Reutter H.
Genome-wide association study and meta-analysis identify ISL1 as genome-wide significant susceptibility gene for bladder exstrophy.
PLoS Genetics 2015; 11:e1005024.

Springvloet L, Willemsen MC, Mons U, van den Putte B, Kunst AE, Guignard R, Hummel K, Allwright S, Siahpush M, de Vries H, Nagelhout GE.
Educational differences in associations of noticing anti-tobacco information with smoking-related attitudes and quit intentions: findings from the International Tobacco Control Europe Surveys.
Health Education Research 2015; 30:719-730.

Rothenbacher D, Dallmeier D, Mons U, Rosamond W, Koenig W, Brenner H.
Sexual activity patterns before myocardial infarction and risk for subsequent cardiovascular adverse events.
JACC 2015; 66:1516-1517.

Brenner H.
Mortality from malignant melanoma in an era of nationwide skin cancer screening.
Deutsches Ärzteblatt 2015; 112:627-628.

Anderson LA, Tavilla A, Brenner H, Luttmann S, Navaro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon f, Sant M, EUROCARE-5 Working Group.
Survival for oesophageal, stomach and small intestine cancers: results from EUROCARE-5.
European Journal of Cancer 2015; 51:2144-2157.

Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, Hackl M, Eisemann N, Brenner H, and the EUROCARE-5 Working Group.
On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe - results from the EUROCARE-5 study.
European Journal of Cancer 2015; 51:2158-2168.

Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, Santaquilani M, Trama A, Allemani C, Belot A, Buzzoni C. Lorez M, De Angelis R, and the EUROCARE-5 Working Group*.
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.
European Journal of Cancer 2015; 51:2104-2119.
*Member from DKFZ: Brenner H.

Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, Micheli A, Lillini R, Francisci S, and the EUROCARE-5 Working Group.
Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study.
European Journal of Cancer 2015; 51:2120-2129.
*Member from DKFZ: Brenner H.

Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L, and the EUROCARE-Working Group.
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study.
European Journal of Cancer 2015; 51:2130-2143.
*Member from DKFZ: Brenner H.

Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J, and the EUROCARE-5 Working Group*.
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.
European Journal of Cancer 2015; 51:2169-2178.
*Member from DKFZ: Brenner H.

Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, Lopez MDC, Innos K, Minicozzi P, Borgognoni L, Pierannunzio D, Eisemann N, and the EUROCARE-5 Working Group*.
Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study.
European Journal of Cancer 2015; 51:2179-2190.
*Member from DKFZ: Brenner H.

Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P, The EUROCARE-5 Working Group*.
Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.
European Journal of Cancer 2015; 51:219-2205.
*Member from DKFZ: Brenner H.

Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, Tavilla A, Van Eycken L, Nicolai N, and the EUROCARE-5 Working Group*.
Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.
European Journal of Cancer 2015; 51:2206-2216.
*Member from DKFZ: Brenner H.

Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M, and the EUROCARE-5 Working Goup*.
Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5.
European Journal of Cancer 2015; 51:2217-2230.
*Member from DKFZ: Brenner H.

Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P, The EUROCARE-5 Working Group*.
Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study.
European Journal of Cancer 2015; 51:2231-2241.
*Member from DKFZ: Brenner H.

Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grinsrud TK, Knijn A, Pastorino U, Salmerón D Trama A, Sant M, and the EUROCARE-5 Working Group*.
Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study.
European Journal of Cancer 2015; 51:2242-2253.
*Member from DKFZ: Brenner H.

De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A, and the EUROCARE-5 Working Group*.
Survival variations by country and age for lymphoid an myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.
European Journal of Cancer 2015; 51:2254-2268.
*Member from DKFZ: Brenner H.

Gao X, Jia M, Zhang Y, Breitling LP, Brenner H.
DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies.
Clinical Epigenetics 2015; 7:113.

Brenner H, Stock C, Hoffmeister M.
Colorectal cancer screening: the time to act is now.
BMC Medicine 2015; 13:262.

Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neals D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, PRACTICAL Consortium, Lathrop M, Smith GD, Martin MR.
The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.
Cancer Causes Control 2015; 26:1603-1616.

Brenner H, Hoffmeister M, Jansen L.
Comparisons of colorectal cancer mortality between screening participants and the general population are strongly biased unless an incidence-based mortality approach is used. 
Journal of Clinical Epidemiology 2014; 67:184-189.

De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; the EUROCARE-5 Working Group.
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study.
The Lancet Oncology 2014; 15:23-34.

Schoeps A, Rudolph A, Seibold P, Dunning A, Milne R, Bojesen S, Swerdlow A, Andrulis I, Brenner H, ..., Dieffenbach AK, Arndt V, Stegmaier C, ..., Hall P, Easton D, Chang-Claude J.
Indentification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.
Genetic Epidemiology 2014; 38:84-93.

Bock JO, Matschinger H, Brenner H, Wild B, Haefeli WE, Quinzler R, Saum KU, Heider D, König HH.
Inequalities in out-of-pocket payments for health care services among elderly Germans - results of a population-based cross-sectional study.
International Journal for Equity in Health 2014; 13:3.

Pulte DP, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H and the GEKID Cancer Survival Working Group.
Survival of adults with acute lymphoblastic leukemia in Germany and the United States.
PLoS One 2014; 9:e85554.

Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H.
F2RL3 methylation as a biomarker  of current and lifetime smoking exposures.
Environmental Health Perspectives 2014; 122:131-137.

Florath I, Butterbach K, Müller H, Bewerunge-Hudler M, Brenner H.
Cross-sectional and longitudinal changes in DNA methylation with age: An epigenome-wide analysis revealing over 60 novel age-associated CpG sites.
Human Molecular Genetics 2014; 23:1186-1201.

Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Zamora P, Benítz J, Milne RL.
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
British Journal of Cancer 2014; 110:1088-1100.

Brenner H, Hoffmeister M.
Darmkrebsfrüherkennung.
Bundesgesundheitsblatt 2014; 57:302-306.

Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M.
Reduced risk of colorectal cancer up to 10 years after screening surveillance or diagnostic colonoscopy.
Gastroenterology 2014; 146:709-717.

Genuneit J, Braig S, Brandt S, Wabitsch M, Florath I, Brenner H, Rothenbacher D.
Infant atopic eczema and subsequent attention-deficit/hyperactivity disorder - a prospective birth cohort study.
Pediatric Allergy and Immunology 2014; 25:51-56.

Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Littel S, Tymrakiewicz M, Wiklund F, ..., Brenner H, ..., COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Easton DF, Muir K, Eeles RA, Kote-Jarai Z.
Fine-mapping the HOXB region detects common variants tagging a rare coding allele - evidence for synthetic association in prostate cancer.
PLoS Genetics 2014; 10:e1004129.

Heider D, Matschinger H, Müller H, Saum KU, Quinzler R, Haefeli WE, Wild B, Lehnert T, Brenner H, König HH.
Health care costs in the elderly in Germany: an analysis applying Andersen's behavioral model of health care utilization.
Health Services Research 2014; 14:71.

Pennells L, Kaptoge S, White IR, Thompson SG, Wood AM; Emerging Risk Factors Collaboration*.
Assessing risk prediction models using individual participant data from multiple studies.
American Journal of Epidemiology 2014; 179:621-632.
* Authors on behalf of the ESTHER study: Brenner H, Schöttker B, Müller H, Rothenbacher D.

Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R, EUROCARE Working Group*.
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 -- a population-based study.
Lancet Oncology 2014; 15:35-47.
*Members from Germany: Meyer M, Stabenow R, Eberle A, Luttmann S, Brenner H, Nennecke A, Engel J, Schubert-Fritschle G, Kieschke J, Batzler W, Holleczek B, Katalinic A.

Tao S, Hoffmeister M, Brenner H.
Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
Clinical Gastroenterology and Hepatology 2014; 12:478-485.

Nagelhout GE, van den Putte B, Allwright S, Mons U, McNeill A, Guignard R, Beck F, Siahpush M, Joossens L, Fong GF, de Vries H, Willemsen MC.
Socioeconomic and country variations in cross-border cigarette purchasing as tobacco tax avoidance strategy. Findings from the ITC Europe Surveys.
Tobacco Control 2014; 23:i30-i38.

Rennen E, Nagelhout GE, von den Putte B, Janssen E, Mons U, Guignard R, Beck F, de Vries H, Thrasher JF, Willemsen MC.
Associations between tobacco control policy awareness, social acceptability of smoking and smoking cessation. Findings from the International Tobacco Control (ITC) Europe Surveys.
Health Education Research 2014; 29:72-82.

Leoncini E, Ricciardi W, Cadoni G, Arzani D, Petrelli L, Paludetti G, Brennan P, Luce D, Stucker I, matsuo K, Talamini R, La Vecchia C, Olshan AF, Winn DM, Herreror R, Franceschi S, Castellsague X, Muscat J, Morgenstern H, Zhang ZF, Levi F, Dal Maso L, Kelsey K, McClean M, Vaughan TL, Lazarus P, Purdue MP, Hayes RB, Chen C, Schwartz SM, Shangina O, Koifman S, Ahrens W, Matos E, Lagiou P, Lissowska J, Szeszenia-Dabrowska N, Fernandez L, Menezes A, Agudo A, Daudt AW, Richiardi L, Kjaerheim K, Mates D, Betka J, Yu GP, Schantz S, Simonato L, Brenner H, Conway DI, Macfarlane TV, Thomson P, Fabianova E, Znaor A, rudnai P, Healy C, Boffetta P, Chuang SC, Lee YC, Hashibe M, Boccia S.
Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium.
European Journal of Epidemiology 2014; 29:35-48.

Müezzinler A, Zaineddin AK, Brenner H.
Body mass index and leukocyte telomere length in adults: a systematic review and meta-analysis.
Obesity Reviews 2014;15:192-201.

Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, and the GEKID Cancer Survival Working Group.
Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century.
British Journal of Haematology 2014; 164:851-857.

Brenner H, Hoffmeister M, Birkner B, Stock C.
Diagnostic performance of guaiac based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.
American Journal of Gastroenterology 2014; 109:427-435.

Milne RL, Herranz J, Michailidou K, Dennis J, Tyrer JP,  Zamora MP, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Benitez J, Malats N, Easton DF.
A large-scale assessment of two-way SNP interactions in breast cancer suceptibility using 46.450 cases and 42.461 controls from the Breast Cancer Association Consortium.
Human Molecular Genetics 2014; 23:1934:1946.

Florath I, Kohler M, Weck MN, Brandt S, Rothenbacher D, Schöttker B, Moß A, Gottmann P, Wabitsch M, Brenner H.
Association of pre- and postnatal parental smoking with offspring body mass index: 8-year follow-up of a birth cohort.
Pedatric Obesity 2014; 9:121-134.

Chen H, Werner S, Tao S, Zörnig I, Brenner H.
Blood antibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
Cancer Letters 2014; 346:178-187.

Hoffmeister M, Jansen L, Stock C, Chang-Claude J, Brenner H.
Smoking, lower gastrointestinal endoscopy, and risk for colorectal cancer.
Cancer Epidemiology, Biomarkers & Prevention 2014: 23:525-533.

The Emerging Risk Factor Collaboration*
Glycated hemoglobin measurement and prediction of cardiovascular disease.
JAMA 2014; 311:1225-1233
*Author on behalf of the ESTHER study: Brenner H.

Brenner H, Hoffmeister M, Birkner B, Stock C.
Men with negative results of guaiac based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
International Journal of Cancer 2014; 134:2927-2934.

Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig S, Brenner H, Arndt V.
Fear of recurrence in long-term breast cancer survivors - still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the Cancer Survivorship - a multi-regional population-based study..
Psycho-Oncology 2014; 23:547-554.

Brenner H, Stock C, Hoffmeister M.
Effect of  screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.
British Medical Journal 2014;348:g2467 doi: 10.1136/bmj.g2467.

Maalmi H, Ordonez-Mena JM, Schöttker B, Brenner H.
Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studies.
European Journal of Cancer 2014; 50:1510-1521.

Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H for the GEKID Cancer Survival Group.
Socio-economic deprivation and cancer survival in Germany.
International Journal of Cancer 2014; 134;2951-2960.

Jansen L, Hoffmeister M, Arndt V, Chang-Claude J, Brenner H.
Stage-speicific associations between beta blocker use and prognosis after colorectal cancer.
Cancer 2014; 120:1178-1186.

Brenner H, Kloor M, Pox C.
Colorectal cancer. 
Lancet 2014; 383:1490-1502.

Figueiredo JC, Hsu L, Hutter CM, Campbell PT, Baron JA, Berndt SI, Shuo J, Casey G, Fortini B, Chan AT, Cotterchio M, Lemire M, Gallinger S, Harrison TA, Le Marchand L, Newcomb PA, Slattery ML, Caan BJ, Carlson CS, Zanke BW, Rosse SA, Brenner H, Giovannucci EL, Wu K, Chang-Claude J, Chanock SJ, Curtis KR, Duggan D, Gong J, Haile RW, Hayes RB, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Qu C, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Stelling DL, Thibodeau SN, Thornquist M, Warnick GS, Henderson BE, Ulrich CM, Gauderman WJ, Potter JD, White E, and Peters U on behalf of CCFR and GECCO.
Genome-wide diet-gene interaction analyses for risk of colorectal cancer.
PLoS Genetics 2014; 10:e1004228.

Sawyer E, Roylance R, Petridis C, Brook MN, Sowinski S, Papouli E, ..., Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, ..., Schmidt MK, Tomlinson I, Garcia-Closas M.
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
PLoS Genetics 2014; 10e1004285.

Kolar DR, Bürger A, Hammerle F, Jenetzky E.
Aversive tension of adolescents with anorexia nervosa in daily course: a case-controlled and smartphone-based ambulatory monitoring trial.
BMJ Open 2014; 4:e004703.

Cheng I, Kocarnik JM, Dumitrescu L, Lindor N, Chang-Claude J, Avery C, Caberto C, Love SA, Slattery ML, Chan AT, Baron J, Hindorff LA, Park SL, Schumacher FR, Hoffmeister M, Kraft P, Butler A, Junkins HA, Duggan D, Hou L, Carlson CS, Monroe K, Lin Y, Carty CL, Mann S, Ma J, Giovannucci E, Fuchs C, Newcomb P, Jenkins M, Hopper J, Haile R, Conti DV, Campbell PT, Potter J, Caan B, Schoen RE, Hayes R, Chanock S, Berndt S, Kury S, Bezieau S, Ambite JL, Kumaraguruparan G, Richardson D, Goodloe RJ, Dikls HH, Baker P, Zanke B, Lemire M, Gallinger S, Hsu L, Jiao S, Harrison T, Seminara D, Haiman CA, Kooperberg C, Wilkens LR, Hutter C, White E, Bush WS, Heiss G, Hudson TJ, Crawford DC, Brenner H, Casey G, Le Marchand L, Peters U.
Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO, and CCFR Consortia.
Gut 2014; 63:800-807.

Pulte D, Redaniel MT, Brenner H, Jansen L, Jeffreys M.
Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.
Leukemia and Lymphoma 2014; 55:1083-1089.

Brenner H, Hoffmeister M, Stock C.
Neue Tests zur Darmkrebsfrüherkennung. Qualitätssicherung in der Routine ist notwendig und gut realisierbar.
Deutsches Ärzteblatt 2014; 19: 842-843.

Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, Holleczek B, Gondos A, Brenner H, and the GEKID Cancer Survival Working Group.
Survival of cancer patients in urban and rural areas of Germany - a comparison.
Cancer Epidemiology 2014; 38: 259-265.

Schöttker B, Saum KU, Perna L, Ordonez-Mena JM, Holleczek B, Brenner H.
Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health?
European Journal of Epidemiology 2014; 29:199-210.

Saum KU, Dieffenbach AK, Müller H, Holleczek B, Hauer K, Brenner H.
Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study.
European Journal of Epidemiology 2014; 29: 171-179.

Zhang B, Jia WH, Matsuda K, ..., Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)*, ..., Shu XO, Zeng YX, Zheng W.
Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.
Nature Genetics 2014; 46: 533.542.
*Authors on behalf of the DACHS study: Brenner H, Chang-Claude J, Hoffmeister M.

Sainz J, Frank B, Da Silva Filho MI, Hoffmeister M, Rudolpf A, Butterbach K, Chang-Claude J, Brenner H, Hemminki K, Försti A.
GWAS-identified common variants for obesity are not associated with the risk of developing colorectal cancer.
Cancer Epidemiology, Biomarkers & Prevention 2014; 23:1125-1128.

Mons U, Hahmann H, Brenner H.
A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements.
Heart 2014; 100:1043-1049.

Jiao S, Peters U, Berndt S, Brenner H, Butterbach K, Caan BJ, Carlson CS, Chan AT, Chang-Claude J, Chanock S, Curtis KR, Duggan D, Gong J, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Kolonel LN, Le marchand L, Potter JD, Prentice RK, Rudolph A, Schoen RE, Seminara D, Slattery L, White E, Hsu L.
Estimate the heritability of colorectal cancer.
Human Molecular Genetics 2014; 23:3898-3905.

Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EHJM, de Groot I, Streppel M, Gardiner J, Ordonez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kampman E, Siganos G, Njølstad I, Mathiesen EB, Kubinová R, Pajak A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P, Brenner H, on behalf of the Consortium on Health and Ageing: Network of cohorts in Europe and the United States (CHANCES).
Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States.
British Medical Journal 2014; 348:g3656.

Perna L, Mons U, Kliegel M, Brenner H.
Serum 25-hydroxyvitamin D and cognitive decline: a longitudinal study among non-demented older adults.
Dementia and Geriatric Cognitive Disorders 2014; 38:254-263.

Wijers CH, de Blaauw I, Zwink N, Draaken M, van der Zanden LF, Brunner HG, Brooks A, Hofstra RM, Sloots CE, Broens PM, Wijnen MH, Ludwig M, Jenetzky E, Reutter H, Marcelis CL, Roeleveld N, van Rooij IA.
No major role for periconceptional folic acid use and its interaction with the MTHFR C677T polymorphism in the etiology of congenital anorectal malformations.
Birth Defects Research (Part A): Clinical Molecular Teratology 2014; 100:483-492.

Freigofas J, Haefeli WE, Schöttker B, Brenner H, Quinzler R.
Indirect evidence for proton pump inhibitor failure in patients taking them independent of meals.
Pharmacoepidemiology and Drug Safety 2014; 23:768-772.

Brenner H, Werner S, Chen H.
Re: Multitarget stool DNA testing for colorectal-cancer screening.
New England Journal of Medicine 2014; 371:184-188.

Gerola S, Nittka S, Kähler G, Tao S, Brenner H, Binelle G, Eils R, Brors B, Neumaier M.
Genetic variants in apoptosis-related genes associated with colorectal hyperplasia.
Genes, Chromosomes & Cancer 2014; 53:769-778.

German National Cohort (GNC) Consortium*.
The German National Cohort: aims, study design and organiziation.
European Journal of Epidemiology 2014; 29:371-382.
* Authors from the German Cancer Research Center: Brenner H. Greiser KH, Kaaks R.

Zhang Y, Yang R, Burwinkel B, Breitling LP, Holleczek B, Schöttker B, Brenner H.
F2RL3 methylation in blood DNA is a strong predictor of mortality.
International Journal of Epidemiology 2014; 43:1215-1225.

Walter V, Jansen L, Hoffmeister M, Brenner H.
Smoking and survival of colorectal cancer patients - Systematic review and meta-analysis.
Annals of Oncology 2014; 25:1517-1525.

Lukczynska A, Logan C, Nieters A, Elgizouli M, Florath I, Schöttker B, Brenner H, Rothenbacher D.
Cord blood 25 (OH) D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm Birth Cohort.
European Journal of Epidemiology 2014; 29:585-594.

Coresh J, Chowdhury T, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; for the CKD Prognosis Consortium*.
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.
Journal of the American Medical Association 2014; 311:2518-2531
*Authors on behalf of the ESTHER study: Rothenbacher D, Brenner H, Müller H, Schöttker B.

Sant M, Minicozzi P, Mounier M, Anderson L, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R, and the EUROCARE-5 Working Group.
Survival for haematological malignancies in Europe 1997-2008 by region and age: results of a EUROCARE-5 population-based study.
The Lancet Oncology 2014; 15:931-942.

Wang H, Burnett T, Kono S, ..., GECCO Consortium members*, ..., CCFR Consortium members, ..., CORECT Consortium members, Tsugane S, Stram DO, Le Marchand L.
Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VT/1A.
Nature Communications 2014; 5:4613.
*GECCO Consortium members from DKFZ: Brenner H, Chang-Claude J, Hoffmeister M.

Brandt S, Moß A, Lennerz B, Koenig W, Weyermann M, Rothenbacher D, Brenner H, Waitsch M.
Plasma insulin levels in childhood are related to maternal factors - Results of the Ulm Birth Cohort Study.
Pediatric Diabetes 2014; 15:453-463.

Brenner H, Altenhofen L, Stock C, Hoffmeister M.
Incidence of colorectal adenomas: Birth cohort analysis among 4.3 million participants of screening colooscopy.
Cancer Epidemiology, Biomarkers & Prevention 2014; 23: 1920-1927.

Hirsch O, Kluckner VJ, Brandt S, Moss A, Weck M, Florath I, Wabitsch M, Hebebrand J, Schimmelmann BG, Christiansen H.
Restrained and external-emotional eating patterns in young overweight childrend - results of the ulm birth cohort study.
PLoS One 2014; 9:e105303.

Ordonez-Mena JM, Brenner H.
Vitamin D and cancer: an overview on epidemiological studies.
Advances in Experimental Medicine and Biology 2014; 810:17-32.

Wild B, Eckl A, Herzog W, Niehoff D, Lechner S, Maatouk I, Schellberg D, Brenner H, Müller H, Löwe B.
Assessing generalized anxiety disorder in elderly people by use of the GAD-7 and GAD-2 scales - results of a validation study.
American Journal of Geriatric Psychiatry 2014; 22:1029-1038.

Dihlmann S, Tao S, Echterdiek F, Herpel E, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Kloor M.
Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
International Journal of Cancer 2014; 135:2387-2396.

Florath I, Brandt S, Weck M, Moss A, Gottmann P, Rothenbacher D, Wabitsch M, Brenner H.
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference.
Nutrition, Metabolism & Cardiovascular Diseases 2014; 24:1112-1119.

Vimaleswaran KS, Cavadino A, Berry DJ, ..., Dieffenbach AK, ..., Schöttker B, Saum KU, ..., Brenner H, ..., Whittaker JC, Järvelin M-R, Hyppönen E.
A causal association between vitamin D status and hypertension: a Mendelian randomization study in up to 146,581 individuals. 
Lancet Diabetes & Endocrinology 2014; 2:719-729.

Kantor ED, Hutter CM, Minnier J, Berndt SI, Brenner H, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Cotterchio M, Du M, Duggan D, Fuchs CS, Giovannucci EL, Gong J, Harrison TA, Hayes RB Henderson BE, Hoffmeister M, Hopper JL, Jenkins MA, Jiao S, Kolonel LN, Le Marchand L, Lemire M, Ma J, Newcomb PA, Ochs-Balcom HM, Pflugeisen BM, Potter JD, Rudolph A, Schoen RE, Seminara D, Slattery ML, Stelling DL, Thomas F, Thornquist M, Ulrich CM, Warnick GS, Zanke BW, Peters U, Hsu L, White E.
Gene-environment interaction involving recently identified colorectal cancer susceptibility loci.
Cancer Epidemiology Biomarkers & Prevention 2014; 23:1824-1833.

Menvielle G, Truong T, Jellouli F, Stücker I, Brenner H, Field JK, Hosgood HD, Hung RJ, Lan Q, Landi MT, Lazarus P, McLaughlin J, Morgenstern H, Muscat JE, Ruano-Ravina A, Schwartz AG, Seow A, Spitz M, Tardon A, Zhang Z-F, Luce D.
Education and lung cancer among never smokers.
Epidemiology 2014; 25:934-935.

Wild B, Heider D, Maatouk I, Slaets J, König HH, Niehoff D, Saum KU, Brenner H, Sönner W, Herzog W.
Significance and costs of complex bio-psycho-social health care needs in elderly people - results of a population-based study.
Psychosomatic Medicine 2014; 76:497-502.

Krilaviciute A, Smailyte G, Brenner H, Gondos A.
Cancer survival in Lithuania after the restoration of independence: rapid improvements, but persisting major gaps.
Acta Oncologica 2014; 53:1238-1244.

Saum KU, Dieffenbach AK, Müezzinler A, Müller H, Stegmaier C, Butterbach K, Canzian F, Stammer H, Boukamp P, Hauer K, Brenner H.
Frailty and telomere length: Cross sectional analysis in 3537 older adults from the ESTHER cohort.
Experimental Gerontology 2014; 58:250-258.

Al Olama AA, Kote-Jarai Z, Berndt SI, ..., Brenner H, ..., The Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL Consortium, The COGS Consortium, The GAME-ON/ELLIPSE Consortium, ..., Easton DF, Eeles R, Haiman CA.
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.
Nature Genetics 2014; 46:1103-1109.

Reutter H, Draaken M, Pennimpede T, Wittler L, Brockschmidt FF, Ebert AK, Bartels E, Rösch W, Boemers TM, Hirsch K, Schmiedeke E, Meesters C, Becker T, Stein R, Utsch B, Mangold E, Nordenskjöld A, Barker G, Kockum CC, Zwink N, Holmdahl G, Läckgren G, Jenetzky E, Feitz WF, marcelis C, Wijers CH, van Rooij IA, Gearhart JP, Herrmann BG, Ludwig M, Boyadjiev SA, Nöthen MM, Mattheisen M.
Genome-wide association  study and mouse expression data identify a highly conserved 32kb intergenic region between WNT3 and WNT9b as possible susceptibility locus for isolated classic exstrophy of the bladder.
Human Molecular Genetics 2014; 23:5536-5544.

Perry JR, Day F, Elks CE, Sulem P, ..., Brenner H, ..., Dieffenbach AK, ..., Stefansson K, Murabito JM, Ong KK.
Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche.
Nature 2014; 514:92-97.

Ghoussaini M, Edwards SL, Michailidou K, ..., Brenner H, Dieffenbach AK, Arndt V, Staegmaier C, ..., French JD, Easton DF, Dunning AM.
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Nature Communications 2014; 4:4999.

Holleczek B, Brenner H.
Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.
BMC Cancer 2014; 14:757.

Breitling LP, Olsen H, Müller H, Schöttker B, Kliegel M, Brenner H.
Self- or physician-reported diabetes, glycemia markers, and cognitive functioning in older adults in Germany.
American Journal of Geriatric Psychiatry 2014; 11:1105-1115.

Purrington KS, Slettedahl S, Bolla MK, ..., Brenner H, ..., Dieffenbach AK, Stegmaier C, Arndt V, ..., Slager S, Vachon CM, Couch FJ.
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
Human Molecular Genetics 2014; 23:6034-6046.

Zeidler C, Woelfle J, Draaken M, Mughai SS, Große G, Hilger AC, Dworschak GC, Boemers TM, Jenetzky E, Zwink N, Lacher M, Schmidt D, Schmiedeke E, Grasshoff-Derr S, Märzheuser S, Holland-Cunz S, Schäfer M, Bartels E, Keppler K, Palta M, Leonhardt J, Kujath C, Rißmann A, Nöthen MM, Reutter H, Ludwig M.
Heterozygous FGF8 mutations in patients presenting cryptorchidism and multiple VATER/VACTERL features without limb anormalies.
Birth Defects Research Part A: Clinical and Molecular Teratology 2014; 100:750-759.

Jia WH, Zhang B, Matsuo K, Shin A, Xiang YB, Jee SH, Kim DH, Ren Z, Cai Q, Long J, Shi J, Wen W, Yang G, Delahanty RJ; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO); Colon Cancer Family Registry (CCFR), Ji BT, Pan ZZ, Matsuda F, Gao YT, Oh JH, Ahn YO, Park EJ, Li HL, Park JW, Jo J, Jeong JY, Hosono S, Casey G, Peters U, Shu XO, Zeng YX, Zheng W (Investigators/Collaborators for the DACHS study in the GECCO Consortium: Brenner H, Butterbach K, Chang-Claude J, Hoffmeister M). 
Genome-wide association analyses in east Asians identify new susceptibility loci for colorectal cancer.
Nature Genetics 2012; 45: 191-196.

Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H, and the GEKID Cancer Survival Working Group.
Survival of ovarian cancer patients in Germany in the early 21st century:a period analysis by age, histology, laterality and stage.
European Journal of Cancer Prevention 2013; 22: 59-67.

Schöttker B, Müller H, Rothenbacher D, Brenner H.
Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.
Diabetologia 2013; 56: 92-100.

Al Olama AA, Kote-Jarai Z, Schumacher FR, ..., Brenner H, …, Muller H, Rothenbacher D…; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The Australian Prostate Cancer Bioresource; The PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA. 
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. 
Human Molecular Genetics 2013; 22: 408-415.

Perna L, Felix J, Breitling LP, Haug U, Raum E, Burwinkel B, Schöttker B, Brenner H.
Genetic variations in the vitamin D binding protein and season specific serum levels of 25-hydroxyvitamin D among older adults.
Epidemiology 2013; 24: 104-109.

Brenner H, Altenhofen L, Tao S.
Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests.
Journal of Clinical Epidemiology 2013; 66: 202-208.

von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M, Aabakken L, Altenhofen L, Ancelle-Park R, Antoljak N, Anttila A, Armaroli P, Arrossi S, Austoker J, Banzi R, Bellisario C, Blom J, Brenner H, Bretthauer M, Cancela MC, Costamagna G, Cuzick J, Dai M, Daniel J, Dekker E, Delicata N, Ducarroz S, Erfkamp H, Espinàs JA, Faivre J, Wood LF, Flugelman A, Frkovic-Grazio S, Geller B, Giordano L, Grazzini G, Green J, Hamashima C, Herrmann C, Hewitson P, Hoff G, Holten I, Jover R, Kaminski MF, Kuipers EJ, Kurtinaitis J, Lambert R, Launoy G, Lee W, Leicester R, Leja M, Lieberman D, Lignini T, Lucas E, Lynge E, Mádai S, Marinho J, Zakotnik JM, Minoli G, Monk C, Morais A, Muwonge R, Nadel M, Neamtiu L, Tuser MP, Pignone M, Pox C, Primic-Zakelj M, Psaila J, Rabeneck L, Ransohoff D, Rasmussen M, Regula J, Ren J, Rennert G, Rey J, Riddell RH, Risio M, Rodrigues V, Saito H, Sauvaget C, Scharpantgen A, Schmiegel W, Senore C, Siddiqi M, Sighoko D, Smith R, Smith S, Suchanek S, Suonio E, Tong W, Törnberg S, Van Cutsem E, Vignatelli L, Villain P, Voti L, Watanabe H, Watson J, Winawer S, Young G, Zaksas V, Zappa M, Valori R.*
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication.
Endoscopy 2013; 45: 51-59.
* European Colorectal Cancer Screening Guidelines Working Group.

Koch L, Jansen L, Brenner H, Arndt V.
Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors-a systematic review of quantitative studies.
Psychooncology 2013; 22: 1-11.

Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H, GEKID Cancer Survival Working Group..
Survival of patients with oral cavity cancer in Germany.
PLoS One 2013; 8: e53415.

Verhoeven RHA, Gondos A, Janssen-Heijnen MLG, Saum KU, Brewster DH, Crocetti E, Rosso S, Hakulinen T, Aareleid T, Brenner H, and the EUNICE Survival Working Group.
Testicular cancer in Europe and the USA: Survival still rising among older patients.
Annals of Oncology 2013; 24: 508-513.

Stock C, Ihle P, Sieg A, Schubert I, Hoffmeister M, Brenner H.
Adverse events requiring hospitalization within 30 days after outpatient screening and non-screening colonoscopy.
Gastrointestinal Endoscopy 2013; 77: 419-429.

Pulte D, Redaniel MT, Jansen L, Brenner H, Jeffreys M.
Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups.
Haematologica 2013; 98: 222-229.

Müezzinler A, Zaineddin AK; Brenner H.
A systematic review of leukocyte telomere length and age in adults.
Ageing Research Reviews 2013; 12: 509-519.

Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP.
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Clinical Research in Cardiology 2013; 102: 193-202).

Brenner H, Jansen L.
Determinants and interpretation of death certificate only (DCO) proportions in the initial years of newly established cancer registries.
European Journal of Cancer 2013.

Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, Kimm H, Kronenberg F, Øien CM, Levey AS, Levin A, Woodward M, Hemmelgarn BR, for the CKD Prognosis Consortium.* Do the associations of eGFR and albuminuria with mortality and renal failure differ by gender? A meta-analysis from a global consortium.
British Medical Journal 213; 346f: f324.
* Authors on behalf of the ESTHER study: Rothenbacher D, Brenner H, Müller H, Schöttker B.

Perna L, Butterbach K, Haug U, Schöttker B, Müller H, Arndt V, Holleczek B, Burwinkel B, Brenner H.
Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 437-442.

Gondos A, Döhler B, Brenner H,Opelz G.
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes.
Transplantation 2013; 95: 267-274.

Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense HW.
Datenqualität oder Unterschiede in der onkologischen Versorgung? ― Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten. 
Das Gesundheitswesen 2013; 75: 94-98.

Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B, Brenner H.
Strong associations of 25-hydroxyvitamin D levels with all-cause, cardiovascular, cancer and respiratory disease mortality in a large cohort study.
The American Journal of Clinical Nutrition 2013; 97: 782-793.

Jansen L, Hakulinen T, Brenner H.
Study populations for period analysis of cancer survival.
British Journal of Cancer 2013; 108: 699-707.

Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H, Brenner H.
Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2. A competing risk analysis in a large population-based cohort of older adults.
European Journal of Epidemiology 2013; 28: 267-275.

Verhoeven RHA, Janssen-Heijnen MLG, Saum K-U, Zanetti R, Caldarella A, Holleczek B, Brewster DH, Hakulinen T, Horenblas S, Brenner H, Gondos A, & the EUNICE Survival Working Group.
Population-based survival of penile cancer patients in Europe and the USA: No improvement since 1990.
European Journal of Cancer 2013; 49: 1414-1421.

Gaudet MM, Kuchenbaecker KB, Vijai J, ..., Brenner H, ...,Chenevix-Trench G, Antoniou AC, Offit K. 
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
PLoS Genetics 2013; 9: e1003173.

Nickels S, Truong T, Hein R, ..., Brenner H, Müller H, Arndt V, ..., Garcia-Closas M, Milne RL, Chang-Claude J.
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.
PLoS Genetics 2013; 9: e1003284.

French JD, Ghoussaini M, Edwards SL,..., Brenner H, Müller H, Arndt V, ..., Chenevix-Trench G , Easton DF, Dunning AM.
Functional variants at the 11q13 risk locus for breast cancer regulate Cyclin D1 expression through long-range enhancers.
American Journal of Human Genetics 2013; 92: 489-503

Holleczek B, Brenner H.
Model based period analysis of absolute and relative survival with R: Data preparation, model fitting and derivation of survival estimates.
Computer Methods and Programs in Biomedicine 2013; 110: 192-202.

Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, ..., Brenner H, Müller H, Arndt V, …, Garcia-Closas M, Pharoah PDP, Chenevix-Trench G, Dunning AM, Benitez J,Easton DF.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. 
Nature Genetics 2013; 45: 353-361.

Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, ... , Brenner H, ...,  Müller H, Arndt V, ..., Easton DF, Berchuck A, Antoniou AC, Chenevix-Trench G, Dunning AM. 
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature Genetics 2013; 45: 371-384.

Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, ..., Brenner H, …, Müller H, Rothenbacher D, …, The COGS–Cancer Research UKGWAS–ELLIPSE (part of GAME-ON) Initiative, The Australian Prostate Cancer Bioresource, The UKGenetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UKProtecT (Prostate testing for cancer and Treatment) Study Collaborators, The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF. 
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. 
Nature Genetics 2013; 45: 385-391.

Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, ... Brenner H, ..., Müller H, Arndt V, Pharoah PD, Vachon C, Easton DF, Haiman CA, Kraft P.
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Nature Genetics 2013; 45: 392-398.

Brenner H, Stock C, Hoffmeister M.
Darmkrebs-Screening.
Therapeutische Umschau 2013; 70: 231-235.

Ulrich CM, Toriola AT, Siegel EM, Brenner H , Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady W on behalf of the ColoCare Consortium.
Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among
international colorectal cancer patients: a pilot study.
Journal of Nutritional Science 2013; 2: e9.

Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H & the GEKID Cancer Survival Working Group.
Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
European Journal of Cancer Prevention 2013; 22: 210-214.

Zwink N, Jenetzky E, Hirsch K, Reifferscheid P, Schmiedeke E, Schmidt D, Reckin S, Obermayr F, Boemers TM, Stein R, Reutter H, Rösch WH, Brenner H, Ebert A-K.
Assisted reproductive techniques and the risk of the exstrophy-epispadias complex: A German case-control study.
The Journal of Urology 2013; 189: 1524-1529.

Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T,  Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia W-H, Kolonel LN, Kooperberg C, Küry S, LaCroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu X-O, Slattery ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng Y-X, Zhang B, Zheng W, Hsu L, On behalf of Colon Cancer Family Registry (CCFR) and Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO).
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-Analysis.
Gastroenterology 2013; 144: 799-807.

Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Kossler T, Pharoah P, Schafmayer C, Hampe J, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, von Holst S, Picelli S, Lindblom A, Jenkins MA, Hopper JL, Casey G, Duggan D, Newcomb PA, Abulí A, Bessa X, Ruiz-Ponte C, Castellví-Bel S, Niittymäki I, Tuupanen S, Karhu A, Aaltonen L, Zanke B, Hudson T, Gallinger S, Barclay E, Martin L, Gorman M, Carvajal-Carmona L, Walther A, Kerr D, Lubbe S, Broderick P, Chandler I, Pittman A, Penegar S, Campbell H, Tomlinson I, Houlston RS.
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals.
Gut 2013; 62: 871-881.

Shen H, Fridley BL, Song H, …, PRACTICAL Consortium*, …, Laird PW, Goode EL, Pearce CL.
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. 
Nature Communications 2013;4:1628. Doi: 10.1038/ncomms2629.
*  Author on behalf of the ESTHER study: Brenner H.

 

Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H.
Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: Evidence from a large population-based study in Germany.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 821-826.

Ordóñez-Mena JM, Schöttker B, Haug U, Müller H, Köhrle J, Schomburg L, Holleczek B, Brenner H.
Serum 25-hydroxyvitamin D and cancer risk in older adults. Results from a large German prospective cohort study.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 905-916.

Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H;Gekid Cancer Survival Working Group.
Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century.
Leukemia and Lymphoma 2013; 54: 979-985.

Chuang SC, Jenab M, Heck JE, Bosetti C, Talamini R, Matsuo K, Castellsague X, Franceschi S, Herrero R, Winn DM, Vecchia CL, Morgenstern H, Zhang ZF, Levi F, Maso LD, Kelsey K, McClean MD, Vaughan T, Lazarus P, Muscat J, Ramroth H, Chen C, Schwartz SM, Eluf-Neto J, Hayes RB, Purdue M, Boccia S, Cadoni G, Zaridze D, Koifman S, Curado MP, Ahrens W, Benhamou S, Matos E, Lagiou P, Szeszenia-Dabrowska N, Olshan AF, Fernandez L, Menezes A, Agudo A, Daudt AW, Merletti F, Macfarlane GJ, Kjaerheim K, Mates D, Holcatova I, Schantz S, Yu GP, Simonato L, Brenner H, Mueller H, Conway DI, Thomson P, Fabianova E, Znaor A, Rudnai P, Healy CM, Ferro G, Brennan P, Boffetta P, Hashibe M.
Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium.
Cancer Causes and Control 2012; 23: 69-88.

Breitling LP, Perna L, Müller H, Raum E, Kliegel M, Brenner H.
Vitamin D and cognitive functioning in the elderly population in Germany.
Experimental Gerontology 2012; 47: 122-127.

Pulte D, Gondos A, Brenner H.
Expected long-term survival of older patients diagnosed with non-Hodgkin lymphoma in 2008-2012. 
Cancer Epidemiology 2012; 36: e19-e25.

Hoffmeister M, Brenner H. 
Re: Sex-specific prevalence of adenomas and colorectal cancer.
JAMA 2012; 307: 142-143.

Schöttker B, Adamu MA, Weck MN, Müller H, Brenner H.
Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study.
Atherosclerosis 2012; 220: 569-574.

Mons U, Nagelhout GE, Guignard, R, McNeill A, van den Putte B, Willemsen MC, Brenner H, Pötschke-Langer M, Breitling, LP.
Comprehensive smoke-free policies attract more support from smokers in Europe than partial policies.
European Journal of Public Health 2012; 22: 10-16. 

Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, LaCroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M, Brenner H, Frank B, Bézieau S, Küry S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G, on behalf of CCFR and GECCO.
Meta-analysis of new genome-wide association studies of colorectal cancer risk.
Human Genetics 2012; 131: 217-234.

Maatouk I, Wild B, Wesche D, Herzog W, Raum E, Müller H, Rothenbacher D, Stegmaier C, Schellberg D, Brenner H.
Temporal predictors of health-related quality of life in elderly people with diabetes: results of a German cohort study.
PLoS One 2012; 7: e31088.

Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H, GEKID Cancer Survival Working Group.
Survival from common and rare cancers in Germany in the early 21st century.
Annals of Oncology 2012; 23: 472-479.

Stott-Miller M, Chen C, Chuang S-C, Lee YC, Boccia S, Brenner H, Cadoni G, Dal Maso L, La Vecchia C, Lazarus P, Levi F, Matsuo K, Morgenstern H, Muller H, Muscat J, Olshan AF, Purdue MP, Serraino D, Vaughan TL, Zhang Z-F, Boffetta P, Hashibe M, Schwartz SM.
History of diabetes and risk of head and neck cancer:a pooled analysis from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.
Cancer Epidemiology Biomarkers & Prevention 2012; 21: 294-304.

Stock C, Pulte D, Haug U, Brenner H.
Subsite-specific colorectal cancer risk in the colorectal endoscopy era.
Gastrointestinal Endoscopy 2012; 75: 621-630.

Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H.
Helicobacter pylori infection and colorectal cancer risk: Evidence from a large population-based case-control study in Germany.
American Journal of Epidemiology 2012; 175: 441-450. 

Frank B, Weck MN, Müller H, Klopp N, Illig T, Raum E, Brenner H.
Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.
European Journal of Cancer 2012; 48: 114-120.

Jansen L, Hakulinen T, Brenner H.
Standard errors of non-standardized and age-standardized relative survival of cancer patients.
British Journal of Cancer 2012; 106: 569-574.

Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J,  Wang J, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, HEBON, Hall P, Czene K, Irwanto A, Liu J,Nevanlinna H, Aittomäki K, Blomqvist C, Meindl A, Schmutzler RK, Müller-Myhsok B, Chang-Claude J, Hein R, Nickels S, Flesch-Janys D, Tsimiklis H, Makalic E, Schmidt D, Bui M, Hopper JJ, Apicella C, Park DJ, Southey M, Broeks A, Verhoef S, Hogervorst FBL, Fasching PA, Sawyer E, Tomlinson I, Kerin M, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Cordina-Duverger E, Menegaux F, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Alonso R, González-Neira A, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke Dur C, Brenner H, Müller H, Arndt V, Stegmaier C, FBCS, Justenhoven C, Brauch H, Pesch B, The GENICA Network, Wang-Gohrke S, Eilber U, Dörk T, Schürmann P, Bremer M, Hillemanns P, Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Khusnutdinova E,  Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma V-M, Hartikainen J, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Manoukian S, Bonanni B, Fortuzzi S, Peterlongo P, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Wang X, Stevens K, Lee A, Giles GG, Baglietto L, Severi G, McLean C, Grenaker Alnæs G, Kristensen V, Børrensen-Dale A-L, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Glendon G, Mulligan AM, Devilee P, van Asperen CJ, Tollenaar RAEM, Seynaeve C, Figueroa JD,  Garcia-Closas M, Brinton L, Lissowska J, Hooning MJ, Hollestelle A, Oldenburg RA, van den Ouweland AMW, Cox A, Reed MWR, Shah M, Jakubowska A, Lubinski J, Jaworska K, Durda K, Jones M, Schoemaker M, Ashworth A, Swerdlow A, Beesley J, Chen X, kConFab Investigators, Australian Ovarian Cancer Study Group, Muir KR, Lophatananon A, Rattanamongkongul S, Chaiwerawattana A, Kang D, Yoo K-Y, Noh D-Y, Shen C-Y, Yu J-C, Wu P-E, Hsiung C-N, Perkins A, Swann R, Velentzis L, Eccles DM, Tapper WJ, Gerty SM, Graham NJ, Ponder BA, Chenevix-Trench G, Pharoah PDP, Lathrop M, Dunning AM, Rahman N, Peto J, Easton DF.
Genome-wide association analyses identifies three new breast cancer susceptibility loci.
Nature Genetics 2012; 44: 312-318.

Holleczek B, Brenner H.
Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.
European Journal of Cancer 2012; 48: 797-804.

Schöttker B, Herder C, Müller H, Brenner H. Rothenbacher D. 
Clinical utility of creatinine and cystatin C based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes.
Diabetes Care 2012; 35: 879-886.

Wild B, Herzog W, Schellberg D, Lechner S, Niehoff D, Brenner H, Rothenbacher D, Stegmaier C, Raum E.
Association between the prevalence of depression and age in a large representative German sample of people aged 53 to 80.
International Journal of Geriatric Psychiatry 2012; 27: 375-381.

Campa D, Sainz J, Pardini B, Vodickova L, Naccarati A, Rudolph A, Novotny J, Försti A, Buch S, von Schönfels W, Schafmayer C, Völzke H, Hoffmeister M, Frank B, Barale R, Hemminki K, Hampe J, Chang-Claude J, Brenner H, Vodicka P, Canzian F.
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.
PLoS One 2012; 7: e32784.

Beyerlein A, Nehring I, Rzehak P, Heinrich J, Müller MJ, Plachta-Danielzik S, Wabitsch M, Weck M, Brenner H, Rothenbacher D, von Kries R.
Gestational weight gain and body mass index in children: results from three German cohort studies.
PLoS One 2012; 7: e33205.

Znaor A, Brenner H, Holleczek B, Gondos A.
Has there been progress in cancer care in Croatia? Assessing outcomes in a partially complete mortality follow-up setting.
European Journal of Cancer 2012; 48: 921-928.

Claessen H, Brenner H, Drath C, Arndt V.
Repeated measures of body mass index and risk of health related outcomes.
European Journal of Epidemiology 2012; 27: 215-224.

Wild B, Herzog W, Lechner S, Niehoff D, Brenner H, Müller H, Rothenbacher D, Stegmaier C, Raum E.
Gender Specific Temporal and Cross-Sectional Associations between BMI-class and Symptoms of Depression in the Elderly.
Journal of Psychosomatic Research (2012; 72: 376-382). 

van de Schans SAM, Gondos A, van Spronsen DJ, Rachtan J, Holleczek B, Zanetti R, Coebergh JWW, Janssen-Heijnen MLG, Brenner H.
Improving relative survival, but large remaining differences in survival for non-Hodgkin lymphoma across Europe and the US during 1990-2004.
Journal of Clinical Oncology 2011; 29: 192-199.

Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M.
Protection from colorectal cancer after colonoscopy: population-based case-control study.
Annals of Internal Medicine 2011; 154: 22-30.

Zigon G, Berrino F, Gatta G, Sánchez M.-J, van Dijk B, van Eycken E, Francisci S, the EUROCARE Working Group.*
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study.
Annals of Oncology 2011; 22: 165-174.
* members from Germany: Brenner H, Ziegler H., Holleczeck B.

Aareleid T, Gondos A, Brenner H, Pokker H, Leppik K, Mägi M.
Testicular cancer survival in Estonia: improving but still relatively low.
Acta Oncologica 2011; 50: 99-105.

Lattka E, Rzehak P, Szabó É, Jakobik V, Weck M, Weyermann M, Grallert H, Rothenbacher D, Heinrich J, Brenner H, Decsi T, Illig T, Koletzko B.
Genetic variants in the FADS gene cluster are associated with arachidonic acid levels of human breast milk at 1.5 and 6 months post partum and influence the course of milk dodecanoic, tetracosenoic and trans-19-octadecenoic acid levels over the duration of lactation.
American Journal of Clinical Nutrition 2011; 93: 382-391.

Lochhead, P*, Frank B*, Hold GL, Rabkin CS, Ng M, Vaughan TL, Risch HA, Gammon MD, Lissowska J, Weck MN, Raum E, Illig T, Klopp N, Dawson A, McColl KE, Brenner H, Chow, W-H, El-Omar EM.(*=equal contributions)
Genetic variation in the PSCA gene and upper gastrointestinal cancer risk in white individuals.
Gastroenterology 2011; 140: 435-441.

Frank B, Hoeft B, Hoffmeister M, Linseisen J, Breitling LP, Chang-Claude J, Brenner H, Nieters A.
Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
Carcinogenesis 2011; 32: 190-196.

Wild B, Lechner S, Herzog W, Maatouk I, Raum E, Müller H, Brenner H, Slaets J, Huyse F, Söllner W.
Reliable integrative assessment of health care needs in elderly persons - the INTERMED for the Elderly (IM-E).
Journal of Psychosomatic Research 2011; 70: 169-178.

 

Heil J, Czink E, Golatta M, Schott S, Hof H, Jenetzky E, Blumenstein M, Maleika A, Rauch G, Sohn C.
Change of aesthetic and functional outcome over time and their relationship to quality of life after breast conserving therapy.
European Journal of Surgical Oncology 2011; 37: 116-121.

Adamu MA, Weck MN, Rothenbacher D, Brenner H.
Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population based cohort study.
International Journal of Cancer 2011; 128: 1652-1658.

Stock C, Knudsen A, Lansdorp-Vogelaar I, Haug U, Brenner H.
Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy.
Gastrointestinal Endoscopy 2011; 73: 435-443.

The Emerging Risk Factors Collaboration.*
Diabetes mellitus, fasting glucose, and risk of cause-specific mortality.
New England Journal of Medicine 2011; 364: 829-841.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer 
C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude J.
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1 and SHBG genes with
colorectal cancer risk.
Endocrine-Related Cancer 2011; 18: 265-276.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Brenner H.
Cancer survival differences between European countries and an urban population from the Philippines.
European Journal of Public Health 2011; 21: 221-228.

Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H.
Tobacco smoking-related differential DNA methylation: 27k discovery and replication.
American Journal of Human Genetics 2011; 88: 450-457.

Tao S, Hundt S, Haug U, Brenner H.
Sensitivity estimates of blood based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease.
American Journal of Gastroenterology 2011; 106: 242-253.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.
Meta-analysis: Circulating vitamin D and ovarian cancer risk.
Gynecologic Oncology 2011; 121: 369-375.

Herder C, Schoettker B, Rothenbacher D, Roden M, Kolb H, Müller H, Brenner H.
Interleukin-6 in the prediction of primary cardiovascular events in 
diabetes patients: results from the ESTHER study.
Atherosclerosis 2011; 216: 244-247.

Yang R, Dick M, Marme F, Schneeweiss A, Langheinz A, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Varon R, Schott S, Weber BHF, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Müller H, Arndt V, Brenner H, Sohn C, Burwinkel B.
Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
Breast Cancer Research and Treatment 2011; 127: 549-554.

Vossen CY, Hoffmeister M, Chang-Claude J, Rosendaal FR, Brenner H.
Clotting factor gene polymorphisms and colorectal cancer risk.
Journal of Clinical Oncology 2011; 29: 1722-1727.

Sankaranarayanan, R, Swaminathan R, Jayant K, Brenner H.
An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services.
In: Sankaranarayanan, R, Swaminathan R (Eds.).
Cancer Survival in Africa, Asia, the Caribbean and Central America.
IARC Scientific Publications No. 162.
International Agency for Research on Cancer, Lyon, 2011, S. 257-291.

Pulte D, Gondos A, Redaniel MT, Brenner H.
Survival of patients with chronic myelocytic leukemia: comparisons of estimates from clinical trial settings and population based cancer registries.
The Oncologist 2011; 16: 663-671.

Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H.
Sensitivity of immunochemical faecal occult blood testing for detecting left- versus right-sided colorectal neoplasia.
British Journal of Cancer 2011; 104: 1779-1785.

Rudolph A, Sainz J, Hein R, Hoffmeister M, Frank B, Försti A, Brenner H, Hemminki K, Chang-Claude J.
Modification of menopausal hormone therapy associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Endocrine-Related Cancer 2011; 18: 371-384.

Zwink N, Jenetzky Ekkehart, Brenner H.
Parental risk factors and anorectal malformations: systematic review and meta-analysis.
Orphanet Journal of Rare Diseases 2011; 6:25.

Grandi NC, Breitling LP, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H.
Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
Heart 2011; 97: 1215-1221.

Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Canzian F, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, J Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, 
Stanford JL, Ostrander EA, Dalsgaard Sorensen K, Dörk T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Gardiner F, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang H-W, Lu Y-J, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O’Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Wahlfors T, Tammela TLJ, Klarskov P, Nordestgaard BG, Røder MA, Tybjærg-Hansen A, Bojesen SE, Travis R, Campa D, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S , Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, FitzGerald L, Kolb S, Kwon EM, Karyadi DM, Falck Orntoft T, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK , Joshi AD, Shahabi A , Rinckleb AE, Ray A, Sellers TA, Lin H-Y, Stephenson RA, Farnham J, Müller H, Rothenbacher D, Tsuchiya N, Narita S, Cao G-W , Slavov C, Mitev V, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Easton DF, Eeles RA..
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
Nature Genetics 2011; 43: 785-791. doi: 10.1038/ng.882.

Nalls MA, Couper DJ, Tanaka T, van Rooij FJA, Chen M-H, Smith AV, Toniolo D, Zakai NA, Yang Q, Greinacher A, Wood AR, Garcia M, Gasparini P, Liu Y, Lumley T, Folsom AR, Reiner AP, Gieger C, Lagou V, Felix JF, Völzke H, Gouskova NA, Biffi A, Döring A, Völker U, Chong S, Wiggins KL, Rendon A, Dehghan A, Moore M, Taylor K, Wilson JG, Lettre G, Hofman A, Bis JC, Pirastu N, Fox CS, Meisinger C, Sambrook J, Arepalli S, Nauck M, Prokisch H, Stephens J, Glazer NL, Cupples LA, Okada Y, Takahashi A, Kamatani Y, Matsuda K, Tsunoda T, Tanaka T, Kubo M, Nakamura Y, Yamamoto K, Kamatani N, Stumvoll M, Tönjes A, Prokopenko I, Illig T, Patel KV, Garner SF, Kuhnel B, Mangino M, Oostra BA, Thein SL, Coresh J, Wichmann H-E, Menzel S, Lin J, Pistis G, Uitterlinden AG, Spector TD, Teumer A, Eiriksdottir G, Gudnason V, Bandinelli S, Frayling TM, Chakravarti A, van Duijn CM, Melzer D, Ouwehand WH, Levy D, Boerwinkle E, Singleton AB, Hernandez DG, Longo DL, Soranzo N, Witteman JCM, Psaty BM, Ferrucci L, Harris TB, O'Donnell CJ, Ganesh SK.
Multiple loci are associated with white blood cell phenotypes.
PLoS Genetics 2011; 7: e1002113.

Schneider M, Du W, Fiedler J, Högel J, Günther KP, Brenner H, Brenner RE.
The (-765 G>C) promoter variant of the COX-2/PTGS2 gene is associated with a lower risk for end-stage hip and knee osteoarthritis.
Annals of the Rheumatic Diseases 2011; 70: 1458-1460.

Luo X, Burwinkel B, Brenner H.
MicroRNA signatures: Novel biomarker for colorectal cancer?
Cancer Epidemiology, Biomarkers & Prevention 2011; 20: 1272-1286.

Haug U, Knudsen AB, Brenner H, Kuntz KM. 
Is fecal occult blood testing more sensitive for left- than for right-sided colorectal neoplasia? A systematic literature review.
Expert Review of Molecular Diagnostics 2011; 11: 605-616.

Lansdorp-Vogelaar I, Knudsen A, Brenner H.
Cost-effectiveness of colorectal cancer screening.
Epidemiologic Reviews 2011; 33: 88-100.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.
Meta-analysis: serum vitamin D and colorectal adenoma risk.
Preventive Medicine 2011; 53: 10-16.

Weck MN, Brenner H.
Apparent incidence of Helicobacter pylori in adulthood: to what extent do new infections reflect misclassification?
Helicobacter 2011; 16: 266-275.

Jansen L, Kiesel A, Stegmaier C, Singer S, Brenner H, Arndt V.
Health-related quality of life over 10 years after diagnosis of colorectal cancer – a population-based study.
Journal of Clinical Oncology 2011; 29: 3263-3269.

Breitling LP, Rothenbacher D, Vossen CY, Hahmann H, Wüsten B, Brenner H.
Validated smoking cessation and prognosis in patients with stable coronary heart disease.
Journal of the American College of Cardiology 2011; 58: 196-197. 

Breitling LP, Müller H, Illig T, Rujescu D, Winterer G, Dahmen N, Nitz B, Raum E, Rothenbacher D, Brenner H.
Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers.
Pharmacogenomics 2011; 12: 1099-1106.

Breitling LP, Koenig W, Fischer M, Mallat Z, Hengstenberg C, Rothenbacher D, Brenner H.
Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: Mendelian randomization study.
PloS ONE 2011; 6: e22318.

Breitling LP, Rothenbacher D, Grandi NC, März W, Brenner H.
Prognostic usefulness of free fatty acids in patients with stable coronary heart disease.
American Journal of Cardiology 2011; 108: 508-513.

Breitling LP, Claessen H, Drath C, Arndt V, Brenner H.
Gamma-glutamyltransferase, general and cause-specific mortality in 19,000 construction workers followed over 20 years.
Journal of Hepatology 2011; 55: 594-601.

Stock C, Ihle P, Schubert I, Brenner H.
Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Endoscopy 2011; 43: 771-779.

Nicolotti N, Chuang S-C, Cadoni G, Arzani D, Petrelli L, Bosetti C, Brenner H, Hosono S, La Vecchia C, Matsuo K, Müller H, Muscat J, Paludetti G, Ricciardi G, Boffetta P, Hashibe M, Boccia S.
Recreational physical activity and risk of head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.
European Journal of Epidemiology 2011; 26: 619-628.

Holleczek B, Arndt V, Stegmaier C, Brenner H.
Trends in breast cancer survival in Germany from 1976 to 2008 - a period analysis by age and stage.
Cancer Epidemiology 2011; 35: 399-406.

Milne RL, Goode EL, Garcia-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Ignacio Arias Perez J, Benítez J, Dork T, Schurmann P, Karstens JH, Hillemanns P, Cox A, Brock IW, Elliott G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, Lanng C, Grenaker Alnaes G, Kristensen V, Borresen-Dale AL, Hopper JL, Dite GS, Apicella C, Southey MC, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Chang-Claude J, Wang-Gohrke S, Radice P, Peterlongo P, Manoukian S, Barile M, Giles GG, Baglietto L, John EM, Miron A, Chanock SJ, Lissowska J, Sherman ME, Figueroa JD, Bogdanova NV, Antonenkova NN, Zalutsky IV, Rogov YI, Fasching PA, Bayer CM, Ekici AB, Beckmann MW, Brenner H, Muller H, Arndt V, Stegmaier C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Meindl A, Heil J, Bartram CR, Schmutzler RK, Thomas GD, Hoover RN, Fletcher O, Gibson LJ, Dos Santos Silva I, Peto J, Nickels S, Flesch-Janys D, Anton-Culver H, Ziogas A, Sawyer E, Tomlinson I, Kerin M, Miller N, Schmidt MK, Broeks A, Vant Veer LJ, Tollenaar RA, Pharoah PD, Dunning AM, Pooley KA, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Jakubowska A, Lubinski J, Jaworska K, Durda K, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Kraft P, Lindström S, Chen X, Beesley J, Hamann U, Harth V, Justenhoven C, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Khusnutdinova E, Bermisheva M, Prokofieva D, Farahtdinova A, Olson JE, Wang X, Humphreys MK, Wang Q, Chenevix-Trench G, Easton DF.
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
Cancer Epidemiology, Biomarkers & Prevention 2011; 20: 2222-2231.

Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M.
Long-term risk of colorectal cancer after negative colonoscopy.
Journal of Clinical Oncology 2011; 29: 3761-3767.

Bünger S, Haug U, Kelly FM, Klempt-Giessing K, Cartwright A, Posorski N, Dibbelt L, Fitzgerald SP, Bruch H-P, Roblick UJ, von Eggeling F, Brenner H, Habermann JK (on behalf of the BMBF-consortium "Colorectal Cancer Screening Chip").
Towards standardized high-throughput serum diagnostics: Multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer.
Journal of Biomolecular Screening 2011; 16: 1018-1026.

Gondos A, Brenner H.
Relative survival of transplant patients: quantifying surplus mortality among renal transplant recipients compared to the general population.
Transplantation 2011; 92: 913-917.

Frank B, Müller H, Weck MN, Klopp N, Illig T, Raum E, Brenner H.
DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study.
BMC Cancer 2011; 11: 440.

Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M.
Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database.
American Journal of Epidemiology 2011; 174: 1140-1146.

Jansen L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V.
Benefit finding and posttraumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life.
British Journal of Cancer 2011; 105: 1158-1165.

Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van 't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne R, Arias JI, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhoven C, Brüningv T; The GENICA network, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkovav N, Rogov Y, Karstens JH, Bermisheva M, Prokofyeva D, Gancev SH, .Khusnutdinova E, Lindblom A, Margolin S, Chenevix-Trench G, Beesley J, Chen X; kConFab AOCS Management Group, Mannermaa A, Kosma VM, Soini Y, Kataja V, Lambrechts D, Yesilyurt BT, Chrisiaens MR, Peeters S, Radice P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton L, Sherman M, Lissowska J, Chanock S, Hooning M, Martens JW, van den Ouweland AM, Collée JM, Hall P, Czene K, Cox A, Brock IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, .Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, .Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-.Ernstoff L, Easton D, Spurdle AB.
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Human Molecular Genetics 2011; 20: 4693-4706.

Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H.
Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
European Journal of Epidemiology 2011; 26: 779-787.

Newson RS, Felix JF, Heeringa J, Hofman A, Witteman JC, Tiemeier H.
Association between serum cholesterol and noncardiovascular mortality in older age.
Journal of the American Geriatrics Society 2011; 59: 1779-1785.

Breitling LP, Arndt V, Drath C, Brenner H.
Liver enzymes: interaction analysis of smoking with alcohol consumption or BMI, comparing AST and ALT to g-GT.
PLoS ONE 2011; 6: e27951.

Raum E, Küpper-Nybelen J, Lamerz A, Hebebrand J, Herpertz-Dahlmann B, Brenner H.
Tobacco smoke exposure before, during and after pregnancy and risk of overweight at age 6.
Obesity 2011; 19: 2411-2417.

Pulte D, Gondos A, Brenner H.
Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.
The Oncologist 2011; 16: 16001603.

Brenner H, Holleczek B.
Deriving valid population-based cancer survival estimates in the presence of non-negligible proportions of cancers notified by death certificates only.
Cancer Epidemiology, Biomarkers & Prevention 2011; 20: 2480-2486.

Jansen L, Hoffmeister M, Chang-Claude J, Koch M, Brenner H., Arndt V.
Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients - a population-based prospective cohort.
The Oncologist 2011; 16: 1741-1751.

Breitling LP.
Erstellung und Auswertung von Directed Acyclic Graphs mit dagR.
Gesundheitswesen 2011; 73: 901-902.

Maerzheuser S, Jenetzky E, Zwink N, Reutter H, Bartels E, Grasshoff-Derr S, Holland-Cunz S, Hosie S, Schmiedeke E, Schwarzer N, Spychalski N, Goetz G, Schmidt D.
German network for congenital uro-rectal malformations: first evaluation and interpretation of postoperative urological complications in anorectal malformations.
Pediatric Surgery International 2011; 27: 1085-9.

Noeker M, Schmitz M, Schmiedeke E, Zwink N, Reutter H, Schmidt D, Jenetzky E.
Medical predictors of psychological anxieties in VATER patients.
Pediatric Surgery International 2011; 27: 1079-83.

Jenetzky E, Wijers CH, Marcelis CM, Zwink N, Reutter H, van Rooij IA.
Bias in patient series with VACTERL association.
American Journal of Medical Genetics, Part  A 2011; 155A: 2039-41.

Reutter H, Boyadjiev SA, Gambhir L, Ebert AK, Rösch WH, Stein R, Schröder A, Boemers TM, Bartels E, Vogt H, Utsch B, Müller M, Detlefsen B, Zwink N, Rogenhofer S, Gobet R, Beckers GM, Bökenkamp A, Kajbafzadeh AM, Jaureguizar E, Draaken M, Lakshmanan Y, Gearhart JP, Ludwig M, Nöthen MM, Jenetzky E.
Phenotype severity in the bladder exstrophy-epispadias complex: analysis of genetic and nongenetic contributing factors in 441 families from North America and Europe.
The Journal of Pediatrics 2011; 159: 825-31.

Nagelhout GE, Mons U, Allwright S, Guignard R, Beck F, Fong GT, de Vries H, Willemsen MC.
Prevalence and predictors of smoking in "smoke-free" bars. Findings from the International Tobacco Control (ITC) Europe Surveys.
Social Science Medicine 2011; 72:1643-1651.

Funke S, Timofeeva M, Risch A, Hoffmeister M, Stegmaier C, Seiler CM, Brenner H, Chang-Claude C.
Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Pharmacogenomics 2010; 11: 33-41.

Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U.
Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
Journal of the National Cancer Institute 2010; 102: 89-95.

Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäkix I, Tuupanenx S, Aaltonen LA, Hemminki K, Lindblom A, Försti, A, Sieber O, Lipton L, van Wezel T, Morreau H, Wijnen JT, Devilee P, Matsuda K, Nakamura Y, Castellvi-Bel S, Ruiz-Ponte C, Castells A, Carracedo A, Ho JW, Sham P, Hofstra RM, Vodicka P, Brenner H, Hampe J, Schafmayer C, Tepel J, Schreiber S, Völzke H, Lerch MM, Schmidt CA, Buch S, Moreno V, Villanueva CM, Peterlongo P, Radice P, Echeverry MM, Velez A, Carvajal-Carmona L, Scott R, Penegar S, Broderick P, Tenesa A, Houlston RS.
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.
British Journal of Cancer 2010; 102: 447-454.

Claessen H, Brenner H, Drath C, Arndt V.
Gamma-Glutamyltransferase and disability pension – a cohort study of construction workers in Germany.
Hepatology 2010; 51: 482-490.

Pulte D, Gondos A, Brenner H.
Expected long-term survival of patients diagnosed with acute myeloblastic leukemia in 2006-2010.
Annals of Oncology 2010; 21: 335-341.

The Emerging Risk Factors Collaboration.* 
C-reactive protein concentration and the risk of coronary heart disease, stroke and mortality.
Lancet 2010; 375: 132-140.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Gao L, Weck M.N., Stegmaier C, Rothenbacher D, Brenner H. 
Alcohol consumption, serum gamma-glutamyltransferase and Helicobacter pylori infection in a population-based study among 9733 older adults.
Annals of Epidemiology 2010; 20: 122-128.

Stock C, Haug U, Brenner H.
Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends.
Gastrointestinal Endoscopy 2010; 71: 366-381.

Claessen H, Arndt V, Drath C, Brenner H.
Smoking habits and disability pension - a cohort study of 14 483 construction workers.
Occupational and Environmental Medicine 2010; 67: 84-90.

Gao L, Weck MN, Raum E, Stegmaier C, Rothenbacher D, Brenner H.
Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany.
International Journal of Epidemiology 2010; 39: 129-134.

Sankaranarayanan R, Swaminathan R, Brenner H, Chen, K, Chia KS, Chen JG, Law SCK, Ahn Y-O, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N.
Cancer survival in Africa, Asia and Central America: a population based study.
Lancet Oncology 2010; 11: 165-173.

Mobascher A, Rujescu D, Mittelstraß K, Giegling I, Lamina C, Nitz B, Brenner H, Fehr C, Breitling LP, Gallinat J, Rothenbacher D, Raum E, Müller H, Ruppert A, Hartmann AM, Möller HJ, Gal A, Gieger C, Wichmann HE, Illig T, Dahmen N, Winterer G.
Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction.
American Journal of Medical Genetics Part B - Neuropsychiatric Genetics 2010; 153B: 684-690.

Brenner H, Haug U, Arndt V, Stegmaier C, Altenhofen L, Hoffmeister M.
Low Risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
Gastroenterology 2010; 138: 870-876.

Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H.
Colorectal cancer and polymorphisms in dna repair genes WRN, RMI1, and BLM.
Carcinogenesis 2010; 31: 442-445.

Haug U, Hundt S, Brenner H.
Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection:
Evaluation in the target population of screening and comparison with qualitative tests.
American Journal of Gastroenterology 2010; 105: 682-690.

Szabó É, Boehm G, Beermann C, Weyermann M, Brenner H, Rothenbacher D, Decsi T.
Fatty acid profile comparisons in human milk sampled from the same mothers at the sixth week and the sixth month of lactation.
Journal of Pediatric Gastroenterology and Nutrition 2010; 50: 316-320.

Breitling LP, Müller H, Raum E, Rothenbacher D, Brenner H.
Low-to-moderate alcohol consumption and smoking cessation rates: retrospective analysis of 4576 elderly ever-smokers.
Drug Alcohol Depend 2010; 108: 122-129.

Gondos A, Doehler B, Opelz G, Brenner H.
Period analysis for more up-to-date graft and patient survival estimates in transplantation: an evaluation using UNOS data.
Transplantation 2010; 89: 580-588.

Breitling LP, Twardella D, Hoffmann M, Witt SH, Treutlein J, Brenner H.
Prospective association of dopamine-related polymorphisms with smoking cessation in general care.
Pharmacogenomics 2010; 11: 527-536.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy GL, Mapua C, Brenner H.
Breast cancer survival in different country settings: comparisons between a Filipino resident population, Filipino-Americans and Caucasians.
The Breast 2010; 19: 109-114.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy G, Brenner H.
Inter-country and ethnic variation in colorectal cancer survival:
comparisons between a Philippine population, Filipino-Americans and Caucasians.
BMC Cancer 2010; 10: 100.

Breitling LP, Brenner H.
Odd odds interactions introduced through dichotomisation of continuous outcomes.
Journal of Epidemiology and Community Health 2010: 64; 300-303.

The Lp-PLA2 Studies Collaboration*
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative
analysis of 32 prospective studies.
Lancet 2010; 375: 1536-1544.
* Authors on behalf of the KAROLA study: Koenig W, Brenner H, Rothenbacher D.

Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration.*
Triglyceride-mediated pathways and coronary disease:
collaborative analysis of 101 studies.
Lancet 2010; 375: 1634-1639.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Medina VM Laudico A, Mirasol-Lumague MR, Brenner H, Redaniel MT.
Cumulative incidence trends of selected cancer sites in a Philippine population from 1983-2002: a joinpoint analysis.
British Journal of Cancer 2010; 102: 1411-1414.

Brenner H, Haug U, Hundt S.
Sex differences in performance of fecal occult blood testing.
American Journal of Gastroenterology 2010; 152: 697-703.

Janssen-Heijnen MLG, Gondos A, Bray F, Brenner H, Coebergh JW, and the EUNICE Survival Working Group.
Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers.
Journal of Clinical Oncology 2010; 28: 2520-2528.

Breitling LP, Grandi NC, Hahmann H, Wüsten B, Rothenbacher D, Brenner H.
Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years .
Atherosclerosis 2010; 210: 649-655.

Chronic Kidney Disease Prognosis Consortium.* 
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Lancet 2010; 375: 2073-2081.
* Authors on behalf of the ESTHER study: Rothenbacher D, Brenner H, Raum E, Koenig W.

Roos M, von Eynatten M, Heemann U, Rothenbacher D, Brenner H. Breitling LP.
Serum fetuin-A, cardiovascular risk factors and 6-year follow-up outcome in patients with coronary heart disease 
American Journal of Cardiology 2010; 105: 1666-1672.

Stock C, Brenner H.
Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries.
Endoscopy 2010; 42: 546-556.

Grandi NC, Breitling LP, Vossen CY, Hahmann H, Wüsten B, März W, Rothenbacher D., Brenner H.
Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease.
American Heart Journal 2010; 159: 1044-1051.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Alcasabas AP, Pulte D, Brenner H.
Geographic and ethnic differences in childhood leukemia and lymphoma survival: comparisons of Philippine residents, Asian-Americans and Caucasians in the United States.
British Journal of Cancer 2010; 103: 149-154.

Zhang Q-L, Brenner H, Koenig W, Rothenbacher D.
Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations.
Atherosclerosis 2010; 211: 342-347.

Jansen L, Koch L, Brenner H, Arndt V. 
Quality of life among long-term (>=5 years) colorectal cancer survivors – systematic review.
European Journal of Cancer 2010; 46:2879-2888.

The Emerging Risk Factors Collaboration.*
Diabetes mellitus, fasting blood glucose concentration , and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
Lancet 2010; 375: 2215-2222.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Truong T, Hung RJ, Amos CI, Wu X, Bickeboeller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, Wrensch M, Hansen H, Kelsey KT, Matsuo K, Tajima K, Schwartz A, Wenzlaff A, Seow A, Ying C, Staratschek-Jox A, Nuernberg P, Stoelben E, Wolf J, Lazarus P, Muscat JE, Gallagher C, Zienolddiny S, Haugen A, van der Heijden HFM, Kiemeney LA, Isla D, Mayordomo JI, Rafnar T, Stefansson K, Zhang ZF, Chang SC, Kim JH, Hong YC, Duell EJ, Andrew AS, Lejbkowicz F, Rennert G, Mueller H, Brenner H, Le Marchand L, Benhamou S, Bouchardy C, Teare MD, Xue X, McLaughlin J, Liu G, McKay JD, Brennan P, Spitz M.
Replication of lung cancer susceptibility loci at chromosome 15q25, 5p15, and 6p21: A pooled analysis from the International Lung Cancer Consortium.
Journal of the National Cancer Institute 2010; 102: 959-971.

Schneider S, Krämer H.
Who uses sunbeds? A systematic literature review of risk groups in developed countries. 
Journal of the European Academy of Dermatology and Venereology 2010; 24: 639-648.

Adamu M, Weck MN, Gao L, Brenner H.
Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies.
European Journal of Epidemiology 2010; 25: 439-448.

Duwensee K*, Breitling LP* (*=gemeinsame Erstautorenschaft), Tancevski I, Rothenbacher D, Demetz E, Patsch JR, Ritsch A, Eller P, Brenner H.
Cholesteryl ester transfer protein in patients with coronary heart disease.
European Journal of Clinical Investigation 2010; 40: 616-622.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.
Meta-analysis: Serum vitamin D and breast cancer risk.
European Journal of Cancer 2010; 46: 2196-2205.

Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H.
Colorectal cancer and polymorphisms in dna repair genes WRN, RMI1, and BLM.
Carcinogenesis 2010; 31: 1381-1386.

Breitling, LP.
dagR a suite of R functions for directed acyclic graphs.
Epidemiology 2010; 21: 586.

Quinnell RJ, Pullan RL, Breitling LP, Geiger SM, Cundill B, Correa-Oliveira R, Brooker S, Bethony JM.
Genetic and household determinants of predisposition to human hookworm infection in a brazilian community.
The Journal of Infectious Diseases 2010; 202: 954-961.

Brenner H, Haug U, Hundt S.
Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests.
International Journal of Cancer 2010; 127: 1643-1649.

Gao L, Weck MN, Rothenbacher D, Brenner H.
Body mass index, chronic atrophic gastritis and heartburn: a population-based study among 8936 older adults from Germany.
Alimentary Pharmacology & Therapeutics 2010; 32: 296-302.

Gondos A, Doehler B, Opelz G, Brenner H.
From cancer to transplantation: an evaluation of period analysis for calculating up-to-date long-term survival estimates.
American Journal of Epidemiology 2010; 172: 613-620.

Lascorz J, Försti A, Chen B, Buch S, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Schulmann K, Goecke T, Kloor M, Engel C, Büttner R, Kunkel N, Weires M, Hoffmeister M, Pardini B, Naccarati A, Vodickova L, Novotny J, Schreiber S, Krawczak M, Bröring CD, Völzke H, Schafmeyer C, Vodicka P, Chang-Claude J, Brenner H, Burwinkel B, Propping P, Hampe J, Hemminki K.
Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility.
Carcinogenesis 2010; 31: 1612-1619.

Grandi NC, Breitling LP, Brenner H.
Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies.
Preventive Medicine 2010; 51: 228-233.

De Vries E, Soerjomataram I, Lemmens VEPP, Coebergh JWW, Barendregt JJ, Oenema A, Møller H, Brenner H, Renehan AG.
Lifestyle changes and reduction of colon cancer incidence in Europe: a scenario study of physical activity promotion and weight reduction.
European Journal of Cancer 2010; 46: 2605-2616.

Gao L, Weck MN, Nieters A, Brenner H.
Grb2-associated binder 1 (Gab1) genetic polymorphism, Helicobacter pylori infection and chronic atrophic gastritis among older adults from Germany.
Molecular Carcinogenesis 2010; 49: 869-873.

Pulte D, Brenner H.
Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis.
The Oncologist 2010; 15: 994-1001.

Claessen H, Brenner H, Drath C, Arndt V.
Serum uric acid and risk of occupational disability: findings from a cohort study of male construction workers in Germany.
Arthritis Care & Research 2010; 62: 1278-1286

Hoffmeister M, Schmitz S, Karmrodt E, Stegmaier C, Haug U, Arndt V, Brenner H.
Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer.
Clinical Gastroenterology and Hepatology 2010; 8: 870-876.

Lansdorp-Vogelaar I, Knudsen A, Brenner H.
Cost-effectiveness of colorectal cancer screening - an overview.
Best Practice & Research: Clinical Gastroenterology 2010; 24: 439-449.

Breitling LP, Arndt V, Drath C, Rothenbacher D, Brenner H.
Smoking and g-glutamyltransferase: opposite interaction with alcohol consumption and body mass index.
PLoS ONE 2010; 5: 13116.

Brenner H, Altenhofen L, Hoffmeister M.
Estimated long-term effects of the initial 6 years of the German screening colonoscopy program.
Gastrointestinal Endoscopy 2010; 72: 784-789.

Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K, GEKID-Arbeitsgruppe „Überlebenszeitanalyse“.
Überlebenschancen von Krebspatienten in Deutschland - auf dem Weg zu repräsentativen, vergleichbaren Aussagen:
Das Gesundheitswesen 2010; 72: 692-699.

Breitling LP, Wolf M, Müller H, Raum E, Kliegel M, Brenner H.
Large-scale application of a telephone-based test of cognitive functioning in older adults.
Dementia and Geriatric Cognitive Disorders 2010; 30: 309-316.

Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H.
Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk.
International Journal of Cancer 2010; 127: 2822-2830.

Brenner H, Altenhofen L, Hoffmeister M.
Zwischenbilanz der Früherkennungs-Koloskopie nach 8 Jahren: eine Hochrechnung.
Dt. Ärzteblatt 2010; 43: 753-759.

Brenner H, Haug U, Hundt S.
Sex differences in performance of fecal occult blood testing.
American Journal of Gastroenterology 2010; 105: 2457-2464.

Thompson S, Kaptoge S, White I, Wood A, Perry P, Danesh J and The Emerging Risk Factors
Collaboration *
Statistical methods for the time-to-event analysis of individual participant data from multiple
epidemiological studies.
International Journal of Epidemiology 2010; 39: 1345-1359.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Winterer G, Mittelstraß K, Giegling I, Lamina C, Fehr C, Brenner H, Breitling LP, Nitz B, Raum E, Müller H, Gallinat J, Gal A, Heim K, Prokisch H, Meitinger T, Hartmann AM, Möller H-J, Gieger C, Wichmann H-E, Illig T, Dahmen N, Rujescu D.
Risk gene variantsfor nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
American journal of medical genetics. Part B, Neuropsychiatric genetics 2010; 153B: 1448-1458.

Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, Crocetti E, Brenner H, and the EUNICE Survival Group.
Up-to date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States.
European Journal of Cancer 2010; 46: 3351-3357.

Brenner H, Tao S, Haug U.
Low-dose aspirin use and performance of immunochemical fecal occult blood tests.
JAMA 2010; 304: 2513-2520.

Genz H, Jenetzky E, Hauer K, Oster P, Pfisterer M H-D.
Palliative Geriatrie: Wie unterscheiden sich onkologische von nichtonkologischen geriatrischen Palliativpatienten im Krankenhaus?
Zeitschrift für Geriatrie und Gerontologie.2010; 43: 369-375. 

Rizos T, Jenetzky E, Herweh C, Unterberg A, Hacke W, Veltkamp R.
Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.
Neurocritical Care 2010; 13: 321-325. 

Wijers CH, de Blaauw I, Marcelis CL, Wijnen RM, Brunner H, Midrio P, Gamba P, Clementi M, Jenetzky E, Zwink N, Reutter H, Bartels E, Grasshoff-Derr S, Holland-Cunz S, Hosie S, Märzheuser S, Schmiedeke E, Crétolle C, Sarnacki S, Levitt MA, Knoers NV, Roeleveld N, van Rooij IA.
Research perspectives in the etiology of congenital anorectal malformations using data of the International Consortium on Anorectal Malformations: evidence for risk factors across different populations
Pediatric Surgery International 2010; 26: 1093-1099.

Rizos T, Rasch C, Jenetzky E, Hametner C, Kathoefer S, Reinhardt R, Hepp T, Hacke W, Veltkamp R.
Detection of paroxysmal atrial fibrillation in acute stroke patients.
Cerebrovasccular Diseases 2010; 30: 410-417. 

Rizos T, Jenetzky E, Herweh C, Hug A, Hacke W, Steiner T, Veltkamp R.
Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage.
Annals of Neurology 2010; 67: 788-793.

Verla-Tebit E, Lilla C, Hoffmeister M, Brenner H, Chang-Claude J.
Exposure to environmental tobacco smoke and the risk of colorectal cancer in a case-control study from Germany.
European Journal of Cancer Prevention 2009; 18: 9-12.

Weyermann M, Rothenbacher D, Brenner H.
Acquisition of Helicobacter pylori infection in early childhood: Independent contributions of infected mothers, fathers and siblings.
American Journal of Gastroenterology 2009; 104: 182-189.

Brenner H, Gondos A, Pulte D.
Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010.
Haematologica – The Hematology Journal 2009; 94: 270-275.

Hundt S, Haug U, Brenner H.
Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
Annals of Internal Medicine 2009; 150: 162-169.

Brenner H, Hakulinen T.
Up-to-date cancer survival: period analysis and beyond.
International Journal of Cancer 2009; 124: 1384-1390.

Gao L, Weck MN, Nieters A, Brenner H.
Association between a pro-inflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany.
European Journal of Cancer 2009; 45-428-434.

Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H.
Cost-effective primary care based strategies to improve smoking cessation – more value for money.
Archives of Internal Medicine 2009; 169: 230-235.

Zhang Q-L, Koenig W, Raum E, Stegmaier C, Brenner H, Rothenbacher D.
Epidemiology of chronic kidney disease: results from a population of older adults in Germany.
Preventive Medicine 2009; 48: 122-127.

Holleczek B, Gondos A, Brenner H.
PeriodR - an R package to calculate long term survival estimates using period analysis.
Methods of Information in Medicine 2009; 48: 123-128.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Pulte D, Mapua C, Brenner H.
Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the US.
British Journal of Cancer 2009; 100: 858-862.

Breitling LP, Raum E, Müller H, Rothenbacher D, Brenner H.
Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase.
Hepatology 2009; 49: 802-808.

Gondos A, Bray F, Hakulinen T, Brenner H and the EUNICE Survival Working Group.
Trends in cancer survival in 11 European populations from 1990-2009: a model-based analysis.
Annals of Oncology 2009; 20: 564-573.

Pulte D, Gondos A, Brenner H.
Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century.
Blood 2009; 113: 1408-1411.

Pulte D, Gondos A, Brenner H.
Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy.
Leukemia and Lymphoma 2009; 50: 179-186.

Gao L, Weck MN, Michel A, Pawlita M, Brenner H.
Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiple serology.
Cancer Research 2009; 69: 2973-2980.

De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, Crocetti E, Pury P, Knijn A, Coleman M, Capocaccia R, the EUROCARE-4 Working Group.*
The EUROCARE-4 database on cancer survival in Europe: 
Data standardisation, quality control and methods of statistical analysis.
European Journal of Cancer 2009; 45: 909-930.
* members from Germany: Brenner H, Kaatsch P, Ziegler H.

Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, the EUROCARE-4 Working Group.*
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.
European Journal of Cancer 2009; 45: 931-991.
* members from Germany: Brenner H, Kaatsch P, Ziegler H.

Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, Pastore G, Peris-Bonet R, Stiller CA, the EUROCARE-4 Working Group.*
Survival of European children and young adults with cancer diagnosed 1995-2002.
European Journal of Cancer 2009; 45: 992-1005.
* members from Germany: Brenner H, Kaatsch P, Ziegler H.

Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, Colonna M, Grande E, Grosclaude P, Vercelli M, the EUROCARE-4 Working Group.
The cancer survival gap between elderly and middle-aged patients in Europe is widening.
European Journal of Cancer 2009; 45: 1006-1016.

Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G, de Angelis R, the EUROCARE-4 Working Group.*
The advantage of women in cancer survival: An analysis of EUROCARE-4 data.
European Journal of Cancer 2009; 45: 1017-1027.
* members from Germany: Brenner H, Kaatsch P, Ziegler H.

Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Allemani C, Ciccolallo L, Coleman M, Sant M, Capocaccia R, the EUROCARE-4 Working Group.
Long-term survival expectations of cancer patients in Europe in 2000-2002.
European Journal of Cancer 2009; 45:1028-1041.

Verdecchia A, Guzzinati S, Francisci S, de Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M, the EUROCARE-4 Working Group.*
Survival trends in European cancer patients diagnosed from 1988 to 1999.
European Journal of Cancer 2009; 45: 1042-1066.
* members from Germany: Brenner H, Kaatsch P, Ziegler H.

Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G, Sant M, Zigon G, Bray F, Janssen-Heijnen M, the EUROCARE-4 Working Group.*
The cure of cancer: A European perspective.
European Journal of Cancer 2009; 45: 1067-1079.
* members from Germany: Brenner H, Kaatsch P, Ziegler H.

Rosso S, de Angelis R, Ciccolallo L, Carrani E, Soerjomataram I, Grande E, Zigon G, Brenner H, the EUROCARE-4 Working Group.
Multiple tumours in survival estimates.
European Journal of Cancer 2009; 45: 1080-1094.

Breitling LP, Dahmen N, Mittelstraß K, Illig T, Rujescu D, Raum E, Winterer G, Brenner H.
Smoking cessation and variations in nicotinic acetylcholine receptor subunits a-5, a-3 and b-4 genes.
Biological Psychiatry 2009; 65: 691-695.

Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MWR, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, Allen-Brady K, Camp NJ, Cox A.
A breast cancer risk haplotype in the Caspase-8 gene.
Cancer Research 2009; 69: 2724-2728.

Claessen H, Arndt V, Drath C, Brenner H.
Overweight, obesity and risk of work disability: a cohort study of construction workers in Germany.
Occupational and Environmental Medicine 2009; 66: 402-409.

Brenner H, Hakulinen T.
Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries.
International Journal of Cancer 2009; 125: 432-437.

Müller H, Raum E, Rothenbacher D, Stegmaier C, Brenner H.
Association of diabetes and body mass index with levels of prostate-specific antigen: Implications for correction of prostate-specific antigen cut-off values?
Cancer Epidemiology, Biomarkers & Prevention 2009; 18: 1350-1356.

Breitling LP, Steyerberg E, Brenner H.
The novel genomic pathway approach to complex diseases: a reason for (over-)optimism?
Epidemiology 2009; 20: 500-507.

Weck MN, Gao L, Brenner H.
Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease.
Epidemiology 2009; 20: 569-574.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.
Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk.
Alimentary Pharmacology & Therapeutics 2009; 30: 113-125.

Brenner H, Hoffmeister M, Brenner G, Altenhofen L, Haug U.
Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy program: estimates based on 1,875,708 screening colonoscopies.
European Journal of Cancer 2009; 45: 2027-2033.

Widschwendter M, Lichtenberg-Frate H, Hasenbrink G, Schwarzer S, Dawnay A, Lam A, Menon U, Apostolidou S, Raum E, Stegmaier C, Jacobs IJ, Brenner H.
Serum oestrogen receptor alpha- and beta-bioactivity are independently associated with breast cancer - a proof of principle study.
British Journal of Cancer 2009; 101: 160-165.

Breitling LP, Rothenbacher D, Stegmaier C, Raum E, Brenner H.
Aufhörversuche und Aufhörwilligkeit in der älteren rauchenden Bevölkerung: Epidemiologische Beiträge zur Diskussion um „Lifestyle“ versus „Sucht“.
Deutsches Ärzteblatt 2009; 27: 451-455.

Breitling LP, Twardella D, Raum E, Brenner H.
Situational temptation scores and smoking cessation in general care.
Psychology of Addictive Behaviors 2009; 23: 362-367.

The Emerging Risk Factors Collaboration.* Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality. Individual data analysis of 126,634 participants from 36 prospective studies. JAMA 2009; 302: 412-423.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. 
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 Helicobacter pylori proteins determined by novel multiplex serology. 
Cancer Research 2009; 69: 6164-6170.

Breitling LP, Dahmen N, Illig T, Rujescu D, Nitz B, Raum E, Winterer G, Rothenbacher D, Brenner H.
Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events.
Pharmacogenetics & Genomics 2009; 19: 657-659.

Breitling LP, Dahmen N, Mittelstraß K, Rujescu D, Gallinat J, Fehr C, Giegling I, Lamina C, Illig T, Müller H, Raum E, Rothenbacher D, Wichmann HE, Brenner H, Winterer G.
Association of nicotinic acetylcholine receptor subunit alpha-4 polymorphisms with nicotine dependence in 5500 Germans.
The Pharmacogenomics Journal 2009; 9: 219-224.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy GL, Toral JA, Benavides D, Brenner H.
Ethnicity and health care in cervical cancer survival: comparisons between a Filipino resident population, Filipino-Americans and Caucasians.
Cancer Epidemiology, Biomarkers & Prevention 2009; 18: 2228-2234.

Funke S, Hoffmeister M, Brenner H, Chang-Claude J.
Effect modification by smoking on the association between genetic polymorphisms in oxidative stress genes and colorectal cancer risk. 
Cancer Epidemiology, Biomarkers & Prevention 2009; 18: 2336-2338.

Brenner H, Gondos A, Pulte D.
Survival Expectations of Patients Diagnosed with Hodgkin Lymphoma in 2006-2010.
The Oncologist 2009; 14: 806-813.

Brenner H, Gondos G, Pulte D.
Long-term survival in chronic myelocytic leukemia after a first primary malignancy.
Leukemia Research 2009; 33: 1604-1608.

Hoffmeister M, Raum E, Krtschil A, Chang-Claude J, Brenner H.
No evidence for variation of colorectal cancer risk by different types of postmenopausal hormone therapy.
Clinical Pharmacology and Therapeutics 2009; 86: 416-424.

Gondos A, Holleczek B, Janssen-Heijnen M, Brewster DH, Bray F, Rosso S, Hakulinen T, Brenner H and the EUNICE Survival Working Group.
Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation.
International Journal of Cancer 2009; 125: 2666-2672.

Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Uy GL, Toral JA, Benavides D, Brenner H.
Ovarian cancer survival population differences: 
a „high resolution study“ comparing Philippine residents, and Filipino-Americans and Caucasians living in the US.
BMC Cancer 2009; 9: 340.

Gao L, Weck MN, Nieters A, Brenner H.
Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: enhanced elimination of the infection during disease progression?
European Journal of Cancer 2009; 45: 2860-2866.

Pulte D, Gondos A, Brenner H.
Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Cancer 2009; 115: 4973-4979.

Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption and chronic atrophic gastritis: population-based study among 9444 older adults from Germany. International Journal of Cancer 2009; 125: 2918-2922.

Funke S, Risch A, Nieters A, Hoffmeister M, Stegmaier C, Seiler CM, Brenner H, Chang-Claude J.
Genetic polymorphisms in genes related to oxidative stress (GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS) and survival of rectal cancer patients after radiotherapy.
Journal of Cancer Epidemiology 2009; Article ID 302047, 6 pages, doi: 10.1155/2009/302047.

Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D.
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease.
European Heart Journal 2009; 30: 2742-2748.

The Emerging Risk Factors Collaboration.*
Major lipids, apolipoproteins and risk of vascular disease.
JAMA 2009; 302: 1993-2000.
* Authors on behalf of the ESTHER study: Brenner H, Raum E, Müller H, Rothenbacher D.

Gao L, Nieters A, Brenner H. Cell poliferation related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis.
European Journal of Human Genetics 2009; 17: 1658-1667.

Yin L, Raum E, Haug U, Arndt V, Brenner H.
Meta-analysis of longitudinal studies: serum vitamin D and prostate cancer risk.
Cancer Epidemiology 2009; 33: 435-445.

Brenner H, Rothenbacher D, Arndt V.
Epidemiology of stomach cancer.
Methods in Molecular Biology 2009; 472: 467-477.

Rizos T, Herweh C, Jenetzky E, Lichy C, Ringleb PA, Hacke W, Veltkamp R.
Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants.
Stroke 2009; 40:3547-3551. 

Raum E, Lietzau S, von Baum H, Marre R, Brenner H.
Changes of E. coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.
Clinical Microbiology and Infection 2008; 14: 41-48.

Brenner H, Hakulinen T.
Period versus cohort modeling of up-to-date cancer survival.
International Journal of Cancer 2008; 122: 898-904.

Brenner H, Gondos A, Pulte D.
Recent major improvement in long-term survival of younger patients with multiple myeloma.
Blood 2008; 111: 2521-2526.

Pulte D, Gondos A, Brenner H.
Ongoing improvement in outcomes for patients diagnosed with non-Hodgkin lymphoma
from the 1990s to the early 21st century. 
Archives of Internal Medicine 2008; 168: 469-476.

Brenner H, Gondos A, Pulte D.
Ongoing improvement in long-term survival of patients with Hodgkin’s disease at all ages and recent catch-up of older patients.
Blood 2008; 111: 2977-2983.

Tan, X-L, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J.
The association of cyclin D1 G870A and E-cadherin C–160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
International Journal of Cancer 2008; 122: 2573-2580.

Pulte D, Gondos A, Brenner H.
Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century.
Haematologica – The Hematology Journal 2008; 93: 594-600.

Brenner H.
Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods. In: Classen M, Maar C (Eds.) Europe against colorectal cancer. Outlining a pan-European colon cancer screening program.
Zeitschrift für Gastroenterologie 2008; 46: S20-S22.

Raum E, Lietzau S, Stegmaier C, Brenner H., Rothenbacher D.
For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
Pharmacoepidemiology and Drug Safety 2008; 17: 485-494.

Tenesa A, Farrington SM, Prendergast JGD, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Wilson R, Semple C, Clarke AJ, Reid FJL, Smith LA, Kavoussanakis K, Kossler T, Pharoah PDP, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Schmidt CO, Hampe J, Wilkening S, Canzian F, Chang-Claude J, Hoffmeister M, Brenner H, Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson IPM, Webb E, Houlston RS, Rennert G, Ballinger D, Rozek L, Gruber SB, Matsuda K, Kidokoro T, Nakamura Y, Zanke BW, Greenwood CMT, Rangrej J, Kustra R, Montpetit A, Hudson TJ, Gallinger S, Campbell H, DunlopMG. 
Genome-wide association scan identifies three colorectal cancer susceptibility loci.
Nature Genetics 2008; 40: 631-637.

Breitling LP, Twardella D, Brenner H.
High effectiveness of short treatment with bupropion for smoking cessation in general care.
Thorax 2008; 63: 476-477.

Brenner H, Gondos A, Pulte D.
Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.
Blood 2008: 111_ 4916-4921.

von Eynatten M, Hamann A, Twardella D, Nawroth P, Brenner H, Rothenbacher D.
Atherogenic dyslipidemia but not total and high molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.
European Heart Journal 2008; 29: 1307-1315.

Riera-Guardia N, Rothenbacher D.
The effect of thiazolidinediones on adiponectin serum level: a meta-analysis.
Diabetes, Obesity and Metabolism 2008; 10: 367-375.

Zhang Q-L, Rothenbacher D.
Prevalence of chronic kidney disease in population-based studies: Systematic review.
BMC Public Health 2008; 8: 117.

Twardella D, Brenner H.
Implications of nonresponse patterns in the analysis of smoking cessation trials.
Nicotine & Tobacco Research 2008; 10: 891-896.

Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG,.
Kurtinaitis J, Brenner H and the EUNICE Survival Working Group.
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based
period analysis from 12 cancer registries.
European Journal of Cancer 2008; 40: 1463-1475.

Weck MN, Brenner H.
Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition.
International Journal of Cancer 2008; 123: 874-881.

Haug U, Hundt S, Brenner H.
Sensitivity and specificity of faecal tumour M 2 pyruvate kinase for detection of colorectal adenomas in a large screening study.
British Journal of Cancer 2008; 99: 133-135.

Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H.
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.
PloS ONE 2008; 3: e2656.

Brenner H, Hoffmeister M, Haug U.
Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology.
British Journal of Cancer 2008; 99: 532-535.

Gao L, Nieters A, Brenner H.
Meta-analysis: Tumor invasion related genetic polymorphisms and gastric cancer susceptibility.
Alimentary Pharmacology Therapeutics 2008; 28: 565-573.

Funke S, Brenner H, Chang-Claude J.
Pharmacogenetics in colorectal cancer: a systematic review.
Pharmacogenomics 2008; 9: 1079-109.

Brenner H, Hoffmeister M, Haug U.
Family history and age at initiation of colorectal cancer screening.
American Journal of Gastroenterology 2008; 103: 2326-2331.

Soerjomataram I, Pukkala E, Brenner H, Coebergh JWW.
On the avoidability of breast cancer in industrialized societies: Older mean age at first birth as an indicator of excess breast cancer risk.
Breast Cancer Research and Treatment 2008; 111: 297-302.

Vossen CY, Hoffmann MM, Hahmann H, Wüsten B, Rothenbacher D, Brenner H.
Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week in-patient rehabilitation program.
Clinical Pharmacology and Therapeutics 2008; 84: 222-227.

Pulte, D, Gondos A, Brenner H.
Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Journal of the National Cancer Institute 2008; 100: 1301-1309.

Müller H, Haug U, Rothenbacher D, Stegmaier C, Brenner H.
Evaluation of serum and urine MRP-14 as marker for early detection of prostate cancer.
Journal of Urology 2008; 180: 1309-1313.

Brenner H., Gondos A, Pulte D.
Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level.
Haematologica 2008; 93: 1544-1549.

Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Estève J, Sullivan R, Coleman MP.
Cancer survival in England and Wales at the end of the 20th century.
British Journal of Cancer 2008; 99 Suppl.1: S2-10.

Arndt V, Stegmaier C, Ziegler H, Brenner H.
Quality of life over five years in women with breast cancer after breast-conserving therapy versus mastectomy - a population based study.
Journal of Cancer Research and Clinical Oncology 2008; 134: 1311-1318.

Haug U, Wente MN, Seiler CM, Jesnowski R, Brenner H.
Stool testing for early detection of pancreatic cancer: rationale and current evidence.
Expert Review of Molecular Diagnostics 2008; 8: 753-759.

COGENT Study, Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Prenegar S; Colorectal Cancer Association Study Consortium, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS; CoRGI Consortium, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S; International Colorectal Cancer Genetic Association Consortium, Campbell H, Dunlop MG.
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.
Nature Genetics 2008; 40: 1426-1435.

Lilla C, Risch A, Verla-Tebit E, Hoffmeister M, Brenner H, Chang-Claude J.
SULT1A1 genotype and susceptibility to colorectal cancer.
International Journal of Cancer 2007; 120: 201-206.

Erb A, Stürmer T, Marre R, Brenner H.
Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations.
European Journal of Clinical Microbiology & Infectious Diseases 2007; 26: 83-90.

Twardella D, Brenner H.
Effects of practitioner education, practitioner payment, and reimbursement of patients' drug costs on smoking cessation in primary care: cluster randomised trial.
Tobacco Control 2007; 16: 15-21.

The Lp-PLA2 Studies Collaboration, Ballantyne C, Cushman M, Psaty B, Furberg C, Khaw KT, Sandhu M, Oldgren J, Rossi GP, Maiolino G, Cesari M, Lenzini L, James SK, Rimm E, Collins R, Anderson J, Koenig W, Brenner H, Rothenbacher D, Berglund G, Persson M, Berger P, Brilakis E, McConnell JP, Koenig W, Sacco R, Elkind M, Talmud P, Rimm E, Cannon CP, Packard C, Barrett-Connor E, Hofman A, Kardys I, Witteman JC, Criqui M, Corsetti JP, Rainwater DL, Moss AJ, Robins S, Bloomfield H, Collins D, Packard C, Wassertheil-Smoller S, Ridker P, Ballantyne C, Cannon CP, Cushman M, Danesh J, Gu D, Hofman A, Nelson JJ, Thompson S, Zalewski A, Zariffa N, Di Angelantonio E, Kaptoge S, Thompson A, Thompson S, Walker M, Watson S, Wood A.
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.
European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 3-11

Brenner H, Hoffmeister M, Arndt V, Haug U.
Gender differences in colorectal cancer: implications for age at initiation of screening.
British Journal of Cancer 2007; 96: 828-831.

Brenner H, Hakulinen T.
Model based hybrid analysis of cancer patient survival.
European Journal of Cancer 2007; 43: 921-927.

Haug U, Hillebrand T, Bendzko P, Löw M, Rothenbacher D, Stegmaier C, Brenner H.
Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras-mutations in stool DNA: High prevalence in a large sample of older adults.
Clinical Chemistry 2007; 53: 787-790.

Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M.
Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study.
Cancer Epidemiology, Biomarkers and Prevention 2007; 16: 494-499.

Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D.
Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany.
European Journal of Cancer 2007; 43: 1283-1289.

Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H.
Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
International Journal of Cancer 2007; 121: 395-400.

Wolkewitz M, Rothenbacher D, Löw M, Stegmaier C, Ziegler H, Radulescu M, Brenner H, Diepgen TL.
Lifetime prevalence of self-reported atopic diseases in a population-based sample of elderly: results of the ESTHER-study.
British Journal of Dermatology 2007; 156: 693-697.

Haug U, Rothenbacher D, Wente MN, Seiler CM, Stegmaier C, Brenner H.
Tumor M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults versus colorectal cancer patients.
British Journal of Cancer 2007; 96: 1329-1334.

Szabó É, Boehm G, Beermann C, Weyermann M, Brenner H, Rothenbacher D, Decsi T.
Trans octadecenoic acid and trans octadecadienoic acid are inversely related to long-chain polyunsaturates in human milk: results of a large birth cohort study.
American Journal of Clinical Nutrition 2007; 85: 1320-1326.

Raum E, Rothenbacher D, Ziegler H, Brenner H.
Heavy physical activity – risk or protective factor for cardiovascular disease? A life course perspective.
Annals of Epidemiology 2007; 17: 417-424.

Tan X-L, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J.
Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Pharmacogenetics and Genomics 2007; 17: 639-645.

Rothenbacher D, Weyermann M, Fantuzzi G, Brenner H.
Adipokines in cord blood and risk of wheezing disorders within the first two years of life.
Clinical and Experimental Allergy 2007; 37: 1143-1149.

Rothenbacher D, Hahmann H, Wüsten B, Koenig W, Brenner H.
Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links.
European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 547-554.

Hoffmeister M, Chang-Claude J, Brenner H.
Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study.
International Journal of Cancer 2007; 121: 1325-1330.

Brenner H, Gondos A, Arndt V.
Recent major progress in long-term cancer patient survival disclosed by modeled period analysis.
Journal of Clinical Oncology 2007; 25: 3274-3280.

Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M.
Case-control study supports extension of surveillance interval after coloscopic polypectomy to at least five years.
American Journal of Gastroenterology 2007; 102: 1739-1744.

Gondos A, Holleczek B, Arndt V, Stegmaier C, Ziegler H, Brenner H.
Trends in population based cancer survival in Germany: to what extent does progress reach older patients?
Annals of Oncology 2007; 18: 1253-1259.

Hoffmeister M, Chang-Claude J, Brenner H.
Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk.
American Journal of Epidemiology 2007; 166: 130-136.

Janssen-Heijnen MLG, Houterman S, Lemmens VEPP, Brenner H, Steyerberg EW, Coebergh JWW.
Prognosis for long-term survivors of cancer.
Annals of Oncology 2007; 18: 1408-1413.

Weck MN, Stegmaier C, Rothenbacher D, Brenner H.
Epidemiology of chronic atrophic gastritis: population based study among 9,444 older adults from Germany.
Alimentary Pharmacology & Therapeutics 2007; 26: 879-887.

Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, Santaquilani M and the EUROCARE Working Group*.
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: results of the EUROCARE-4 study.
Lancet Oncology 2007; 8: 773-783.
* members from Germany: Brenner H, Ziegler H.

Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I and the EUROCARE-4 Working Group.
Recent cancer survival in Europe: a period analysis 2000-2002 of the EUROCARE 4 data.
Lancet Oncology 2007; 8: 784-796.

Arndt V, Rothenbacher D, Zschenderlein B, Schuberth S, Brenner H.
Body mass index and premature mortality in physically heavily working men - a ten year follow up of 20,000 construction workers. 
Journal of Occupational and Environmental Medicine 2007; 49: 913-921.

Brenner H, Hakulinen T.
Maximizing the benefits of model based period analysis of cancer patient survival.
Cancer Epidemiology, Biomarkers and Prevention 2007; 16: 1675-1681.

Steliarova-Foucher E, Arndt V, Parkin DM, Bernino F, Brenner H.
Timely disclosure of progress in childhood cancer survival by period analysis in the automated childhood cancer information system.
Annals of Oncology 2007; 18: 1554-1560.

Brenner H, Steliarova-Foucher E, Arndt V.
Up-to-date monitoring of childhood cancer long-term survival in Europe. Methodology and application to all forms of cancer combined.
Annals of Oncology 2007; 18: 1561-1568.

Brenner H, Coebergh JW, Parkin DM, Izarzugaza I, Clavel J, Arndt V, Steliarova-Foucher E.
Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas.
Annals of Oncology 2007; 18: 1569-1577.

Arndt V, Kaatsch P, Steliarova-Foucher E, Peris-Bonet R, Brenner H.
Up-to-date monitoring of childhood cancer long-term survival in Europe: central nervous system tumours.
Annals of Oncology 2007; 18: 1722-1733.

Arndt V, Lacour B, Steliarova-Foucher E, Spix C, Znaor A, Pastore G, Stiller C, Brenner H.
Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours and soft tissue sarcomas.
Annals of Oncology 2007; 18: 1734-1742.

Sieg A, Brenner H.
Cost-saving analysis of screening colonoscopy in Germany.
Zeitschrift für Gastroenterologie 2007; 45: 945-951.

Shanmugam KS, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B.
The functional genetic variant Arg324Gly of frizzled-related protein (FRZB) is associated with colorectal cancer risk.
Carcinogenesis 2007; 28: 1914-1917.

Brenner H, Hakulinen T.
Patients with previous cancer should not be excluded in international comparative survival studies.
International Journal of Cancer 2007; 121: 2274-2280.

Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U.
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies.
Gut 2007; 56: 1585-1589. 

Lietzau S, Raum E, von Baum H, Marre R, Brenner H.
Household contacts were key factor for children’s colonization with resistant Escherichia coli in community setting.
Journal of Clinical Epidemiology 2007; 60: 1149-1155.

Weyermann M, Brenner H, Rothenbacher D.
Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study.
Epidemiology 2007; 18: 722-729.

Brenner H, Rothenbacher D, Weck MN.
Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value.
International Journal of Cancer 2007; 121: 2782-2786.

Hoffmeister M, Raum E, Winter J, Chang-Claude J, Brenner H.
Hormone replacement therapy, body mass and the risk of colorectal cancer among
postmenopausal women from Germany.
British Journal of Cancer 2007; 97: 1486-1492.

Raum E, Rothenbacher D, Löw M, Stegmaier C, Ziegler H, Brenner H.
Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach.
European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 809-814.

Pechlivanis S, Wagner K, Chang-Claude J, Hoffmeister M, Brenner H, Försti A.
Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Cancer Detection and Prevention 2007; 31: 408-416.

Raum E, Gebhardt K, Buchner M, Schiltenwolf M, Brenner H.
Long-term and short-term alcohol consumption and levels of C-reactive protein.
International Journal of Cardiology 2007; 121: 224-226.

Hundt S, Haug U, Brenner H.
Blood markers for early detection of colorectal cancer: a systematic review.
Cancer Epidemiology, Biomarkers and Prevention 2007; 16: 1935-1953.

Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H.
The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study.
Journal of Clinical Epidemiology 2006; 59: 82-89.

Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.
Effect of NAT1 und NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 99-107.

Gondos A, Parkin DM, Chokunonga E, Brenner H.
Calculating age adjusted cancer survival estimates when age specific data are sparse: an empirical evaluation of various methods.
British Journal of Cancer 2006; 94: 450-454.

Twardella D, Rothenbacher D, Hahmann H, Wüsten B, Brenner H.
The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease: prospective cohort study.
Journal of the American College of Cardiology 2006; 47: 887-889.

Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H.
The impact of body weight on smoking cessation in German adults.
Preventive Medicine 2006; 42: 109-113.

Houterman S, Janssen-Heijnen MLG, van de Poll-Franse LV, Brenner H, Coebergh JWW.
Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis.
Annals of Oncology 2006; 17: 709-712.

Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H.
Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Arteriosclerosis, Thrombosis, and Vascular Biology 2006; 26: 194-199. 

Spahr, A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze M, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W.
Periodontal Infections and Coronary Heart Disease.
Archives of Internal Medicine 2006; 166: 554-559.

Müller H, Brenner H.
Urine markers as possible tools for prostate cancer screening: a review focusing on performance characteristics and practicalness.
Clinical Chemistry 2006; 52: 562-573.

Lietzau S, Hoewner M, von Baum H, Marre R, Brenner H.
Antibiotic resistant fecal isolates of enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Pharmacoepidemiology and Drug Safety 2006; 15: 275-277.

Weyermann M, Adler G, Brenner H, Rothenbacher D.
The mother as source of Helicobacter pylori infection.
Epidemiology 2006; 17: 332-334.

von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D.
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia and heart failure in patients with coronary heart disease.
Clinical Chemistry 2006; 52: 853-859.

Twardella D, Merx H, Hahmann W, Wüsten B, Rothenbacher D, Brenner H.
Long-term adherence to dietary recommendations after inpatient rehabilitation: prospective follow up study of patients with coronary heart disease.
Heart 2006; 92: 635-640.

Haug U, Wente MN, Seiler CM, Rothenbacher D, Büchler MW, Brenner H.
Tumor-M2-PK as a stool marker for colorectal cancer: stability at room temperature and implications for application in the screening setting.
Clinical Chemistry 2006; 52: 782-784.

Wang H, Rothenbacher D, Löw M, Stegmaier C, Brenner H, Diepgen TL.
Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung und colorectum.
International Journal of Cancer 2006; 119: 695-701.

Verla-Tebit E, Lilla C, Hoffmeister M, Brenner H, Chang-Claude J.
Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study.
International Journal of Cancer 2006; 119: 630-635.

Guech-Ongey M, Brenner H, Twardella D, Rothenbacher D.
Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study.
BMC Cardiovascular Disorders 2006; 6: 17.

Brenner H, Hakulinen T.
Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision.
Journal of Clinical Epidemiology 2006; 59: 570-575.

Löw M, Hoffmann MM, Hahmann H, März W, Brenner H, Rothenbacher D.
Genotype combinations of plasminogen activator inhibitor-1 and angiotensin converting enzyme genes and risk for early onset of coronary heart disease.
European Journal of Cardiovascular Prevention and Rehabilitation 2006; 13: 449-456.

Ramroth H, Specht-Leible N, König HH, Brenner H.
Hospitalizations during the last months of life of nursing home residents: a retrospective cohort study from Germany.
BMC Health Services Research 2006; 6: 70.

Koenig W, Twardella D, Brenner H, Rothenbacher D.
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function and hemodynamic stress.
Arteriosclerosis, Thrombosis and Vascular Biology 2006; 26: 1586-1593.

Weck MN, Brenner H.
Prevalence of chronic atrophic gastritis in different parts of the world.
Cancer Epidemiology, Biomarkers & Prevention 2006; 15: 1083-1094.

Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D.
Helicobacter pylori infection and colorectal cancer risk: a meta-analysis.
Helicobacter 2006; 11: 75-80.

Rothenbacher D, Rüter G, Brenner H.
Prognostic value of physicians' assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study.
BMC Family Practice 2006; 7: 42.

Rothenbacher D, Koenig W, Brenner H.
Life time physical activity patterns and risk of coronary heart disease.
Heart 2006; 92: 1319-1320.

Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M.
Does a negative screening colonoscopy ever need to be repeated?
Gut 2006; 55: 1145-1150.

Lietzau S, Raum E, von Baum H, Marre R, Brenner H.
Clustering of antibiotic resistance of E.coli in couples: suggestion for a major role of conjugal transmission.
BMC Infectious Diseases 2006; 6: 119 (Epub ahead of print).

Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H.
Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population based study.
European Journal of Cancer 2006; 42: 1848-1857.

Hoffmeister M, Chang-Claude J, Brenner H.
Do older adults using non-steroidal anti-inflammatory drugs have a reduced risk of colorectal cancer?
Drugs and Aging 2006; 23: 513-523.

Guech-Ongey M, Brenner H, Twardella D, Hahmann H, Rothenbacher D.
Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
International Journal of Cardiology 2006; 111: 98-103.

Brenner H, Weyermann M, Rothenbacher D.
Clustering of Helicobacter pylori infection in couples: differences between high and low prevalence population groups.
Annals of Epidemiology 2006; 16: 516-520.

Weyermann M, Rothenbacher D, Brenner H.
Duration of breastfeeding and risk of overweight in childhood: a prospective birth cohort study from Germany.
International Journal of Obesity 2006; 30: 1281-1287.

Brenner H, Hakulinen T.
Up-to-date and precise estimates of cancer patient survival: model based period analysis.
American Journal of Epidemiology 2006; 164: 689-696.

Gebhardt K, Brenner H, Stürmer T, Raum E, Richter W, Schiltenwolf M, Buchner M.
The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain – a 6 months prospective longitudinal study.
European Journal of Pain 2006; 10: 711-719.

Brenner H, Hakulinen T.
Up-to-date estimates of cancer patient survival even with common latency in cancer registration.
Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 1727-1732.

Ramroth H, Specht-Leible N, König H-H, Mohrmann M, Brenner H.
Inanspruchnahme stationärer Krankenhausleistungen durch Pflegeheimbewohner.
Deutsches Ärzteblatt 2006; 103: A2710-A2713.

Weyermann M, Beermann C, Brenner H, Rothenbacher D.
Adiponectin and leptin in maternal serum, cord blood, and breast milk.
Clinical Chemistry 2006; 52: 2095-2102.

Frank B, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B.
ARLTS1 variants and risk of colorectal cancer.
Cancer Letters 2006; 244: 172-175.

Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B.
Death receptor 4 variants and colorectal cancer risk. 
Cancer Epidemiology, Biomarkers & Prevention 2006; 15: 2002-2005.

Arndt V, Stegmaier C, Ziegler H, Brenner H.
The impact of specific symptoms on quality of life in women with breast cancer one year after diagnosis: a population-based study.
Cancer 2006; 107: 2496-2503.

Rothenbacher D, Koenig W, Brenner H.
Comparison of N-terminal-pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Archives of Internal Medicine 2006; 166: 2455-2460.

Dreinhöfer KE, Dieppe P, Stürmer T, Gröber-Grätz D, Flören M, Günther KP, Puhl W, Brenner H.
Indications for total hip replacement: comparison of assessments of orthopaedic surgeons and referring physicians.
Annals of the Rheumatic Diseases 2006; 65: 1346-1350.

Ramroth H, Specht-Leible N, Brenner H.
Hospitalization before and after nursing home admission: a retrospective cohort study from Germany.
Age and Ageing 2005; 34: 291-294.

Küpper-Nybelen J, Thefeld W, Rothenbacher D, Brenner H.
Patterns of alcohol consumption and Helicobacter pylori infection: results of a population based study from Germany among 6545 adults.
Alimentary Pharmacology & Therapeutics 2005; 21: 57-64.

Brenner H, Arndt V.
Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Journal of Clinical Oncology 2005; 23: 441-447.

Koenig W, Twardella D, Brenner H, Rothenbacher D.
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.
Clinical Chemistry 2005; 51: 321-327.

Weyermann M, Rothenbacher D, Gayer L, Bode G, Adler G, Grab D, Flock F, Brenner H.
Role of Helicobacter pylori infection in iron deficiency during pregnancy.
American Journal of Obstetrics and Gynecology 2005; 192: 548-553.

Brenner H, Hakulinen T.
Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration.
British Journal of Cancer 2005; 92: 576-579.

Brenner H, Arndt V.
Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed.
European Journal of Cancer 2005; 41: 438-444.

Hoffmeister A, Rothenbacher D, Kunze M, Brenner H, Koenig W.
Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease.
European Journal of Internal Medicine 2005; 16: 47-52.

Haug U, Brenner H.
A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy.
Cancer Epidemiology, Biomarkers and Prevention 2005; 14: 422-428.

Lamerz A, Küpper-Nybelen J, Bruning N, Wehle C, Trost-Brinkhues G, Brenner H, Hebebrand J, Herpertz-Dahlmann B.
Prevalence of obesity, binge eating, and night eating in a cross-sectional field survey of 6 year old children and their parents in a German urban population.
Journal of Child Psychology and Psychiatry 2005; 46: 385-393.

Küpper-Nybelen J, Lamerz A, Bruning N, Hebebrand J, Herpertz-Dahlmann B, Brenner H.
Major differences in prevalence of overweight according to nationality in preschool children living in Germany: determinants and public health implications.
Archives of Diseases in Childhood 2005; 90: 359-363.

Brenner H, Hakulinen T.
Substantial overestimation of standard errors of relative survival rates of cancer patients.
American Journal of Epidemiology 2005; 161: 781-786.

Lamerz A, Küpper-Nybelen J, Wehle C, Bruning N, Trost-Brinkhues G, Brenner H, Hebebrand J, Herpertz-Dahlmann B.
Social class, parental education, and obesity prevalence in a study of six-year-old children in Germany.
International Journal of Obesity 2005; 29: 373-380.

Gondos A, Brenner H, Wabinga H, Parkin DM.
Cancer survival in Kampala, Uganda.
British Journal of Cancer 2005; 92: 1808-1812.

Zumkeller N, Koenig W, Hoffmann MM, Kolb H, Brenner H, Rothenbacher D.
Helicobacter pylori seropositive subjects do not show a pronounced systemic inflammatory response even in the presence of the interleukin-1 receptor antagonist gene polymorphism.
Epidemiology and Infection 2005; 133: 569-572.

Stürmer T, Raum E, Buchner M, Gebhardt K, Schiltenwolf M, Richter W, Brenner H.
Pain and high-sensitivity C-reactive protein in patients with chronic low back pain and acute sciatic pain.
Annals of the Rheumatic Diseases 2005; 64: 921-925.

Brenner H, Arndt V, Stegmaier C, Ziegler H, Stürmer T.
Reduction of clinically manifest colorectal cancer by endoscopic screening: empirical evaluation and comparison of screening at various ages.
European Journal of Cancer Prevention 2005; 14: 231-237.

Brenner H, Stegmaier C, Ziegler H.
Long-term survival of cancer patients in Germany achieved by the beginning of the 3rd millennium.
Annals of Oncology 2005; 16: 981-986.

Vogel C, Brenner H, Pfahlberg A, Gefeller O.
The effects of joint misclassification of exposure and disease on the attributable risk.
Statistics in Medicine 2005; 24: 1881-1896.

Rothenbacher D, Löw M, Hardt PD, Klör HU, Ziegler H, Brenner H.
Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population based study.
Scandinavian Journal of Gastroenterology 2005; 40: 697-704.

Löw M, Hoffmann MM, Hahmann H, Maerz W, Rothenbacher D, Brenner H.
Smoking, apolipoprotein E genotype, and early onset of coronary heart disease.
European Journal of Cardiovascular Prevention and Rehabilitation 2005; 12: 268-270.

Twardella D, Brenner H.
Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany.
European Journal of Public Health 2005; 15: 140-145.

Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W.
Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
BMC Cardiovascular Disorders 2005; 5: 10.

Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H.
Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer.
Journal of Clinical Oncology 2005; 23: 4945-4953.

Brenner H, Hakulinen T.
Age adjustment of cancer survival rates: methods, point estimates and standard errors.
British Journal of Cancer 2005; 93: 372-375.

Arndt V, Rothenbacher D, Daniel U, Zschenderlein B, Schuberth S, Brenner H.
Construction work and risk of occupational disability – a 10-year follow-up of 14 474 male workers.
Occupational and Environmental Medicine 2005; 62: 559-566.

Bergk V, Haefeli WE, Gasse C, Brenner H, Martin-Facklam M.
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature. European Journal of Clinical Pharmacology 2005; 61: 327-335.

Rothenbacher D, Weyermann M, Beermann C, Brenner H.
Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study.
Clinical and Experimental Allergy 2005; 35: 1014-1021.

Khuseyinova N, Imhof A, Rothenbacher D, Trischler G, Kuelb S, Scharnagl H, März W, Brenner H, Koenig W.
Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis. 
Atherosclerosis 2005; 182: 181-188.

Rothenbacher D, Brenner H, März W, Koenig W.
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
European Heart Journal 2005; 26: 1640-1646.

Küpper-Nybelen J, Rothenbacher D, Brenner H.
Relationship between lifetime alcohol consumption and Helicobacter pylori infection.
Annals of Epidemiology 2005; 15: 607-613.

Brenner H, Arndt V.
Further enhanced monitoring of cancer patient survival by stage adjusted period analysis.
Cancer Epidemiology, Biomarkers & Prevention 2005; 14: 1917-1921.

Brenner H, Hakulinen T.
Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment.
European Journal of Cancer 2005; 41: 1788-1793.

Stürmer T, Dreinhöfer K, Gröber-Grätz D, Brenner H, Dieppe P, Günther KP, Puhl W.
Differences in the views of orthopaedic surgeons and referring practitioners on the determinants of outcome after total hip replacement.
Journal of Bone and Joint Surgery 2005; 87-B: 1416-1419.

Weyermann M, Borowski C, Bode G, Gürbüz B, Adler G, Brenner H, Rothenbacher D.
The Helicobacter pylori-specific immune response in maternal serum, cord blood, and human milk among mothers with and without current Helicobacter pylori infection.
Pediatric Research 2005; 58: 897-902.

Loew M, Hoffmann MM, Koenig W, Brenner H, Rothenbacher D.
Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events.
Arteriosclerosis, Thrombosis and Vascular Biology 2005; 25: 1470-1474.

Brenner H, Rothenbacher D.
Helicobacter pylori und Magenkrebs – eine unterschätzte Beziehung.
Deutsches Ärzteblatt 2005; 102: A1740-1743.

Haug H, Brenner H.
New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness.
International Journal of Cancer 2005; 117: 169-176.

Rothenbacher D, Brenner H, Rüter G.
Typ-2-Diabetes-mellitus: Betreuung von chronisch Kranken in der Hausarztpraxis.
Deutsches Ärzteblatt 2005; 102: A2408-A2412.

Brenner H, Stegmaier C, Ziegler, H.
Verbesserte Langzeitüberlebensraten von Krebspatienten.
Die unterschätzten Fortschritte der Onkologie.
Deutsches Ärzteblatt 2005; 102: A2628-A2633.

Huch K, Müller KAC, Stürmer T, Brenner H, Puhl W, Günther K-P.
Sports activities 5 years after total knee or hip arthroplasty. The Ulm Osteoarthritis Study.
Annals of the Rheumatic Diseases 2005; 64: 1715-1720.

Stürmer T, Gefeller O, Brenner H.
A computer program to estimate power and relative efficiency of flexibly matched case-control studies.
Methods of Information in Medicine 2005; 44: 693-696.

Arndt V, Talbäck M, Gefeller O, Hakulinen T, Brenner H.
Modification of SAS macros for more efficient analysis of relative survival rates.
European Journal of Cancer 2004; 40: 778-779.

Brenner H, Wahl H-W, Rott C.
The German Center for Research on Aging at the University of Heidelberg:
an interdisciplinary approach.
Experimental Gerontology 2004; 39: 3-9.

Brenner H, Gefeller O, Hakulinen T.
Period analysis for up-to-date cancer survival data: theory, empirical evaluation,computational realization and applications.
European Journal of Cancer 2004; 40: 326-335.

Brenner H, Arndt V.
Epidemiology in aging research.
Experimental Gerontology 2004; 39: 679-686. 

Perez-Perez GI, Rothenbacher D, Brenner H.
Epidemiology of Helicobacter pylori infection.
Helicobacter 2004; 9 (Suppl. 1): 1-6.

Brenner H. 
The period analysis methodology in survival analysis: towards more up-to-date
monitoring of long-term survival rates.
Nowotwory Journal of Oncology 2004; 54: 441-445.

Rothenbacher D, Schultze V, Jähnig P, Scharschmidt B, Brenner H. Evidence of a
rapid decrease of H pylori infection in children of a high risk group living in Germany.
European Journal of Pediatrics 2004; 163: 339-340.

Stürmer T, Brenner H, Koenig W, Günther KP.
Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high-sensitivity C-reactive protein.
Annals of the Rheumatic Diseases 2004; 63: 200-205.

Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. 
Is Helicobacter pylori infection a necessary condition for non-cardia gastric cancer ? 
American Journal of Epidemiology 2004; 159: 252-258.

Brenner H, Hakulinen T.
Are patients diagnosed with breast cancer below age 50 ever cured ?
Journal of Clinical Oncology 2004; 22: 432-438.

Arndt V, Merx H, Stürmer T, Stegmaier C, Ziegler H, Brenner H.
Age specific detriments to quality of life among breast cancer patients one year after diagnosis.
European Journal of Cancer 2004; 40: 673-680.

Coleman MP, Rachet B, Woods L, Mitry E, Riga M, Cooper N, Quinn MJ, Brenner H, Estève J.
Trends and socio-economic inequalities in cancer survival in England and Wales up to 2001.
British Journal of Cancer 2004; 90: 1367-1373

Arndt V, Rothenbacher D, Daniel U, Zschenderlein B, Schuberth S, Brenner H.
All-cause and cause specific mortality in a cohort of 20 000 construction workers;results from a 10 year follow up.
Occupational and Environmental Medicine 2004; 61: 419-425.

Stürmer T, Erb A, Marre R, Brenner H.
Prevalence and determinants of antibiotic resistance in fecal Escherichia coli among unselected patients attending general practitioners in southwest Germany.
Pharmacoepidemiology and Drug Safety 2004; 13: 303-308.

Stürmer T, Gefeller O, Brenner H. 
A computer program to estimate power and relative efficiency to assess multiplicative interactions in flexibly matched case-control studies. 
Computer Methods and Programs in Biomedicine 2004; 74: 261-265.

Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE.
Drug interactions in primary care: impact of a new algorithm on risk determination.
Clinical Pharmacology and Therapeutics 2004; 76: 85-96.

Rothenbacher D, Weyermann M, Bode G, Kulaksiz M, Stahl B, Brenner H.
Role of Lewis A and Lewis B blood group antigens in Helicobacter pylori infection.
Helicobacter 2004; 9: 324-329.

Lietzau S, Stürmer T, Erb A, von Baum H, Marre R, Brenner H.
Prevalence and determinants of nasal colonization with antibiotic resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany.
Epidemiology and Infection 2004; 132: 655-662.

Brenner H, Arndt V, Gefeller O, Hakulinen T.
An alternative approach to age adjustment of cancer survival rates.
European Journal of Cancer 2004; 40: 2317-22. 

Gondos, A, Chokunonga E, Brenner H, Parkin DM, Sankila R, Borok MZ, Chirenje ZM, Nyakabau AM, Bassett MT.
Cancer survival in a southern African urban population.
International Journal of Cancer 2004; 112: 860-864.

Twardella D, Rothenbacher D, Küpper-Nybelen J, Hahmann H, Wüsten B, Brenner H.
Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements.
European Heart Journal 2004; 25: 2101-2108.

Arndt V, Rothenbacher D, Krauledat R, Daniel U, Brenner H.
Age, alcohol consumption, and all-cause mortality.
Annals of Epidemiology 2004; 14: 750-753.

Brenner H, Rachet B.
Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases.
European Journal of Cancer 2004; 40: 2494-2501.

Ongey M, Brenner H, Thefeld W, Rothenbacher D.
Helicobacter pylori and hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population based study.
European Journal of Cardiovascular Prevention and Rehabilitation 2004; 11: 471-476.

Löw M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H.
Die ESTHER-Studie: Eine bevölkerungsbezogene prospektive Kohortenstudie zur Erforschung neuer Wege der Früherkennung und Prävention chronischer Erkrankungen in der älteren Bevölkerung.
Deutsche Medizinische Wochenschrift 2004; 129: 2643-2647.

Brenner H, Arndt V.
Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient.
Cancer Causes and Control 2004; 15: 903-910.

Arndt, V, Merx H, Stegmaier C, Ziegler H, Brenner H.
Quality of life in patients with colorectal cancer one year after diagnosis compared to the general population: a population-based study.
Journal of Clinical Oncology2004; 23: 4829-4836.

Merx H, Schröder P, Stürmer T, Dreinhöfer K, Puhl W, Günther KP, Brenner H.
International variation in hip replacement rates. 
Annals of the Rheumatic Diseases 2003; 62: 222-226. 

Arndt V, Stürmer T, Stegmaier C, Ziegler H, Becker A, Brenner H.
Provider delay among patients with breast cancer in Germany – a population based study.
Journal of Clinical Oncology 2003; 21: 1440-1446.

Rothenbacher D, Brenner H.
Burden of Helicobacter pylori and H.pylori-related diseases in developed countries: recent developments and future implications.
Microbes and Infection 2003; 5: 693 – 703.

Rothenbacher D, Rüter G, Saam S, Brenner H.
Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value.
British Journal of General Practice 2003; 53: 389-391.

Bode G, Brenner H, Adler G, Rothenbacher D.
Recurrent abdominal pain in children: Evidence from a population based study that social and familial factors play a major role but not Helicobacter pylori infection.
Journal of Psychosomatic Research 2003; 54: 417- 421.

Rothenbacher D, Hoffmeister A, Brenner H, Koenig W.
Physical activity, coronary heart disease, and inflammatory response.
Archives of Internal Medicine 2003; 163: 1200-1205.

Brenner H.
Up-to-date survival curves of children with cancer by period analysis.
British Journal of Cancer 2003; 88: 1693-1697

Loew M, Boeing H, Stürmer T, Brenner H.
Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption and levels of gamma glutamyltransferase.
Alcohol 2003; 29: 131-135.

Küpper-Nybelen J, Rothenbacher D, Hahmann H, Wüsten B, Brenner H.
Veränderungen von Risikofaktoren während und ein Jahr nach stationärer Rehabilitation bei Patienten mit koronarer Herzkrankheit. 
Deutsche Medizinische Wochenschrift 2003; 128: 1525-1530.

Weyermann M, Brenner H, Adler G, Yasar Z, Handke-Vesely A, Grab D, Kreienberg R, Rothenbacher D. 
Helicobacter pylori infection and occurrence and severity of gastrointestinal symptoms during pregnancy.
American Journal of Obstetrics and Gynecology 2003; 189: 526-531.

Brenner H, Spix C. 
Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates.
British Journal of Cancer 2003; 89: 1260-1265.

Hoffmeister A, Imhof A, Rothenbacher D, Khuseyinova N, Brenner H, Koenig W.
Moderater Alkoholkonsum und Plasmakonzentration sensitiver Entzündungsmarker –Hinweise auf einen atheroprotektiven Zusammenhang. 
Deutsche Medizinische Wochenschrift 2003; 128: 2237-2241.

Rothenbacher D, Brenner H, Hoffmeister A, Mertens T, Persson K, Koenig W. 
Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. 
Atherosclerosis 2003; 170: 339-345.

Imhof A, Rothenbacher D, Khuseyinova N, Hoffmeister A, Maerz W, Nauck M,
Scharnagl H, Koenig W, Brenner H. 
Plasma lipoprotein Lp(a), markers of hemostasis and inflammation and risk of coronary heart disease. 
Journal of Cardiovascular Risk 2003; 10: 362-370.

Brenner H, Hakulinen T.
On crude and age adjusted relative survival rates. 
Journal of Clinical Epidemiology 2003; 56: 1185-1191.

Küpper-Nybelen J, Rothenbacher D, Jacobi E, Brenner H.
Die prognostische Bedeutung von Variablen aus dem Qualitätssicherungsprogramm und dem Reha-Entlassungsbericht der LVA Württemberg für die Erwerbs- oder Berufsunfähigkeit: Ergebnisse einer retrospektiven Kohortenstudie.
Rehabilitation 2003; 42: 335-342.

Brenner H, Hakulinen T, Gefeller O.
Computational realization of period analysis for monitoring cancer patient survival.
Epidemiology 2002; 13: 611-612.

Brenner H, Hakulinen T.
Very long term survival rates of patients with cancer.
Journal of Clinical Oncology 2002; 20: 4405-4409.

Brenner H, Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G.
Präventionspotenzial endoskopischer Vorsorgeuntersuchungen für kolorektale Karzinome. Evidenz aus internationalen Studien und aktuelle Ergebnisse der ersten epidemiologischen Studie aus Deutschland.
Deutsches Ärzteblatt 2002; 99: A 2186-2192. 

Günther KP, Puhl W, Brenner H, Stürmer T.
Klinische Epidemiologie von Hüft- und Kniegelenkarthrosen: Eine Übersicht über
Ergebnisse der „Ulmer Osteoarthrose-Studie“.
Zeitschrift für Rheumatologie 2002; 61: 244-249.

Stürmer T, Schlindwein G, Kleiser B, Roempp A, Brenner H.
Clinical diagnosis of ischemic versus hemorrhagic stroke: Applicability of existing scores in the emergency situation and proposal of a new score.
Neuroepidemiology 2002; 21: 8-17.

Brenner H, Hakulinen T.
Up-to-date long term survival curves of patients with cancer by period analysis. 
Journal of Clinical Oncology 2002; 20: 826-832.

Marre R, Scheringer I, Erb A, Zeitler H-P, Stürmer T, Brenner H.
Prävalenz der E. coli Antibiotikaresistenz in der Allgemeinbevölkerung.
Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2002; 45: 130-137.

Bode G, Marchildon P, Peacock J, Brenner H, Rothenbacher D.
Diagnosis of Helicobacter pylori in children: comparison of a salivary immunoglobulin G antibody test with the C13 urea breath test. Clinical and Diagnostic Laboratory Immunology 2002; 9: 493-495.

Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stürmer T.
Risk of gastric cancer among smokers infected with Helicobacter pylori.
International Journal of Cancer 2002; 98: 446-449.

Brenner H, Gefeller O, Hakulinen T.
A computer program for period analysis of cancer patient survival.
European Journal of Cancer 2002, 38: 690-695.

Stürmer T, Brenner H.
Flexible matching strategies to increase power to detect and efficiency to estimate gene-environment interactions in case-control studies.
American Journal of Epidemiology 2002; 155: 593-602.

Rothenbacher D, Fischer HG, Hoffmeister A, Hoffmann MM, März W, Bode G, Rosenthal J, Koenig W, Brenner H.
Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.
Atherosclerosis 2002; 162: 193-200. 

Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H.
Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study.
British Journal of Cancer 2002; 86: 1034-1040.

Brenner H, Söderman B, Hakulinen T.
Use of period analysis for providing more up-to-date estimates of long term survival rates: Empirical evaluation among 370.000 cancer patients in Finland.
International Journal of Epidemiology 2002; 31:456-462.

Rothenbacher D, Rüter G, Saam S, Brenner H.
Versorgung von Patienten mit Typ-2-Diabetes. Ergebnisse aus 12 Hausarztpraxen.
Deutsche Medizinische Wochenschrift 2002; 127: 1183-1187.

Rothenbacher D, Bode G, Brenner H. 
History of breastfeeding and Helicobacter pylori infection in pre-school children: results of a population based study from Germany.
International Journal of Epidemiology 2002; 31: 632-637.

Bode G, Brenner H, Adler G, Rothenbacher D.
Dyspeptic symptoms in middle-aged to old adults: The role of Helicobacter pylori infection, and various demographic and lifestyle factors.
Journal of Internal Medicine 2002; 252: 41-47.

Koenig W, Khuseyinova N, Hoffmann MM, März W, Fröhlich M, Hoffmeister A, Brenner H, Rothenbacher D.
CD14 C(-260) T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections, and risk of stable coronary artery disease.
Journal of the American College of Cardiology 2002; 40: 34-42.

Rothenbacher D, Winkler M, Gonser T, Adler G, Brenner H.
Role of infected parents in transmission of H. pylori to their children.
Pediatric Infectious Disease Journal 2002; 21: 674-679.

Stürmer T, Wang-Gohrke S, Arndt V, Boeing H, Kong X, Kreienberg R, Brenner H.
Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk of breast cancer. 
British Journal of Cancer 2002; 87: 519-523.

Stürmer T, Thürigen D, Spiegelman, D, Blettner M, Brenner H.
The performance of two measurement error correction methods and two standard methods of analysis in case-control studies with validation data: a simulation study.
Epidemiology 2002; 13: 507-516.

Rothenbacher D, Bode G, Brenner H.
Dynamics of Helicobacter pylori infection in early childhood in a high risk group living in Germany: loss of infection higher than acquisition.
Alimentary Pharmacology & Therapeutics 2002; 16: 1663-1668.

Bode G, Piechotowski I, Rothenbacher D, Brenner H.
Helicobacter pylori specific immune response of children: implications for future vaccination strategy.
Clinical & Diagnostic Laboratory Immunology 2002; 9: 1126-1128.

Brenner H, Hakulinen T.
Advanced detection of time trends in long term cancer patient survival: experience from 50 years of cancer registration in Finland.
American Journal of Epidemiology 2002; 156: 566-577. 

Burkhardt-Hammer T, Spix C, Brenner H, Kaatsch P, Berthold F, Hero B, Michaelis J.
Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany.
Medical and Pediatric Oncology 2002; 39: 156-162.

Brenner H.
Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.
Lancet 2002; 360: 1131-1135.

Aareleid T, Brenner H.
Trends in cancer patient survival in Estonia before and after the transition from a Soviet republic to an open market economy.
International Journal of Cancer 2002; 102: 45-50.

Hoffmeister A, Rothenbacher D, Khuseyinova N, Brenner H, Koenig W.
Plasminogen levels and risk of coronary artery disease.
American Journal of Cardiology 2002; 90: 1168-1170.

Rothenbacher D, Bode G, Gonser T, Adler G, Brenner H.
Prävalenz, Übertragung und Auswirkungen der Helicobacter pylori Infektion
bei Kindern. Ausgewählte Ergebnisse der Ulmer Studien.
Deutsches Ärzteblatt 2001; 98: A986-A989.

Stürmer T, Brenner H.
Matching and gain in power and efficiency in case-control studies.
Epidemiology 2001; 12: 101-108.

Brenner H, Bode G, Adler G, Hoffmeister A, Koenig W, Rothenbacher D.
Alcohol as a gastric disinfectant? The complex relation between alcohol consumption and current Helicobacter pylori infection. 
Epidemiology 2001; 12: 209-214.

Hoffmeister A, Rothenbacher D, Bäzner U, Fröhlich M, Brenner H, Hombach V, Koenig W.
Role of novel markers of inflammation in patients with stable coronary heart disease.
American Journal of Cardiology 2001; 87: 262-266.

Hoffmeister A, Rothenbacher D, Bode G, Persson K, März W, Nauck MA, 
Brenner H, Hombach V, Koenig W.
Current infection with Helicobacter pylori but not seropositivity to Chlamydia pneumoniae or cytomegalovirus is associated with an atherogenic modified lipid profile.
Arteriosclerosis, Thrombosis, and Vascular Biology 2001; 21: 427-432.

Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig H. 
Effect of alcohol consumption on systemic markers of inflammation.
Lancet 2001; 357: 763-767.

Rothenbacher D, Hoffmeister A, Bode G, Miller M, Koenig W, Brenner H.
Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids.
Atherosclerosis 2001; 156: 193-199.

Berg G, Bode G, Blettner M, Boeing H, Brenner H.
Helicobacter pylori infection and serum ferritin – a population based study among 1806 adults in Germany.
American Journal of Gastroenterology 2001; 96: 1014-1018.

Müller E, Stürmer T, Brenner H.
Alcohol intake and HDL cholesterol: comparison of food frequency questionnaire and diet record in a general population sample.
Journal of Epidemiology and Biostatistics 2001; 6: 297-303.

Brenner H, Rothenbacher D, Bode G, März W, Hoffmeister A, Koenig W.
Coronary heart disease risk reduction in a predominantly beer-drinking population.
Epidemiology 2001; 12: 390-395.

Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H.
Sociodemographic factors, health behavior and late stage diagnosis of breast cancer in Germany – a population based study.
Journal of Clinical Epidemiology 2001; 54: 719-727.

Brenner H, Gefeller O, Stegmaier C, Ziegler H.
More up-to-date monitoring of long term survival rates by cancer registries: an empirical example.
Methods of Information in Medicine 2001; 40: 248-252. 

Brenner H, Hakulinen T.
Long term cancer patient survival achieved by the end of the 20th century. Most up-to date estimates from the nationwide Finnish Cancer Registry.
British Journal of Cancer 2001; 85: 367-371.

Stürmer T, Brenner H, Brenner RE, Günther KP.
Non-insulin dependent diabetes mellitus and patterns of osteoarthritis- the Ulm Osteoarthritis Study.
Scandinavian Journal of Rheumatology 2001; 30: 169-171.

Brenner H, Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G.
Long lasting reduction of risk of colorectal cancer following screening endoscopy.
British Journal of Cancer 2001; 85: 972-976.

Koenig W, Rothenbacher D, Hoffmeister H, Griesshammer M, Brenner H.
Plasma fibrin D-dimer levels and risk of coronary artery disease: results of a large case-control study.
Arteriosclerosis, Thrombosis and Vascular Biology 2001; 21: 1701-1705.

Brenner H, Kaatsch P, Burkhardt-Hammer T, Harms DO, Schrappe M, Michaelis J.
Long term survival of children with leukemia achieved by the end of the 2nd millenium.
Cancer 2001; 92: 1977-1983.

Siebert U, Rothenbacher D, Daniel U, Brenner H.
Demonstration of the healthy worker survivor effect in a cohort of workers in the construction industry.
Occupational and Environmental Medicine 2001; 12: 774-779.

Stürmer T, Erb A, Keller F, Günther KP, Brenner H.
Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the role of half-life and other medications.
American Journal of Medicine 2001; 111: 521-527.

Bode G, Hoffmeister A, Koenig W, Brenner H, Rothenbacher D.
Characteristics of differences in Helicobacter pylori serology and 13C-urea breath testing in an asymptomatic sample of blood donors.
Scandinavian Journal of Clinical and Laboratory Investigation 2001; 61: 603-608.

Stöve J, Stürmer T, Kessler S, Brenner H, Puhl W, Günther KP.
Hysterectomy and patterns of osteoarthritis – the Ulm Osteoarthritis Study.
Scandinavian Journal of Rheumatology 2001; 30: 340-345.

Bode G, Rothenbacher D, Brenner H.
Helicobacter pylori colonization and diarrheal illness: Results of a population-based cross-sectional study in adults. 
European Journal of Epidemiology 2001; 17: 823-827.

Hoffmeister A, Rothenbacher D, Wanner P, Bode G, Persson K, Brenner H,
Hombach V, Koenig W.
Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease - negative results of a case-control study.
Journal of the American College of Cardiology 2000; 35: 112-118. 

Brenner H, Bode G, Boeing H.
Helicobacter pylori infection among offspring of patients with stomach cancer.
Gastroenterology 2000; 118: 31-35. 

Stürmer T, Brenner H.
Potential gain in efficiency and power to detect gene-environment interactions by matching in case-control studies.
Genetic Epidemiology 2000; 18: 63-80. 

Stürmer T, Glynn RJ, Kliebsch U, Brenner H.
Analytic strategies for recurrent events in epidemiologic studies:background and application to hospitalization risk in the elderly.
Journal of Clinical Epidemiology 2000; 53: 57-64. 

Brenner H, Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G.
Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric cancer.
Cancer 2000; 88: 274-279. 

Brenner H, Bode G, Adler G, Rothenbacher D.
Does maternal smoking hinder mother-child transmission of Helicobacter pylori infection?
Epidemiology 2000; 11: 71-75. 

Stürmer T, Günther KP, Brenner H.
Obesity, overweight and patterns of osteoarthritis: the Ulm Osteoarthritis Study.
Journal of Clinical Epidemiology 2000; 53: 75-81. 

Erb A, Brenner H, Günther KP, Stürmer T.
Hormone replacement therapy and patterns of ostheoarthritis: baseline data from the Ulm Osteoarthritis Study.
Annals of the Rheumatic Diseases 2000; 59: 105-109. 

Kliebsch U, Fleischle B, Busch S, Huchler U, Pfaff A, Brenner H.
Determinants of the utilization of financial versus professional aid for home nursing care in the German statutory nursing care insurance.
Zeitschrift für Gesundheitswissenschaften 2000; 8: 78-90. 

Kliebsch U, Siebert H, Brenner H.
Extent and determinants of hospitalization in a cohort of elderly disabled persons.
Journal of the American Geriatrics Society 2000; 48: 289-294. 

Rothenbacher D, Inceoglu J, Bode G, Brenner H.
Acquisition of Helicobacter pylori infection in a high risk population occurs within the first two years of life.
Journal of Pediatrics 2000; 136: 744-748. 

Rothenbacher D, Bode G, Brenner H.
Diagnosis of Helicobacter pylori infection with a novel stool antigen-based assay in children.
Pediatric Infectious Disease Journal 2000; 19: 364–366. 

Stürmer T, Brenner H.
Potential gain in precision and power by matching on strong risk factors in case-control studies: the example of laryngeal cancer.
Journal of Epidemiology and Biostatistics 2000; 5: 125-131. 

Bode G, Brenner H, Adler G, Rothenbacher D.
Helicobacter pylori infection, intake of analgesics or anti-inflammatory medication and personal factors in relation to dyspeptic symptoms in out-patients of a general practitioner.
British Journal of General Practice 2000; 50: 615-619. 

Rothenbacher D, Blaser MJ, Bode G, Brenner H.
An inverse relationship between gastric colonisation of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study.
Journal of Infectious Diseases 2000; 182: 1446-1449. 

Liese AD, Hense H-W, Brenner H, Löwel H, Keil U.
Assessing the impact of classical risk factors on myocardial infarction by rate advancement periods.
American Journal of Epidemiology 2000; 152: 884-888. 

Thürigen D, Spiegelman D, Blettner M, Heuer C, Brenner H.
Measurement error correction using validation data: a review of methods and their applicability in case-control studies.
Statistical Methods in Medical Research 2000; 6: 447-474. 

Fröhlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R,
Brenner H, Koenig W.
Association between C-reactive protein and features of the metabolic 
syndrome: a population-based study.
Diabetes Care 2000; 23: 1835-1839. 

Sun Y, Brenner H, Sauerland S, Günther KP, Puhl W, Stürmer T.
Serum uric acid and patterns of radiographic osteoarthritis – the Ulm Osteoarthritis Study.
Scandinavian Journal of Rheumatology 2000; 29: 380-386.